The role of the ezrin-radixin-moesin (ERM) proteins in development and post-injury responses of central nervous system neurons by Haas, MA
The role of the ezrin-radixin-moesin (ERNI) 
proteins in development and 
post-injury responses of central nervous 
system neurons 
by 
Matildai'Haas, BSc(Hons) 
Submitted in fulfilment of the 
requirement for the Degree of 
Doctor of Philosophy 
University of Tasmania (November, 2006) 
COPYRIGHT STATEMENT 
This thesis contains no material which has been accepted for a degree or diploma by the 
University or any other institution, except by way of background information duly 
acknowledged in the thesis, and to the best of my knowledge and belief no material 
previously published or written by another person except where due acknowledgement is 
made in the text of the thesis, nor does the thesis contain any material that infringes 
copyright. 
Matilda Haas 
STATEMENT OF AUTHORITY OF ACCESS 
This thesis may be made available for loan and limited copying in accordance with the 
Copyright Act 1968. 
1/1116f4,_ 
Matilda Haas 
111 
Part of the work submitted in this thesis has been published or submitted for publication 
as follows; 
M.A. Haas, J.A. Chuckowree, R.S. Chung, J.C. Vickers and T.C. Dickson. 
Identification and characterization of a population of motile neurons in long-term 
cortical culture. Cell Motility and the Cytoskeleton - in press 
M.A. Haas, J.0 Vickers and T.0 Dickson. Rho kinase activates ezrin-radixin-moesin 
(ERM) proteins and mediates their function in cortical neuron growth, morphology and 
motility, in vitro. Journal of Neuroscience Research - in press 
M.A Haas, J.0 Vickers and T.0 Dickson (2004) Binding partners Li cell adhesion 
molecule and the ezrin-radixin-moesin (ERM) proteins are involved in development and 
the regenerative response to injury of hippocampal and cortical neurons. European 
Journal of Neuroscience 20(6): 1436-1444. (Cover illustration) 
iv 
SUMMARY 
The ezrin-radbdn-moesin (ERM) family of proteins mediate diverse cytoskeletal 
processes, such as cell adhesion and morphology, as well as cell migration. These 
functions have primarily been elucidated in non-neuronal cell phenotypes, with only 
limited data pertaining to a role for ERM proteins in CNS neurons. The few studies 
examining ERM functions in neurons indicate that they contribute to important aspects 
of developmental neuron growth and morphogenesis; processes that must be precisely 
executed for the establishment of appropriate connectivity during brain development. 
Further alluding to their potential importance in the CNS was the identification of ezrin 
as a binding partner of the developmentally crucial cell adhesion molecule (CAM) Li. 
After completion of brain development, the mature CNS has very little capacity for 
regeneration and functional recovery following injury, partly because upon maturation 
neurons lose their intrinsic ability for substantial growth, but mainly because the mature 
nervous system environment is inhibitory to growth, particularly following traumatic 
injury. Therefore, a current and widely accepted theory is that recapitulation of aspects 
of CNS development is required for regeneration to occur in the more mature nervous 
system. Thus, investigation of developmentally significant proteins may provide clues 
as to the requirements for more mature CNS neurons to mount a regenerative response. 
This thesis investigated ERM protein function in CNS neurons, both during 
development and regeneration, with investigations focussed on ERM proteins' binding 
relationship with L 1. ERM proteins were specifically expressed during early neuronal 
morphogenesis, localised to areas associated with motility and growth, and they co-
localised with Li, particularly in the axonal growth cone. Perturbation of ERM proteins 
function utilising transfection of a dominant negative form of ezrin implicated ERMs in 
multiple aspects of development, including neurite initiation and outgrowth, growth 
cone morphology, neurite branching and neuron migration. Investigation of ERM 
function in models of injury to mature neurons demonstrated a re-expression of ERM 
proteins, potentially to participate in regenerative attempts, including neurite initiation 
and outgrowth, as well as post-injury neuron motility. Interrupting ERM activation 
using an inhibitor of Rho kinase significantly perturbed many of these developmental 
and post-injury functions, confirming a role for Rho kinase in ERM activation. These 
results show that ERM proteins play significant roles in aspects of neuronal growth and 
morphology in both developing and regenerating CNS neurons. Furthermore, 
elucidation of the roles of ERM proteins and Li show that common mechanisms are 
required for developmental and regenerative nervous system growth, which is important 
for uncovering potential mechanisms of regenerative growth, and identifying therapeutic 
targets for encouraging post-injury regeneration. 
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1 INTRODUCTION 
1.1 THE ERM PROTEINS 
The ezrin-radixin-moesin (ERM) family of proteins have previously been considered as 
general membrane-cytoskeleton linker proteins, abundant in dynamic structures such as 
microvilli, membrane ruffles and filopodia (Bretscher et al., 1983), in many cell types 
throughout the body. Their localisation reflects their function in facilitating cellular 
processes such as cell-cell and cell-substrate contacts, maintenance of cell shape, cell 
motility and membrane trafficking (Louvet-Vallee, 2000). More recently, they have 
been considered integral to signal transduction pathways and organisation of the cell 
cytoskeleton during processes of growth and motility. As recently described by 
Bretscher (1999), the `ERM proteins have emerged from relative obscurity to a 
prominence where they are proposed to play structural and regulatory roles in numerous 
plasma membrane based processes'. Furthermore, they are now becoming recognised 
for their importance in the CNS, particularly in developmental processes. 
1.1.1 The cell cytoskeleton 
The cell cytoskeleton lies directly beneath the plasma membrane and is required for 
establishment of polarity, determination of cell morphology, as well as attachment to 
other cells and the extracellular matrix via adhesion molecules (Bretscher, 1999). It 
functions in membrane trafficking, cell division, migration, growth regulation and 
differentiation (Bretscher, 1999). Its numerous and varied functions are testament to the 
fact that, rather than simply providing the cell with its structural framework, the 
cytoskeleton is a highly dynamic structure that constantly changes in response to the 
cells surrounding environment. 
The main constituents of the cell cytoskeleton are microfilaments, microtubules and 
intermediate filaments. Microfilaments consist of filamentous actin (F-actin) strands, 
which are made up of polymerised globular actin (G-actin) monomers (Bear, 2001). 
Actin filaments are densely localised to areas of high motility and growth, such as the 
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filopodia and lamellipodia of neuronal growth cones (section 1.2.2). They determine the 
shape of the cell and are required for whole-cell motility (Alberts et al., 2002). 
Microtubules are largely composed of tubulin molecules that consist of dimers of a- and 
13-tubulin proteins. They provide structural support during growth and in neurons are 
imperative to fast axonal transport. Microtubule associated proteins (MAPs, such as 
MAP2 and tau) coat the surface of microtubules and provide a link between 
microtubules and other cellular structures. Finally, there is a great diversity of 
intermediate filaments in different cell types, and in neurons they are more commonly 
referred to as neurofilaments (NFs), and include the neurofilament triplet and a-
internexin. In all cells they are responsible for providing a structural framework for the 
cell. They are mechanically very strong, and less dynamic than microfilaments and 
microtubules (Bear, 2001). 
In living cells, all three types of cytoskeletal filaments undergo continual remodelling 
through the assembly and disassembly of their subunits, with the assistance of accessory 
proteins, to grow or alter the cells shape or position in response to the changing 
environment. The ERM proteins link plasma membrane proteins to both actin and 
microtubule cytoskeletal components (Birgbauer and Solomon, 1989; Algrain et al., 
1993), and are likely to play important roles in cytoskeletal remodelling. 
1.1.2 ERM protein structure 
Ezrin, radixin and moesin are three proteins of approximately 82, 80 and 751cDa, 
respectively, that make up the ERM family of cytoskeletal-linker proteins (Bretscher et 
al., 1983; Lankes et al., 1988; Tsukita et al., 1989). They are grouped together due to 
their high degree of sequence homology, sharing between 70-85% amino acid identity. 
The ERM proteins also share a high level of homology (60%) with the protein merlin 
(moesin/ezrin/radixin-like). The ERMs and merlin belong to the band 4.1 superfamily, 
because they have 85% amino acid identity to the N-terminal half of human erythroid 
band 4.1 protein. The N-terminal domain of proteins belonging to the erythroid band 4.1 
superfamily is highly conserved, and has been named the FERM (four.1 protein, ezrin, 
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radixin, moesin) domain (Chishti et al., 1998). The FERM domain is common to many 
proteins that link proteins to the plasma membrane (Bretscher et al, 2002). 
Structurally, the proteins can be divided into three domains 1) a highly conserved N-
terminal FERM domain 2) a central alpha-helical domain that is predicted to form 
coiled-coils, and 3) a C-terminal domain (Figure 1.1 A). The N-terminal half of ezrin 
binds the cytosolic tails of plasma membrane proteins, via the FERM domain, which 
consists of a 298 amino acid domain that forms three structural modules that together 
form a compact clover-shaped structure (Pearson et al., 2000). The C-terminal half has 
an extended structure consisting of 107 amino acids, the last 34 of which bind to F-actin 
of the cell cytoskeleton (Algrain et al., 1993). Both the N- and C-terminal domains of 
the ERM proteins have protein-binding capacity, which indicated a cytoskeletal-linker 
function (Algrain et al., 1993). 
Like many cytoskeletal proteins, the ERM proteins' activity is regulated by 
conformation. In their inactive conformation, ERM N- and C-terminals self-associate 
(Figure 1.1 B), which conceals both the plasma membrane and F-actin binding sites 
(reviewed in Bretscher et al., 2002), and is commonly referred to as "head-to-tail" 
association. More specifically, 296 (1-296) amino terminal residues at the N-terminal 
domain known as N-ERMAD (N-ERM associated domain) interact with the 107 (479- 
585) residue C-terminal area known as C-ERMAD (C-ERM associated domain) 
(Bretscher et al., 1995; Gary and Bretscher, 1995). When ezrin is inactive, both the 
membrane binding FERM domain and the C-terminal actin binding sites are masked. In 
vivo, the proteins have also been shown to form intermolecular structures; dimers and 
oligomers, but their molecular mechanism and physiological relevance is still unknown 
(Tsukita et al., 1999). 
1.1.3 Regulation of activity 
While the abundance and biological activity of many proteins is controlled at the DNA 
or RNA level, ERM activity is controlled at the protein level. Approximately half of the 
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Figure 1.1 ERM structure and activation. A. Structurally, ERM proteins can be 
divided into three domains 1) a highly conserved N-terminal FERM domain 2) a 
central alpha-helical domain that is predicted to form coiled-coils, and 3) a 
C-terminal domain. The N-terminal binds plasma membrane proteins, via the 
FERM domain, which forms three structural modules that together form a compact 
clover-shaped structure (Pearson et al., 2000). The last 34 amino acids of the C-
terminal bind to F-actin (Algrain et al., 1993). B. In their inactive conformation, 
ERM N- and C-terminals self-associate, which conceals both the plasma membrane 
and F-actin binding sites, and is commonly referred to as "head-to-tail" association. 
More specifically, 296 (1-296) amino terminal residues at the N-terminal domain 
known as N-ERMAD (N-ERM associated domain) interact with the 107 (479-585) 
residue C-terminal area known as C-ERMAD (C-ERM associated domain) 
(Bretscher et al., 1995; Gary and Bretscher, 1995). When ezrin is inactive, both the 
membrane binding FERM domain and the C-terminal actin binding sites are masked. 
In vivo, the proteins have also been shown to form intermolecular structures; dimers 
and oligomers, but their molecular mechanism and physiological relevance is still 
unknown (Tsukita et al., 1999). Phosphatidylinositol 4,5 bis-phosphate (PIP 2) binding 
to the FERM domain, combined with phosphorylation of a specific C-terminal 
threonine (T558 is moesin, 1567 in ezrin and T564 in radixin) are involved in the 
activation of ERM proteins. The resultant open conformation allows binding to 
plasma membrane proteins and the cytoskeleton to occur. Figure adapted from 
Ivetic and Ridley, 2004. 
Chapter 1 — Introduction 
cellular ERM proteins exist in a soluble, inactive state in the cytoplasm, while the other 
half exist in their activated, insoluble conformation, associated with the cell cytoskeleton 
(Kondo et al., 1997). The inactive conformation is most likely alleviated by 
phosphatidylinositol 4,5 bis-phosphate (PIP 2) binding to the FERM domain, combined 
with phosphorylation of a specific C-terminal threonine (T558 in moesin, T567 in ezrin 
and T564 in radixin) (Figure 1.1 B). However, the specific order of events, species 
requirements, the differences between cell types and activation mechanisms in vitro and 
in vivo are so far unresolved. 
Evidence suggests that PIP2 binding to the N-terminal region is initially required, 
followed by phosphorylation of the C-terminal threonine (Fievet et al., 2004). The 
requirement for PIP2 in ERM activation was demonstrated when ERM mediated 
microvillar collapse occurred in L cells when PIP 2 was diminished (Yonemura et al., 
2002). However, the physiological site of PIP 2 binding remains unclear (Bretscher, 
2002). It is hypothesised that the binding site is in the FERM domain, but this seems 
controversial since much of the FERM domain is obscured in the proteins' inactive 
conformation. 
Phosphorylation at the C-terminal threonine site is thought to stabilise the active, open 
conformation by preventing interaction of the N- and C-terminal domains (Tsukita et al., 
1999). Several lcinases have been shown to phosphorylate the C-terminal threonine of 
ERM proteins, including PIP 2 (Matsui et al., 1999; Fievet et al., 2004), protein kinase C 
(PKCa and PK03) (Ng et al., 2001) and the Rho effector Rho kinase (also known as 
ROCK) (Matsui et al., 1998). One of the first experiments to show Rho kinase can 
phosphorylate ERM proteins was performed in Swiss 3T3 fibroblasts, where activation 
of RhoA led to increased ERM phosphorylation and the formation of cell surface 
structures (Shaw et al., 1998). In a hippocampal progenitor cell line, Jeon (et al., 2002) 
demonstrated that glutamate stimulates RhoA and Rho kinase dependent 
phosphorylation of moesin. However, whether Rho kinase phosphorylates ERM 
proteins in many cell types in vivo is not clear (Matsui et al., 1998; Yonemura et al., 
2002). Finally, a relative of Rho kinase, Myotonic dystrophy kinase-related Cdc42- 
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binding kinase (MRCK), has also been shown to phosphorylate moesin, initially in a 
cell-free system, and supported by dominant negative MRCK transfection experiments 
in NIH 3T3 cells (Nakamura et al., 2000). Louvet-Vallee (2000) reviewed ERM 
phosphorylation and concluded that moesin is phosphorylated by PKC-O, and 
ezrin/radixin by Rho kinase, however it is likely that the kinase(s) involved in ERM 
phosphorylation may be different depending on the cell type involved and the biological 
context. 
1.1.4 ERM localisation 
All three ERM proteins are localised in cells throughout the body (Bretscher et al., 1983; 
Franck et al., 1993), in actin rich surface structures such as microvilli, membrane ruffles 
and filopodia (Bretscher et al., 1983). Demonstrating the widespread tissue expression 
of the ERM proteins is that ezrin was first isolated from intestinal brush borders 
(Bretscher et al., 1983), radixin from rat liver (Tsukita et al., 1989), and moesin from 
smooth muscle cells of bovine uterus (Lankes et al., 1988). 
Melendez-Vasquez et al., (2001) examined the expression and distribution of the ERM 
proteins in Schwann cells and neurons of the PNS, in vitro and in vivo. Schwann cells 
expressed high levels of all three ERM proteins in the membrane, whereas neurons 
expressed lower levels of radixin and moesin. In vivo, the ERM proteins were 
concentrated at nodal processes of myelinating Schwann cells. A more recent study 
found ERM proteins localised in microvillar tips of Schwann cells during node 
formation (Gatto et al., 2003). Both studies implicate ERMs in the myelination process. 
Relatively few studies have examined the expression of ERM proteins in the CNS, but 
some studies suggest that ezrin, radixin and moesin are widely expressed in the adult 
human brain. Moesin is localised to areas such as the hippocampus, frontal cortex and 
white matter, cerebellum, spinal cord and leptomeninges (Stemmer-Rachamimov et al., 
1997), while ezrin is expressed in adult human cerebral cortex, basal ganglia, 
hippocampus, hypophysis and optic nerve (Gronhohn et al., 2005). 
5 
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Indicating a primarily developmental function for the ERM family proteins, peak 
expression of all three proteins occurs in late embryonic and early postnatal developing 
rat brain, according to Western blot studies (Paglini et al., 1998), and ezrin expression in 
mouse whole brain lysates disappears after one month of age (Gronholm et al., 2005). 
Mintz and colleagues (2003) examined ezrin expression in neonatal rat brain by 
immunoblotting at time-points between embryonic day 15 (E15) and post-natal day 0 
(PO), finding that ezrin was at peak levels between E17 and E19. Immunohistochemical 
analyses have demonstrated an abundance of ERM immunolabelling localised to the 
intermediate zone (Johnson et al., 2002; Mintz et al., 2003), a region present only in the 
developing brain composed of migrating cortical neurons and growing axons, which 
suggests a role for ERM proteins in these developmental processes. 
Recently, a study of ezrin localisation in developing and adult human, rat and mouse 
CNS, utilising both in vitro and in vivo analyses, reported that ezrin is predominantly 
expressed in astrocytes, with expression in neurons in more restricted locations in the 
brain (Gronholm et al., 2005). In neurosphere cultures ezrin was present in astrocytes, 
while expression was absent in neurons, and interestingly, ezrin was not present in 
primary hippocampal neuron cultures either (Gronholm et al., 2005). Another 
immunohistochemical study of human foetus did not reveal ezrin staining in neurons of 
the cortex (Johnson et al., 2002). Moesin is expressed by glia, such as oligodendrocytes, 
astrocytes (Stemmer-Rachamimov et al., 1997) and microglia, but not neurons (Johnson 
et al., 2002). In contrast, a number of in vitro studies have demonstrated expression of 
one or all three ERM proteins in various neuronal phenotypes, including dorsal root 
ganglion (Castelo and Jay, 1999), chick sympathetic neurons (Gonzalez-Agosti and 
Solomon, 1996), cerebellar granule cells (Cheng et al., 2005) and hippocampal neurons 
(Paglini et al., 1998; Dickson et al., 2002). 
At the sub-cellular level, localisation in neurons is of a membranous or diffuse 
cytoplasmic pattern (Stemmer-Rachamimov et al., 1997), and mostly confined to areas 
of high motility and growth, such as growth cone lamellipodia and filopodia (Paglini et 
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al., 1998; Castelo and Jay 1999; Dickson et al., 2002;), which strongly supports a role in. 
neurite outgrowth and the cytoskeletal remodelling associated with growth. 
1.1.5 ERMs link the cytoskeleton to plasma membrane proteins 
Experiments by Algrain et al., (1993) showed that when the individual N- and C-
terminal halves of ezrin were transfected into fibroblasts the C-terminal targets actin-
filament bundles, while the amino terminal targets the plasma membrane. These 
experiments identified the ERM proteins as cytoskeletal-linker proteins. 
1.1.5.1 Cytosolic proteins 
A 34 amino acid residue site on the C-terminal of ezrin was identified as an F-actin 
binding site (Algrain et al., 1993; Turunen et al., 1994), a site that is conserved in radixin 
and moesin (Pestonjamasp et al., 1995). This is the major actin-binding site, but one 
study has shown the capability of another sequence at the C-terminal of ezrin to bind G-
actin as well (Roy et al., 1997). Also, Birgbauer and Solomon (1989) demonstrated that 
ezrin almost completely co-localised with tubulin in the marginal band of erythrocytes, 
indicating that microtubules are another cytoskeletal binding partner of the ERM 
proteins. Recent data also suggests that ezrin may, at least transiently, associate with 
intermediate filaments in epithelial cells (Wald et al., 2005). 
1.1.5.2 Plasma membrane proteins 
ERM proteins can bind to plasma membrane proteins by either direct or indirect 
mechanisms (Louvet-Vallee, 2000). The first membrane-binding partner to be identified 
was CD44, as they directly co-localise in epithelial cells and fibroblasts, and further 
immunoprecipitation experiments showed a direct interaction between the ERM proteins 
and the cytoplasmic domain of CD44 (Tsulcita et al., 1994). Other membrane protein-
binding partners include CD43, ICAM-1-3, syndecan-2 (a heparan sulfate proteoglycan) 
and NHE-1. These membrane proteins do not share a universal cytoplasmic sequence 
recognised by the N-terminal FERM domain of the ERMs, their juxtamembrane 
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positively charged amino acid clusters are probably responsible for ERM binding 
(reviewed by Bretscher, 2000). 
Indirect attachments occur when proteins that span the membrane many times are 
attached via adaptors, such as the first discovered EBP5O/NHERF (Reczek and 
Bretscher, 1998). EBP5ONHERF interacts directly with the N-terminal of ezrin and 
moesin. Other adaptors have since been identified, including E3KARP (Yun et al., 
1998). The indirect linkage appears to be important for regulating the activity of ion 
transporters, regulating endocytosis of membrane proteins, and localisation of these 
proteins within the plasma membrane (reviewed by Bretscher, 2002). 
1.1.5.2.1 ERM proteins directly link Li CAM to the actin cytoskeleton 
Neural CAM families, including the integrin, cadherin and inununoglobulin families, are 
vital for normal development of the CNS, but almost certainly retain important functions 
throughout life. They are involved in many steps of axon guidance including initial 
outgrowth and growth cone formation, axon fasciculation, de-fasciculation, branching, 
target acquisition, and synapse formation and maintenance (Wiencken-Barger et al., 
2004). Also, CAMs are involved in neuronal migration that takes place during CNS 
development (section 1.2.3.1). A role for CAMs in the CNS neuronal response to stress 
(reviewed by Sandi et al., 2004) and trauma (for example, Roonprapunt et al., 2003) 
have been demonstrated more recently, and expression changes in age related 
pathologies have been investigated (for example, Yew et al., 1999; Strekalova et al., 
2006). 
Yeast two-hybrid analysis has recently revealed the CAM Li as a binding partner of 
ezrin (Dickson et al., 2002). Li, which is homologous with NILE (Stallcup and Beasley, 
1984; Bock et al., 1985) and Ng-CAM (Friedlander et al., 1986), is a well-studied neural 
CAM belonging to the inununoglobulin superfamily (see reviews by Hortsch, 1996; 
Walsh and Doherty, 1997; Kamiguchi, 2003). Li has demonstrated roles in many 
developmental processes including axon growth and guidance, neuron migration, cell 
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adhesion, axon pathfinding and axon fasciculation (Hortsch, 1996) and more recently 
has been implicated in neuronal morphogenesis (Dickson et al., 2002; Cheng et al., 
2005). Li is a 2001(Da, phosphorylated glycoprotein that is associated with the plasma 
membrane, and is comprised of 6 immunoglobulin domains, 5 fibronectin type III 
repeats, a single transmembrane spanning domain and a short cytoplasmic tail. The 
cytoplasmic tail may bind directly to ankyrin in the cell cytoskeleton, or may be linked 
to the cytoskeleton via another protein, such as the ERM proteins. Ezrin binds the 
cytoplasmic tail of Li, by its C-terminal RSLE sequence and juxtamembrane domain 
(Cheng et al., 2005). 
1.1.6 ERM Function 
1.1.6.1 Perturbation of ERM protein expression and activity 
One approach to studying the unique functions, expression and localisation of the 
individual ERM proteins has been the use of knockout mutants. Moesin and radixin 
knockout mice are both phenotypically normal (Doi et al., 1999; Kikuchi et al., 2002), 
only the radixin knockout shows some liver abnormalities (Kikuchi et al., 2002). 
Furthermore, disruption of moesin does not affect ERM-dependent functions, and does 
not result in increased expression of ezrin or radixin (Doi et al., 1999), indicating that 
the loss of one of the proteins is not compensated for by the upregulation of others. 
However, it has been shown that in vivo ERM localisation is tissue specific, which 
would suggest specific tissue related functions (Berryman et al., 1993). 
In vitro, cultured cells co-express the ERM proteins, and antisense oligonucleotide 
suppression of one of the three proteins does not have any phenotypic effects (Takeuchi 
et al., 1994). However, the suppression of all three ERM proteins abolishes cell-cell 
contacts, cell-substrate adhesion and microvilli in mouse epithelial and thymoma cells 
(Takeuchi et al., 1994). These data, combined with the high amino acid sequence 
homology of the proteins, may be indicative of redundancy of the individual proteins at 
the cellular level. 
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The variable expression patterns and possible functional redundancy of ERM proteins 
suggests that the reason for having all three proteins is that they are individually 
important at a particular stages of development (Johnson et al., 2002). Further 
investigation into this hypothesis may finally solve the puzzle surrounding the roles of 
individual ERM proteins. 
1.1.6.2 ERM proteins and intracellular signal transduction 
ERM proteins were previously considered general cross-linkers between the plasma 
membrane and actin cytoskeleton. However, more recently their role as intracellular 
signal transducers has been revealed. There is mounting evidence that the ERM proteins 
have multiple roles in the signal transduction pathways of the Rho family of GTPases. 
1.1.6.2.1 The Rho family of small GTPases 
The Rho family of small GTPases consists of seven identified proteins; Rho (A, B and C 
isoforms), Rac (1 and 2 isoforms), Cdc42 (Cdc42Hs and G25K isoforms), RhoD, RhoG, 
RhoE and TC10 (Mackay and Hall, 1998). The most widely studied are Rho, Rac and 
Cdc42 (Luo, 2000), which are known to trigger a variety of cellular responses, including 
reorganisation of the actin cytoskeleton (Hall, 1998). Given that the Rho GTPases are 
potent inducers of cellular changes, the activation of GTPases must be temporally and 
spatially controlled. Switching from the inactive, GDP-bound, to active GTP-bound 
state, combined with the displacement of RhoGDI, brings about the activation of Rho 
GTPases. This is facilitated by guanine nucleotide exchange factors (GEFs), or Rho 
GEFs (see reviews by Mackay and Hall, 1998; Bishop and Hall, 2000; Ivetic and Ridley, 
2004). Some Rho GEFs appear to be specific for individual GTPases, whereas others 
act on all three GTPases, such as Dbl (Rossman et al., 2005), a stimulatory GDP/GTP 
exchange factor of Rho family members. There are little data to explain the mechanism 
of activation of Rho GEFs by extracellular agonists. GTPase activating proteins (GAPs) 
switch Rho GTPases off, by stimulating their intrinsic GTPase. activity. 
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Rho, Rac and Cdc42 have been shown to control the organisation of the actin 
cytoskeleton in eukaryotic cells, implicating them in processes such as cell movement, 
axonal guidance, cytokinesis, and morphogenetic processes involving cell shape and 
polarity (Mackay and Hall, 1998). 
1.1.6.2.2 ERMs participate in Rho GTPase signal transduction 
Studies by Kotani et al., (1997) indicated that phosphorylation of ERMs during their 
activation, prior to translocation to the plasma membrane, was a Rho-dependent 
mechanism, and later Shaw and colleagues (1998) pinpointed RhoA as a requirement. 
Thus, direct inhibition of RhoA, using the toxin C3 transferase, resulted in inactivation 
of ERM proteins and a concomitant microvillar collapse (Yonemura et al., 2002). An 
example from another system is that ERM proteins and RhoA are localised to Schwann 
cell microvilli during node formation in the myelination process, which may indicate 
Rho-mediated activation of ERM proteins has a direct role in the process (Gatto et al., 
2003). 
Data relating to a role for ERM proteins in Rac and Cdc42 signalling are less abundant. 
However, a review of recent data identified that Rac and ERM proteins are both required 
for membrane ruffling and lamellipodial extension, and cell migration in phagocytes 
(Bretscher et al., 2002). Also, Rac regulates PIP 2 activation (Tolias et al., 2000), which 
in turn activates the ERM proteins. Recently, it was shown that Cdc42 and ERM 
proteins appear to be involved in the formation of filopodia, because transfection of NIH 
3T3 cells with constitutively active Cdc42 resulted in increased filopodia formation and 
phosphorylated ERM proteins at the tips of filopodia (Nakamura et al., 2000). 
Louvet-Vallee (2000) reviewed the data and proposed a model for the relationship 
between Rho GTPases and ERMs. Initially, extracellular signals activate Rho, which 
activates its targets and leads to an increase in PIP2 levels. PIP2 binds the N-ERMAD, 
inhibiting the intra-molecular association, and allowing the phosphorylation of the C-
terminal threonine, possibly by Rho kinase; thus activating and stabilising the ERM 
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molecule to function as a cross-linker between the plasma membrane and actin 
cytoskeleton. Then, once activated, ERMs can activate Rho, since the N-terminus 
interacts with Dbl. RhoGDI then displaces Dbl from ERM, and the new interaction 
leads to activation of Rho by releasing the GDI inhibition (Takahashi et al., 1997), 
allowing activation of Rho through exchange of GDP to GTP. Contrary to this report, 
Bretscher (2002) suggested that the radixin/Dbl interaction does not seem to have any 
activity, and suggests that instead, N-ERMAD binds directly to RhoGDI, which releases 
Rho, initiating Rho activation (Figure 1.2). 
1.1.6.3 Non-nervous system functions 
The ERMs participate in numerous processes, including the formation of microvilli, cell-
cell contacts, maintenance of cell shape, cell motility, and membrane trafficking 
(Louvet-Vallee, 2000), in a wide range of cell phenotypes throughout the body. 
1.1.6.3.1 Cell morphology 
Early experiments implicated ERM proteins in the formation of cell surface structures 
and regulation of cell shape. For example, antisense oligonucleotide suppression of 
individual ERM proteins in mouse epithelial and thymoma cell lines resulted in the 
abolition of microvilli (Takeuchi et al., 1994) and expression of chimeras containing the 
ERM-binding regions of CD44, CD43 or ICAM-2 in fibroblasts has been shown to 
result in the elongation of microvilli (Yonemura et al., 1999), indicating some of the 
ERM relationships involved in cell surface structure formation. Ezrin perturbation by 
micro-CAL! (chromophore assisted laser inactivation) in Fos-transformed and normal 
Rat-1 fibroblasts blocked membrane ruffling or caused a collapse of the cells leading 
edge, respectively, identifying roles for ezrin in both pseudopodial extension and 
maintenance of cell shape (Lamb et al., 1997). Recently, it has also been shown that 
inactivation of the ERM proteins in lymphocytes causes microvillar collapse, a 
necessary preceding step to lymphocyte migration (Nijhara et al., 2004). 
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Figure 1.2 A model for the relationship between Rho GTPases and ERMs. 
Initially, extracellular signals activate Rho, which activates its targets and leads to 
an increase in PIP 2 levels. PIP2 binds the ERM N-terminal site, inhibiting the intra-
molecular association, and allowing the phosphorylation of the C-terminal 
threonine, possibly by Rho kinase (1); allowing the ERM molecule to link plasma 
membrane proteins to the actin cytoskeleton (2). Then, once activated, ERMs can 
activate Rho, since the N-terminus interacts with Dbl, a stimulatory GDP/GTP 
exchange factor of Rho family members. RhoGDI then displaces Dbl from ERM, 
and the new interaction leads to activation of Rho by releasing the GDI inhibition 
(Takahashi et al., 1997), allowing activation of Rho through exchange of GDP to 
GTP. Alternatively, N-ERMAD may bind directly to RhoGDI, which releases Rho, 
initiating Rho activation (3). Figure adapted from Louvet-Vallee, 2000; Ivetic and 
Ridley, 2004. 
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1.1.6.3.2 Localisation of membrane proteins 
Yonemura et al., (1993) first demonstrated that CD43 and ERM proteins co-localised in 
cleavage furrows of dividing cells, but more recent results also suggest that ERM-CD43 
binding in lymphocytes results in re-localisation of CD43, excluding the molecules from 
the immunological synapse, which is required for T cell activation (reviewed by 
Bretscher et al., 2002; Gautreau et al., 2002). Similarly, natural killer cells need to 
recruit ICAM-2 to their uropod before they are activated by IL-2. This recruitment is 
dependent on ezrin, and cells that lack ezrin have uniform distribution of ICAM-2 
(Helander et al., 1996, reviewed by Bretscher et al., 2002). ERM proteins also recruit 
CAMs to the lymphocyte uropod in mechanisms of cell motility. The uropod is a 
structure that forms at the rear edge of the cell body, and is concentrated with adhesion 
molecules including CD43, CD44, ICAM-1 and ICAM-3, as well as members of the 
ERM family (section 1.1.6.3.3). 
1.1.6.3.3 Cell motility 
Tsukita et al., (1994) demonstrated a direct interaction between ERM proteins and the 
broadly distributed cell surface glycoprotein CD44, in baby hamster kidney cells. The 
CD44-ezrin linkage has subsequently been shown to be important for directional cell 
motility (Legg et al., 2002). Phosphorylated ERM proteins are involved in the migration 
of lymphocytes, as they are localised to the uropod (reviewed by Lee et al., 2004). In 
some situations, the uropod is considered the "sticky" part of the cell, which may 
contain the concentration of surface adhesion molecules that would slow migration if 
located at the leading edge of the cell (reviewed by Lee et al., 2004), or alternatively, 
CAMs may be clustered on the uropod to act as a platform for the recruitment of other 
leucocytes during migration (reviewed by Ivetic and Ridley, 2004). ERM proteins are 
involved in the localisation of these CAMs to the uropod, as demonstrated by Lee and 
colleagues, who showed that introduction of a constitutively active form of ezrin results 
in augmentation of uropod morphology and other processes associated with motility 
(Lee et al., 2004). In addition, overproduction of wild-type ezrin enhances the motility 
of epithelial cells (Crepaldi et al., 1997). Finally, a potential role for ERM proteins in 
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tumour progression has arisen recently, particularly in cell invasion and metastasis, 
probably due to its roles in cell motility, as well as survival and proliferation (reviewed 
by Gautreau et al., 2002; Sahai and Marshall, 2003). 
1.1.6.4 The role of ERM proteins in CNS neurons 
There is limited, but compelling, data implicating a functional role for the ERM proteins 
in neurons, particularly during late embryonic and early post-natal development (Mintz 
et al., 2003). It was originally demonstrated that the abundance and association of ezrin 
with the neuronal cyto skeleton increases upon the onset of neuronal differentiation, and 
was particularly enriched in the growth cone (Birgbauer et al., 1991). Later, Gonzalez-
Agosti and Solomon (1996) showed that the withdrawal of nerve growth factor (NGF) 
from chick sympathetic neurons induced rapid growth cone collapse, with a concomitant 
decrease in radixin labelling. In contrast, the addition of NGF resulted in rapid growth 
cone formation and re-localisation of radixin. Castelo and Jay (1999) used the micro-
CALI technique to cause localised inactivation of radixin in dorsal root ganglion (DRG) 
neuronal growth cones. This resulted in a 30% reduction in the area of growth cone 
lamellipodia, indicating a role for radixin in lamellipodial stability in growth cone 
motility and neurite outgrowth. In another study of cultured hippocampal neurons, 
antisense oligonucleotide suppression of radixin and moesin resulted in a reduction of 
growth cone size, disappearance of radial striations, reduction of growth cone 
lamellipodia, disorganisation of actin filaments, and failure to produce an axon, thus 
severely effecting the morphology, motility, and process formation of growth cones 
(Paglini et al., 1998). Interestingly, the same effects were not observed when ezrin-
radixin or ezrin-moesin was inactivated. 
Dickson and colleagues (2002) investigated the function of Li -ERM binding in neurons 
by using neuronal transfection of a dominant negative form of ezrin. Most mammalian 
ERM function has been examined using the dominant negative ezrin, where the protein 
is truncated to comprise only the amino-terminal FERM domain (for example, Crepaldi 
et al., 1997). Hippocampal neurons transfected with the dominant negative form of 
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ezrin and grown on an Li substrate for 72 hours exhibited increased axonal branching 
compared with those grown on a poly-l-lysine or laminin substrate. This result indicated 
a role for the L 1-ERM-actin linkage in the generation of normal neuronal 
morphogenesis, cytoskeleton stabilisation and appropriate axonal arborisation during 
early neuronal development. Also, irrespective of growth substrate, the dominant 
negative ezrin transfection resulted in an abnormal number of fine protrusions on neurite 
shafts (Dickson et al., 2002). This is in agreement with several studies in non-neuronal 
cells that have shown that expression of only N-terminal or C-terminal halves of the 
protein lead to the formation of long surface structures, indicating that the full-length 
protein has a role in aspects of cell morphology (Henry et al., 1995; Martin et al., 1995; 
Mackay et al., 1997; Martin et al., 1997). It has subsequently been shown that 
transfection of cells with a truncated form of Li, therefore interrupting the L 1-ERM 
linkage, causes morphological abnormalities in neurite branching in cultured cerebellar 
granule cells (Cheng et al., 2005). 
Furthermore, Mintz et al., (2003) showed that Li and ERM co-localise in the embryonic 
brain, but after birth this transfers to Li and ankyrin co-localisation, indicating a switch 
in the predominant cytoskeletal-linker protein used by Ll. But interestingly, this study 
also reported that Li and ERMs co-localise in the embryonic brain during a period of 
rapid axon growth and cortical expansion. In particular, they co-localise in the 
intermediate zone, a developmental structure that is densely packed with migrating 
neurons and growing axons, further supporting a role for Li and ERM in neuron growth, 
but also suggesting a role in neuron migration. 
While ERM protein expression and functions within the nervous system have gained 
little attention so far, investigations strongly support their importance, particularly in the 
developing nervous system. ERM proteins are likely to be involved in crucial aspects of 
cortical development, including neuron migration and growth, due to their localisation in 
the CNS, and previously identified functions in cytoskeletal remodelling and signal 
transduction in non-neuronal cell types. 
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1.2 CORTICAL DEVELOPMENT 
During evolution the higher vertebrates developed a larger cerebral cortex, with the 
outermost layer named the neocortex (meaning new cortex). A notable feature of the 
neocortex is the sorting of neurons in the outer region into six horizontal layers. This 
layered organisation is conserved over the entire surface of the brain, but can be more 
distinct in certain areas of the neocortex and can range in thickness (Nolte, 2002). Layer 
I, at the pial surface is the molecular layer, layer II the external granular layer, layer III 
the external pyramidal layer, layer IV the internal granular layer, layer V the internal 
pyramidal layer, layer VI, the multiform layer (Figure 1.3). The names reflect the cell 
types that predominantly reside in each layer. Perhaps most remarkable is the fact that 
early neurons must undergo a highly co-ordinated migratory journey from their 
birthplace in order to take up these specific positions, which is sometimes a considerable 
distance. For instance, in the primate brain distances required to migrate can reach up to 
several thousand micrometres (Rakic, 2003). Neurons then develop multiple neurites, 
the axon and dendrites, which extend and form synaptic connections with other cells, 
establishing CNS circuitry. 
1.2.1 Neuron migration 
Neurons destined to form the neocortex are generated at the ventricular lining and 
periventricular zones. More specifically, cortical pyramidal neurons are generated in the 
germinal ventricular zones of the dorsal telencephalon, whereas sources of cortical 
interneurons include the lateral ganglionic eminence (LGE) and medial ganglionic 
eminence (MGE) of the ventral telencephalon (reviewed by Parnavelas, 2000; Kriegstein 
and Noctor, 2004). Due to the locations of their generation, cortical pyramidal neurons 
generally follow a relatively radial path to their position in the neocortex, while 
interneurons must travel circuitously and a greater distance. 
The migratory routes and modes of migration are more complex than previously thought 
(Kriegstein and Noctor, 2004). Post-mitotic neurons migrate toward the margin of the 
cerebral wall to form the primordial plexiform layer, or preplate. Subsequently born 
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Figure 1.3 Laminar structure of the neocortex. Schematic representation of the 
six layers of the neocortex that form during CNS development. The names of each 
layer reflect the cell types that predominantly reside in that layer. Early neurons 
must undergo a highly co-ordinated migratory journey from their birthplace in 
order to take up these specific positions. Figure adapted from Bear et al., 2001; 
Nolte, 2002. 
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neurons migrate into the preplate and as they accumulate form a new series of layers 
called the cortical plate, which splits the preplate into a superficial marginal zone (layer 
I) and a deeper layer, the subplate (layers II-VI). The later born post-mitotic neurons 
that form layers II-VI of the cortical plate are arranged in an 'inside-out' sequence, 
where new cells migrate through the existing cells before stopping at the top of the plate 
(reviewed by Parnavelas, 2000; Kriegstein and Noctor, 2004). The subplate and 
ventricular zone are separated by the intermediate zone, which will eventually contain 
the axons of the cortex (Bielas and Gleeson, 2004) (Figure 1.4). 
Recent advances in live imaging techniques have lead to the identification of the 
characteristics of neuron migration through the cortex at the cellular level. Two modes 
of migration, radial and tangential migration, have been described (Nadarajah et al., 
2001). A third mode of migration, termed 'multipolar migration' may also exist (Tabata 
and Nakajima, 2003). 
1.2.1.1 Radial migration 
Neurons of the cerebral cortex, such as those destined to become pyramidal neurons, 
take on a mode of radial migration, moving in a direction perpendicular to the pial 
surface. However, recent studies have shown that it is not an entirely smooth, 
directionally focussed process, as neurons pass through transitory phases in which they 
may alter cellular morphology, direction and speed of movement (Kriegstein and 
Noctor, 2004). Two characteristic modes of movement during radial migration have 
been defined, and they have been categorised as translocation and locomotion. 
In translocation, cells migrate from the ventricular zone after establishing a long pia-
directed process that forms a stable attachment to the pial surface. This indicates that 
the migratory route is determined before the cell exits the ventricular zone (Nadarajah et 
al., 2001). The translocating cell moves its nucleus and other contents of the soma 
radially within this fixed leading process to reach its appropriate position in the cortex. 
As the soma advances toward the pial surface the leading process becomes progressively 
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Figure 1.4 A. Radial migration. Neurons of the cerebral cortex arise in the 
ventricular zone, which lies at the surface of the lateral ventricles, and migrate 
toward the margin of the cerebral wall to form the preplate. Subsequently born 
neurons migrate into the preplate and as they accumulate form a new series of layers 
called the cortical plate, which splits the preplate into the marginal zone (layer I) and 
a deeper layer, the subplate (layers II-VI). The later born neurons that form layers 
II-VI of the cortical plate are arranged in an 'inside-out' sequence, where new cells 
migrate through the existing cells before stopping at the top of the plate 
(represented by darker green). The subplate and ventricular zone are separated by 
the intermediate zone, which will eventually contain the axons of the cortex. 
B. The two major modes of cortical migration. In translocation (left), cells 
migrate from the ventricular zone after establishing a long pia-directed process 
that forms a stable attachment to the pial surface. The translocating cell moves its 
nucleus and other contents of the soma radially within this fixed leading process to 
reach its appropriate position in the cortex. In locomotion (right), freely migrating 
cells have a relatively short, free leading process that remains a fairly constant 
length. Locomoting cells move along radial glia as they receive directional 
guidance signals. Figure adapted from Bides et al., 2004. 
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shorter and thicker, since its terminal remains attached to the pial surface, while the 
trailing process remains short. Translocating cells do not require glial guides and move 
with a smooth action, progressing about 60Rm/hour (Nadarajah et al., 2001). 
Radial glial cells are mitotically active, giving rise to neuronal precursors that utilise a 
mode of migration termed locomotion (reviewed by Chotard and Saleeker, 2004). 
Locomoting cells are free migrating cells that in contrast with translocating cells have a 
relatively short, free leading process that remains a fairly constant length, and migrate 
along radial glial guides. Locomoting cells move along radial glia as they receive 
guidance signals (Nadarajah et al., 2001). Neurons show a saltatory pattern of short 
bursts of forward migration (Nadarajah et al., 2003), with an average speed of 
locomotion of 35Rtn/hour, slower than translocating cells because their movement is 
saltatory rather than smooth (Nadarajah et al., 2001). 
It has been suggested that translocation is the mode of migration utilised during the 
earliest stages of neocortical development, and that glial-guided locomotion becomes 
more common in later stages (Nadarajah et al., 2001; Kriegstein and Noctor, 2004). It is 
also thought that translocation is the older form of migration, with locomotion arising 
only when the cortex became larger, and the 'inside-out' pattern of the neocortex 
developed. Studies of migration disorders lend support to this idea, where in some cases 
cortical layer formation is disturbed, but migration in the deeper parts of the cortex is 
unaffected (Nadarajah et al., 2003). For example, in mice lacking the Rho family kinase 
Cdk5 or its activator, p35, the preplate and early cortical plate form normally, but later-
generated cortical neurons collect below the subplate in abnormal positions (Chae et al., 
1997; Gilmore et al., 1998). 
1.2.1.2 Tangential migration 
Not all precursor neurons are able to reach their appropriate destination by radial 
migration alone and therefore are required to migrate tangentially. An example is early 
neurons of the rostral migratory stream (RMS), which migrate from the subventricular 
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zone of the anterior forebrain rostrally, to form interneurons of the olfactory bulb 
(reviewed by Guan and Rao, 2003). In addition, many cells migrate using a combination 
of tangential and radial migration. Interestingly, tangentially migrating neurons move at 
about 50[tm/hour, generally more rapidly than those migrating radially (reviewed by 
Kriegstein and Noctor, 2004). 
It is still unclear what signals guide neurons undergoing tangential migration. However, 
in contrast to radial migration, cells appear to be attached to one another or axons, rather 
than glial cells, forming chains of migrating neurons (Lois et al., 1996). A number of 
guidance cues contribute to tangential migration, including those of CAM, neuregulin, 
semaphorin and slit families (Kriegstein and Noctor, 2004), which are probably 
strategically placed along migration pathways. Particularly high numbers of tangentially 
migrating neurons have been observed in the subventricular zone and lower intermediate 
zone, regions probably rich in signals that influence migration of both interneurons and 
pyramidal cells (Kriegstein and Noctor, 2004). 
1.2.1.3 Multipolar migration 
Tabata and Nakajima (2003) reported the presence of a previously undescribed 
population of multipolar cells in the intermediate zone of the developing brain that did 
not resemble cells migrating by locomotion or translocation. These cells did not exhibit 
fixed cell polarity, extending and retracting processes in a dynamic manner and changed 
direction frequently. Multipolar cells were not highly associated with radial fibers, 
unlike cells undergoing locomotion. In addition, immunocytochemical studies 
suggested that the cells were not tangentially migrating neurons, but were early-
generated cortical projection neurons (that would normally undergo radial migration). 
Multipolar cells migrated very slowly toward the pial surface compared with other 
modes of migration, at a net directional speed of 2.2m/hour toward the pia. The 
authors reported that 88% of cells in the intermediate zone exhibited multipolar 
migration, suggesting that it is a major mode of migration. However, upon leaving the 
intermediate zone the cells were likely to switch to locomotion. 
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Nadarajah and colleagues may have previously observed this phenomenon (2001; 2002), 
describing a population of cells that were bipolar at onset of migration from the 
ventricular zone, but took on a multipolar form when reaching the intermediate zone. 
These neurite processes were highly motile, and often formed then retracted branches, 
which may indicate sensing of directional guidance cues. The cells then continued 
radial migration or migrated tangentially. Their identity and site of origin remains 
unclear, but they were likely to be interneurons (reviewed by Nadarajah et al., 2003). It 
is still unclear whether this is a legitimate form of migration undertaken by neurons in 
the intermediate zone and the neuronal phenotype involved is also unresolved. 
However, a recent review by LoTurco and Bai (2006) suggests that this is a true stage of 
migration, potentially undertaken by all migrating pyramidal neurons, and may be a 
phenomenon that reflects the competitive interaction between migrating cells for limited 
radial glial scaffolding to guide them to the cortical plate. 
1.2.2 Axon outgrowth 
After completing migration a neuron enters a phase of growth, the first stage of which 
involves developing multiple neurites. One process grows more rapidly than the others, 
becoming the axon, while the other shorter, highly branched processes become 
dendrites. The axon elongates, seeking out its path to its appropriate target by 
integrating information from multiple signals in the environment, in particular molecular 
guidance cues. The axon is able to sense and respond to this information through its 
terminal structure known as the growth cone. 
Growth cones (Figure 1.5) are highly dynamic structures that sense the surrounding 
environment and integrate signals to consolidate the direction of axon growth. They are 
so sensitive that they are capable of detecting a concentration difference as small as one 
molecule across their spatial extent (Rosoff et al., 2004). Structurally, they consist of 
long, slender highly dynamic sensory protrusions called filopodia, which rapidly extend 
and retract while seeking out molecular guidance signals. Filopodia are composed 
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Figure 1.5 The neuronal growth cone. A. Scanning electron microscopy image 
of a hippocampal neuron growth cone, showing distinct filopodia and lamellipodia. 
B. Diagrammatic representation of the growth cone. The peripheral (P) domain 
consists of long slender, highly dynamic filopdial protrusions, which contain F-actin, 
longitudally arranged in bundles, but very few microtubules. Lamellipodia are broad, 
fan shaped structures which consist of crosslinked F-actin, and microtubules. The 
central (C) domain contains F-actin and microtubules. Figure adapted from 
Gungabissoon and Bamburg, 2003. 
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primarily of F-actin, with very few microtubules present. Lamellipodia are the broad, 
flat, fan-like structures of the growth cone, which contain F-actin and microtubules, but 
not intermediate filaments. In combination, the filopodia and lamellipodia form the 
actin rich peripheral domain of the growth cone. The central domain of the growth cone 
contains both actin and microtubules (reviewed by Tanaka and Sabry, 1995). 
In both filopodia and lamellipodia actin filaments are arranged so that their fast growing 
ends are oriented toward the periphery of the cell (Lewis and Bridgeman, 1992) and 
actin polymerisation at the tips of filopodia results in extension of the axon (reviewed by 
Selzer, 2003). The re-arrangements and extension of actin filaments and microtubules in 
response to extracellular guidance cues result in axon outgrowth. 
1.2.3 Guidance cues 
In the past two decades, countless CNS molecular guidance cues have been discovered 
(for example, Table 1.1), and their roles in axon guidance during development have been 
described. Less is understood about the molecular mechanisms guiding neuronal 
migration (Wu et al., 1999), however, the same molecular cues that guide axon 
outgrowth and targeting are also involved in neuronal migration (Song and Poo, 2001). 
The main disparity is that in axon guidance, the guidance cue acts on the growth cone, 
whereas in migration it is not yet clear whether molecules only act on the growth cone, 
or whether they also act on the cytoskeleton of the cell body. This may be an important 
factor accounting for different responses to the same molecular guidance cues. The 
following sections describe the effects of individual molecular guidance cues on axon 
outgrowth and neuron migration. 
1.2.3.1 Neural Cell Adhesion Molecules 
The ability of a neuron to extend its axon and innervate targets is to a large extent 
governed by binding of CAMs on the growth cone to CAMs on the surface of other 
axons and non-neuronal cells (Skaper et al., 2001). In some cases, the binding of CAMs 
provides strong enough adhesive interactions between the cell and its substrate to create 
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Table 1.1 Classification of molecular guidance cues* 
Family Class Members Receptors Section(s) 
Cell Adhesion Ig Superfamily Li homophilic 1.2.3.1 
Molecules 
(CAMs) 
NCAM 
PSA NCAM 
binding, 
Integrins 
1.3.3.1 
Extracellular Laminins laminin-1 Integrins 1.2.3.2 
Matrix CSPGs NG2 undetermined 1.3.2.2.1 
Molecules 
(ECMs) 
versican 
neurocan 
brevican 
phosphacan 
1.3.3.1.1 
Slits Slit-1 Robo • 
Slit-2 
Netrins Netrin- 1 DCC 1.2.3.3 
Netrin-2 UNC-5 
Ephrins ephrin A's ephrin A5 Eph A 1.2.3.4 
ephrin B's ephrin B2 Eph B 
Semaphorins Sema 3A — neuropilins 1.2.3.5 
3F plexins 1.3.3.1.2 
Sema 6A 
Myelin 
associated 
inhibitors 
MAG 
Omgp 
Nogo 
Nogo 1.3.2.2.2 
*A summary of the guidance cues discussed in this thesis. 
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enough tension to pull the growth cone forwards, causing axon growth (Lamourex et al., 
1989). CAMs are also important for forming adhesive interactions between cells and the 
substrate during the migration of cells in multiple systems throughout the body, 
including neurons during early CNS development. 
1.2.3.1.1 Li 
Much of the information about Ll's role in axon growth and guidance has been provided 
by the analysis of patients with Ll genetic mutations (for example Fransen et al., 1995; 
Wong et al., 1995). In such patients, the phenotype can include absence or diminuation 
of two major axon tracts; the corticospinal tract (CST) and the corpus canon= (Wong 
et al., 1995). This has also been demonstrated in vitro for numerous neuronal 
phenotypes, where assays have shown increased outgrowth of axons grown on an Li 
substrate (for example Doherty et al., 1995; Kamiguchi and Yoshihara, 2001). 
Furthermore, Ll function blocking antibodies perturbed neurite outgrowth and caused 
pathfinding errors in sensory axons (Honig et al., 2002). 
Studies of Li deficient mice have provided examples of cross-talk between guidance 
cues. Li was identified as a component of the Sema 3A receptor complex with 
Neuropilin-1 (NP-1), the receptor complex must be internalised for Sema 3A to have its 
repulsive action, and therefore cortical axons from Li-deficient mice fail to respond to 
Sema 3A signals (Castellani et al., 2000; 2004). Similarly, growth cone collapse 
stimulated by Ephrin B was abolished when retinal axon growth cones were co-
stimulated with Li, showing that axon guidance molecules impinge on each other to 
modulate growth cone responses (Suh et al., 2004). 
Several lines of evidence support a role for Li in neuron migration, which was originally 
identified when Li antibodies disrupted the migration of cerebellar granule cells, in vitro 
(Persohn and Schachner, 1987; Asou et al., 1992a; Miura et al., 1992). Additionally, rat 
cerebellar granule cells co-cultured on a substrate of Li-expressing astrocytes showed 
increased migration compared with neurons cultured with control astrocytes (Yazaki et 
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al., 1996) and an Li substrate increased the speed of migration of cerebellar neurons 
(Asou et al., 1992b). Immunohistochemistry has shown that in vivo Li is expressed by 
migrating neurons in the developing neocortex (for example, Fushiki and Schachner, 
1986; Godfraind et al., 1988; Mintz et al., 2003). 
Li knockout mice have also demonstrated the role of Li in the migration and 
organisation of dopaminergic neurons in brain development (Demyanenko et al., 2001), 
while cortical neurons and cortical lamination appeared normal in Li-minus mice 
(Demyanenko et al., 2001). NCAM, and its polysialated form PSA-NCAM are close 
relatives of Li, and both have been implicated in neuron migration, because NCAM and 
PSA-NCAM mutant mice show reduction in size of the olfactory bulb, due to the 
decreased migration of neuronal precursors which accumulate in the RMS, never 
reaching the bulb (reviewed by Sobeih and Corfas, 2002). 
1.2.3.2 The Extracellular Matrix 
The extracellular matrix (ECM) is a complex network of proteins and polysaccharides 
that fills the intercellular space. Key components of the ECM include laminins, 
chondroitin sulphate proteoglycans (CSPGs), slits, collagens, tenascins, fibronectin and 
reelin. Cells produce all components of the ECM, and are in turn affected by them 
(Sobeih and Corfas, 2002). The ECM influences development of the nervous system, 
including axonal guidance and neuron migration. The ECM may 1) contribute to the 
formation of gradients of attractants or repellents 2) allow for the combined presentation 
of some regulatory signals 3) regulate the formation of brain structures necessary for 
migration, such as axon tracts 4) modulate the signalling of receptors for guidance or 
migration modulating cues (Sobeih and Corfas, 2002). 
1.2.3.2.1 Laminins 
Laminins are considered amongst the most potent, well-studied, but least understood 
neurite-outgrowth promoting families (Grimpe and Silver, 2002). Although it is not 
commonly specified, most studies have investigated the functions of Laminin-1. 
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Knockouts of one subunit of laminin are not viable, with the failure to assemble the 
earliest basement membranes of the endoderm (Smyth et al., 1999). In the nervous 
system, laminin is transiently expressed during development, localised to the outer pial 
surface where pioneering axon tracts commonly form (Hopker et al., 1999), primarily in 
extracellular locations, associated with Schwann and astroglial cells. Whether neurons 
express laminin remains controversial (Grimpe and Silver, 2002). Latninin is virtually 
undetectable in the adult brain, except for the hippocampus (reviewed by Colognato et 
al., 2005). They have long been recognised for their involvement in developmental 
processes including neuronal differentiation (Tate et al., 2004), cell polarisation 
(Matsuzawa et al., 1996; Yurcheno and Wadsworth, 2004) and neurite outgrowth 
(Kearns et al., 2003; Turney and Bridgman, 2005), and it has been widely demonstrated 
that laminin, or specific laminin peptides, support neurite outgrowth, in vitro (for 
example Bixby et al., 1989; Freire et al., 2002; Liu et al., 2002; Adams et al., 2005; 
Turney and Bridgeman, 2005). 
Laminins are also involved in neuron migration, localised to radial glial fibers along the 
routes of migrating neurons and axons (reviewed by Liesi, 1990). Mutations in 
basement membrane laminin in the developing CNS lead to abnormal neuron migration 
and lissencephaly. Neural progenitor cells from the ganglionic eminence grown on a 
number of substrates show significantly enhanced migration on laminin (Tate et al., 
2004) and laminin also promotes significantly increased cell migration velocity (Kearns 
et al., 2003). Laminin, present in the developing cerebellum, acts as a permissive 
migratory substrate for granule cell precursors to migrate from the external granule cell 
layer into the internal granule cell layer (Pons et al., 2001), and function blocking 
antibodies inhibit cerebellar granule cell migration in vitro (Liesi et al., 1995). 
1.2.3.2.2 Chondroitin Sulfate Proteoglycans (CSPGs) 
CSPGs are components of the ECM, generally classified as growth inhibitory molecules 
that function by restricting axon growth to inappropriate targets (Treloar et al., 1996; 
Laabs et al., 2005) and serving as choice points for growing axons. For example, in the 
25 
Chapter I — Introduction 
developing CNS, retinal ganglion cells (RGCs) grown on laminin stop and turn to avoid 
a CSPG substrate (Snow et al., 1991). In addition, the presence of CSPGs causes 
reduced cell attachment, neurite outgrowth, neurite initiation and rates of growth cone 
migration (Snow et al., 1996). In the more mature CNS, CSPGs are associated with 
plasticity, and are inhibitory to regeneration, being a major component of the glial scar 
that inhibits axon regeneration (section 1.3.2). 
The effect of CSPGs on neuron migration has not been widely studied. Neural crest 
cells avoid regions containing CSPGs at several points in their pathway, and inhibition 
of CSPG synthesis causes them to make aberrant trajectories (Kubota et al., 1999). The 
CSPG versican has also been shown to inhibit migration of neural crest cells (Landolt et 
al., 1995). 
1.2.3.2.3 Slits 
Slits are bifunctional ECM molecules, which bind to Roundabout (Robo) 
transmembrane receptors expressed on target neurons (Kidd et al., 1999). Early slit 
mutant studies showed disorganisation of axons at the midline, which was consistent 
with a role in either the development of midline cells or axon guidance (Rothberg et al., 
1990). Slits are now known to be involved in multiple pathways of axon projection 
(including hippocampal, retinal, olfactory, spinal motor and commissural axons) and 
neuron migration (including the RMS and neocortex) (Patel et al., 2001; Yanamoto et 
al., 2002). They may also regulate axonal branching (Wang et al., 1999). 
Demonstrating their bifunctional nature and complexity of action is that slits can repel 
axons from the spinal cord of Xenopus, as well as modestly promoting their outgrowth, 
in vitro (Stein and Tessier-Lavigne, 2001). Furthermore, the spatial and temporal 
regulation of expression of netrin- deleted in colorectal cancer (DCC) and slit-robo 
systems prevents conunissural growth cones that have already crossed the midline from 
re-crossing (Stein and Tessier-Lavigne, 2001; reviewed by Chotard and Selecker, 2004). 
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Slit proteins can repel various classes of migrating neuronal cells in vertebrates (Hu, 
1999; Wu et al., 1999; Zhu et al., 1999). They are repellent for the migration of both 
interneuron precursors from the anterior subventricular zone in the telencephalon to the 
olfactory bulb, and GABA-containing neurons from an extracortical region to the 
neocortex (Zhu et al., 1999; Song and Poo, 2001). Experimentally, extracellular 
gradients of Slit-2 cause a reversal in the direction of migration without affecting 
migration speed (Xu et al., 2004). Uniform application of slit to growth medium of 
subventricular zone explants causes a significant reduction in the number of neurons 
migrating out of the explants (Mason et al., 2001), which indicated that slit was 
inhibitory to migration, but later experiments by Ward et al., (2003) showed that slit was 
a repellent in neuron migration rather than inhibitory. Slits are repulsive for anterior 
subventricular zone cells, since in vitro assays showed that cells migrated away from the 
source of slit (Wu et al., 1999) and application of slit expressing cells to the top of the 
RMS in brain slices results in complete abolition of migration to the olfactory bulb (Wu 
et al., 1999). 
1.2.3.3 Netrins 
The first family of guidance cues to be identified in the vertebrate nervous system was 
the netrins. Serafini et al., (1994) purified Netrin-1 and Netrin-2, secreted molecules 
related to laminin, from embryonic chick brain and demonstrated their ability to promote 
growth of commissural axons. Later, the importance of netrins was demonstrated in 
Netrin-1 deficient mice, which lack the main forebrain commissures; the corpus 
callosum, hippocampal commissure and the anterior conunissure (Serafini et al., 1996). 
In the developing brain, Netrin-1, the most studied of the family, is expressed in the 
ventral region of the spinal cord, and the midline and ventral ventricular zones (reviewed 
by Barallobre et al., 2005). 
Netrins have since been shown to be bifunctional guidance molecules; attractive to some 
axons but repulsive to others. For example, netrin cues help attract commissural axons 
to the ventral midline but repel motor axons from the same region (Chisolm and Tessier- 
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Lavigne, 1999). Two different classes of membrane receptors are involved in mediating 
netrin attractive/repulsive actions; DCC, which mediate the chemoattractive functions 
and the UNC-5 family of receptors, which mediate repulsive functions. 
More recent experiments investigating netrin function have illustrated the complexity of 
axon guidance in the developing and adult brain. Firstly, in Xenopus young retinal 
axons are attracted to the optic nerve by Netrin-1, whereas later in development it repels 
the same axons (reviewed by Barallobre et al., 2005). Furthermore, although Netrin-1 is 
attractive to axons, in the presence of Laminin-1 this attraction is converted to repulsion 
(Hopker et al., 1999). 
There is evidence for a role for netrins in neuron migration, in several areas of the brain 
where migration is observed, particularly for dopaminergic neurons of the midbrain, 
cerebellar granule cells and in the RMS, both in development and throughout life 
(reviewed by Barallobre et al., 2005). In addition, netrins direct the migration of basilar 
pontine neurons from their origin to the ventral midline (Yee et al., 1999) and repel 
neurons that migrate from the anterior forebrain to the olfactory bulb (Wu et al., 1999; 
Liu and Rao, 2003). They also play a role in the laminar organisation of the cerebellum 
(reviewed by Hedgecock and Norris, 1997). 
1.2.3.4 Ephrins 
Ephrins are membrane bound, chemorepellent guidance molecules that have been 
implicated in axon pathfinding, causing collapse and repulsion of growth cones, as well 
as neuronal migration (reviewed by Sobeih and Corfas, 2002). In the adult nervous 
system epluins have a role in synaptic plasticity, partly through the regulation of actin 
dynamics during dendritic spine morphogenesis (Penzes et al., 2003, Murai et al., 2003). 
Ephrin A's are linked to the membrane by a GPI linkage, whereas ephrin B's are 
transmembrane proteins. Ephrin receptors are Eph A and Eph B. Generally, ephrin A's 
show an affinity toward Eph A receptors, while ephrin B's have an affinity for Eph B 
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receptors (reviewed by Klein, 2004). The same set of receptors are involved in both 
growth cone pathfinding and neuron migration (Song and Poo, 2001). 
In vitro, ephrins repel RGC axons (Nakamoto et al., 1996; Monschau et al., 1997) and 
are involved in the formation of the retinotectal map. Ephrin A5 acts as a repulsive 
signal for neurons in the upper cortical layers, but has no axon guidance function for 
cells in the deeper cortical layers, instead promoting axon branching in some cortical 
neurons (Castellani et al., 1998). Ephrins may cause growth cone collapse in stripe 
assays, but in other instances promote cell outgrowth or cell migration (reviewed by 
Chisolm and Tessier-Lavigne, 1999), which provides another example of the complexity 
of molecular guidance cue action. 
The ephrins and their receptors appear to be important for providing short-range 
repulsive cues in guiding the migration of neural crest cells, as well as differentiated 
neurons such as cerebellar granule cells (Sobeih and Corfas, 2002; Klein, 2004). For 
example, ephrin B2 and its receptor EphB2 are expressed in the external granule layer of 
the cerebellum specifically at the onset of migration of post-mitotic cerebellar granule 
cells toward the internal granule layer, which combined with the loss of responsiveness 
to the chemoattractive chemokine SDF-la (Lu et al., 2001), induces granule cell 
migration. 
1.2.3.5 Semaphorins 
The semaphorins are predominantly chemorepellent membrane-associated or secreted 
proteins, and fibroblasts are their main source of expression in the nervous system 
(Grimpe and Silver, 2002). Sema 3A was the first member of the family to be 
discovered, and was originally called Collapsin-1, due to its ability to induce growth 
cone collapse and paralysis (Luo et al., 1993). Their receptor classes include neuropilins 
(NP's) and plexins. 
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Polleux et al., (1998) demonstrated a number of properties of semaphorin action, 
including 1) that cortical neurons respond to a gradient of Sema 3, 2) that Sema 3 can act 
as a diffusible chemorepellent to cortical axons, and 3) that endogenous Sema 3 
contributes to directed cell growth of cortical axons. Finally, they showed that in vivo, 
approximately half of the neurons in the Sema 3 null mice display aberrantly oriented 
apical dendrites and axons, indicating Sema 3 is required for appropriate morphological 
development. 
However, semaphorins and their receptors do not always have repellent actions. For 
example, recently it was shown that Sema 3B is involved in the formation of two 
pathways of the anterior commissure, actually by attracting some axons, which was in 
contrast to the role of Sema 3F in the same system (Julien et al., 2005). In many cell 
types, including sensory ganglion cells, Sema 3A causes growth cone collapse and axon 
repulsion, but retinal ganglion cell growth cones are unresponsive. In addition, Sema D 
is chemorepellent to cortical axons, whereas Sema E acts as an attractive guidance cue to 
cortical axons (Bagnard et al., 1998). These data demonstrate that semaphorin 
interactions in the developing CNS cannot always be categorised as repellent. 
More recently, semaphorins have been implicated in neuron migration. Tamamaki et al., 
(2003) showed that placing COSI cells expressing Sema 3A or Sema 3F on neocortical 
slices reduced, but not completely blocked, the migration of GABA neurons from the 
ganglionic eminence. However, cell migration was almost completely blocked when 
cell clusters expressing both Sema 3A and Sema 3F were applied. Similarly, cortical 
interneurons do not enter the striatum in part due to Sema 3A and Sema 3F expression 
(Mann et al., 2001). In other experiments, mice deficient of the transmembrane 
semaphorin, Sema 6A, were shown to have mostly normal cerebellar development, with 
the exception of aspects of granule cell migration (Kerjan et al., 2005). In combination, 
their results suggested a role for Sema 6A specifically in the control of initiation of 
cerebellar granule cell radial migration. Semaphorins also promote cell movement in 
other systems, such as endothelial cells during remodelling of the vasculature (reviewed 
by Kruger et al., 2005). 
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1.2.4 The intracellular response to guidance cues 
Amongst other intracellular signalling molecules, the Rho family of small GTPases 
regulate cell motility. In general, Rho activation is inhibitory to neurite growth, while 
Rae and Cdc42 activation promote neurite outgrowth. There is mounting evidence from 
in vitro studies that Rho GTPases are involved in cell migration via their action on the 
actin cytoskeleton (Bar-Sagi and Hall, 2000). Migrating cortical neurons transfected 
with dominant negative and constitutively active Cdc42 and Racl show significantly 
inhibited radial migration (Konno et al., 2005). 
It is becoming clear that Rho GTPase activity in neuron growth and migration is 
modulated by guidance cues. For example, it has been shown that Rho GTPases play a 
role in Sema 3A induced growth cone collapse, as introduction of dominant negative 
Racl into DRG neurons attenuates their response to Sema 3A (Jin and Strittmatter, 
1997). Similarly, Kuhn et al., (1999) demonstrated that Sema 3A induced collapse of 
motor neuron growth cones is mediated by Rae 1. Ephrin AS induced growth cone 
collapse occurs through the activation of Rho and Rho kinase (Wahl et al., 2000). Rho 
GTPases are involved in Netrin-1 dependent neuronal migration (Causeret et al., 2004), 
and brain derived neurotrophic factor (BDNF) attraction is mediated by Cdc42 
activation in developing neurons. This is a relatively new area of research and these 
data represent the beginnings of our knowledge about the relationship between 
molecular guidance cues and intracellular signalling. 
1.2.5 CNS development and regeneration may share common mechanisms 
The importance of understanding CNS developmental mechanisms has taken on a new 
perspective in recent years. It is now thought that for neuronal regrowth to occur 
following injury a similar set of events must occur. Consequently, there is now a focus 
toward understanding the mechanisms of axon growth and pathfinding, as well as 
neuron migration, and the attractive and inhibitory factors that would influence the 
ability of the mature nervous system to undergo functional regeneration. Furthermore, 
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whether mature neurons respond to molecular guidance cues the same way as they do 
during development is uncertain, and is therefore the subject of recent investigation. 
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1.3 CNS INJURY AND THE REGENERATIVE RESPONSE 
Without manipulation, the adult mammalian CNS has a very limited capacity for 
regeneration after injury, when compared with the embryonic CNS, the PNS, and the 
CNS of lower vertebrates. If CNS neurons do survive injury, sprouting axons extend 
only for very short distances, about one millimetre, before they cease growing and 
degenerate at the lesion border (reviewed by Stichel and Muller, 1998). A number of 
factors account for the inability of the CNS to regenerate, including the susceptibility of 
neurons to death after injury, a reduced capacity for post-mitotic neuron growth, and the 
absence of appropriate neurotrophic factors and permissive guidance cues. The glial or 
astrocytic scar acts as a physical barrier to regrowth. Also, the mature CNS environment 
contains chemical inhibitory factors, such as components of mammalian 
oligodendrocytes, CNS myelin and repulsive guidance cues. 
It is now thought that that in order to regenerate, particular environmental and cellular 
aspects of the developmental nervous system must be recapitulated (see recent review by 
Harel and Sttittmatter, 2006). Identification of important cytoskeletal proteins and 
growth promoting or inhibitory factors during development and within the post-injury 
milieu will facilitate investigation into possible manipulation of the cellular response to 
injury, with the ultimate aim being to induce functionally significant regeneration in the 
injured nervous system. 
1.3.1 The intrinsic capacity for mature CNS growth and regeneration 
In the past there was a firm belief that the mature nervous system was remarkably 
unadaptable compared with the developing nervous system, and axons and dendrites 
retained very little potential for plasticity and could not undergo growth. However, over 
two decades ago, David and Aguayo (1985) reported significant evidence supporting 
that mature neurons retain the ability to grow, but instead inhibition was due to their 
environment. When they provided the injured CNS with a peripheral nerve graft, CNS 
neurons were able to regenerate. More recent studies using varied approaches to aid 
regeneration have supported this theory (reviewed by Fawcett and Geller, 1998). 
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Indeed, there are a number of examples demonstrating the plasticity of the mature CNS, 
including the ability of neurons derived from stem cells to integrate into existing 
neuronal circuitry, that axons can sprout into denervated regions and collateral sprouting 
can occur following injury, as well as the non-injury related dynamic nature of dendritic 
spines and synapses in the mature CNS (reviewed by Chuckowree et al., 2004). 
1.3.1.1 Expression of developmentally significant cytoskeletal proteins 
For the mature nervous system to mount a regenerative response to injury, the 
expression of components required for the assembly of new cytoskeletal structures 
would be required. Indeed, some investigations, particularly in in vitro models of axonal 
injury, have demonstrated experimental application, re-expression and re-localisation of 
growth-associated cytoskeletal proteins, including GAP-43 (for example, Christman et 
al., 1997; Avwenagha et al., 2003; Zhang et al., 2005; Ikegami et al., 2005), CAP-23, 
MAP 1B (Emery et al., 2000; reviewed by Bulsara et al., 2002), tau (Chuckowree and 
Vickers, 2003), a-internexin (Dickson et al., 2005), 13-III-tubulin (McKerracher et al., 
1993; Avwenagha et al., 2003; Chuckowree and Vickers, 2003), F-actin (Avwenagha et 
al., 2003; Chuckowree and Vickers, 2003) and phosphorylated neurofilament 
(Chuckowree and Vickers, 2003). Furthermore, when the microtubule stabilising and 
destabilising agents, taxol and nocodazole, respectively, were applied to transected 
cortical axons in vitro, the result in both cases was a substantial negative effect on the 
post-injury sprouting response (Chuckowree and Vickers, 2003), indicating the 
importance of cytoskeletal components in regenerative growth. 
1.3.2 Inhibition of regeneration in the mature CNS 
1.3.2.1 The glial scar 
In the hours to weeks after CNS injury takes place, a number of different cell types, all 
with different roles in the post-injury response, infiltrate the injury site. The main cell 
types involved include astrocytes, microglia, oligodendrocyte precursors, meningeal 
cells and stem cells. Cells recruited to the injury site fill the vacant space forming a 
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zone of reactive gliosis. This reactive gliosis is characterised by a dense web of 
interlacing glial processes that form within a lesioned area (Stichel and Milner, 1998) 
forming a physical barrier to regeneration, as well as having inhibitory biochemical 
properties that hinder regenerative growth. Glial reactions peak at about two to three 
weeks post-injury, but may persist for up to two years (reviewed by Stichel and Muller, 
1998). The properties of the glial scar, and the growth inhibitory properties of 
oligodendrocytes and CNS myelin are amongst the more completely understood 
inhibitors of regeneration. 
1.3.2.2 Inhibitory molecules of the injured CNS 
There are two main sources of inhibitory molecules in the post-injury environment. The 
first is the cells of the glial scar, which secrete inhibitory guidance molecules, including 
ECM molecules of the CSPG family. The second source is myelin, the breakdown 
products of which may be inhibitory to neurite growth, and thus regeneration. 
1.3.2.2.1 CSPGs 
CSPGs are produced by reactive astrocytes, oligodendrocyte precursor cells and 
meningeal cells of the glial scar (reviewed by Fawcett and Asher, 1999; Tang, 2003; De 
Winter et al., 2002) and are thought to be inhibitory to regeneration in the mature 
nervous system based on at least three interrelated findings; 1) they inhibit axon growth 
in vitro, 2) there is considerable expression of CSPGs in the injury site and 3) disruption 
of CSPGs in tissue culture models of the glial scar reduces inhibition of regeneration 
(reviewed by Morgenstern et al., 2002). Expression of the CSPGs NG2, brevican, 
neurocan, versican and phosphacan is upregulated following brain injury has been 
demonstrated in numerous investigations (McKeon et al., 1991; reviewed by 
Morgenstern et al., 2002; Jones et al., 2003), and in a recent review, Tang (2003) 
speculated that elevated levels of CSPGs may prove to be the ultimate stumbling block 
for any neuronal regeneration. 
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CSPGs interact with a number of molecules on the cell surface and extracellular matrix, 
with complex and varied effects, compounding the difficulties of determining 
mechanisms of inhibition (Tang, 2003). To this end, a number of studies using different 
approaches have successfully inhibited CSPGs to facilitate neurite outgrowth. For 
example, chondroitin sulfate (CS) degrading enzyme improved axonal regeneration and 
brought about functional recovery of spinal cord axons when the enzyme was applied to 
rats subjected to spinal cord injury (Bradbury et al., 2002). Similarly, digestion of 
CSPG by chondroitinase ABC promoted axonal regeneration in the rat nigrostriatal 
system (Moon et al., 2001), and suppression of CSPG signalling through particular Rho 
pathway members is successful in increasing axon regeneration (Jain et al., 2004). 
In a glial scar model used by McKeon and colleagues (1991), nitrocellulose filters 
implanted in the injured rat cerebral cortex were removed and used as a substrate for 
neurite growth in vitro. The filters contained a large amount of CSPG and were very 
poor substrates for neurite outgrowth. However, treatment of the filters with a CSPG 
enzyme increased neurite outgrowth. 
Interestingly, one mechanism by which NG2 (a CSPG) inhibits regeneration is by 
binding laminin and, thereby inhibiting laminin's neurite growth promoting ability (Burg 
et al., 1996). Furthermore, the presence of Li on a mixed substrate of laminin and NG2 
abolished the inhibitory effects of NG2 (Dou and Levine, 1994). These interesting data 
demonstrate the complexity of interaction of molecular guidance in the mature CNS, 
much like during development. In another example, a fibroblast bridge expressing 
CSPGs, Li and laminin was permissive to regeneration, indicating that a balance of 
inhibitory and permissive cues in favour of permissive cues is required for regeneration 
and it is perhaps not necessary to completely abolish inhibitory cues (Jones et al., 2003). 
1.3.2.2.2 Myelin inhibitors 
Myelin derived inhibitors of axonal regeneration include myelin associated glycoprotein 
(MAG), Nogo and oligodendrocyte myelin glycoprotein (Omgp) (Qiu et al., 2000; 
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reviewed by Grados-Munro and Fournier, 2003). While all three proteins are quite 
different, they have been shown to bind to the same receptor, the Nogo receptor (NgR) 
(reviewed by Watkins and Barres, 2002). This was an exciting discovery for the field of 
regeneration as blocking the receptor provides an ideal target for regeneration-promoting 
strategies. 
MAG is released when the myelin sheath surrounding injured neurons degenerates, but 
interestingly, it is not inhibitory to embryonic neurons, in vitro (Tang et al., 2001). Its 
inhibitory properties in mature brain injury and regeneration have been widely 
demonstrated using a variety of approaches. For example, when animals are immunised 
with myelin they extensively regenerate axons, with some functional recovery (Huang et 
al., 1999). In contrast, others have reported, MAG may not be a major contributing 
factor to inhibition of regeneration, since in vivo, axons can grow through degenerating 
myelin (reviewed by Stichel and Muller, 1998), and MAG deficient mice do not show 
improved regeneration (Bartsch, 1996). However, it is unlikely to be a coincidence that 
the PNS has a much better regenerative ability than the CNS, and MAG is ten times 
more abundant in the CNS than PNS (Trapp 1988; 1990, reviewed by Filbin, 2006). 
1.3.3 The role of molecular guidance cues in the post-injury regenerative response 
Many developmental guidance molecules (section 1.2.3) and their receptors show 
continued expression in the mature nervous system, suggesting that these molecules play 
a role in the CNS throughout life. However, there appears to be differences in the 
distribution patterns of these molecules, and additionally, CNS injury appears to induce 
changes in the expression of guidance molecules such as CAMs and semaphorins. Thus, 
a question that is currently being asked is whether the expression and action of these 
guidance cues can be manipulated to result in a recapitulation of the orderly events that 
occurred during the development of the CNS in order to encourage regeneration in the 
mature nervous system (Koerberle and Bahr, 2004). 
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1.3.3.1 Li 
The CAM Li has been proposed to play a role in repair attempts after injury. In an early 
study, optic nerve crush in the fish resulted in a 25% increase in Li immunoreactivity 
(shown by radioimmunoassay) (Blaugrund et al., 1990). Subsequently, Poltorak and 
colleagues (1993) showed that frontal cortical lesions promoted an increase in Li (and 
N-CAM) expression in the striatum. Similarly, after axotomy of CST axons expression 
of Li (and a number of other growth-associated molecules) was up-regulated seven days 
post-injury (Mason et al., 2003). 
In more recent years, a number of studies have examined the effects of applying, or 
experimentally up-regulating Li in the injured nervous system. For example, Woolhead 
and colleagues (1998) showed that when Purkinje cells, which do not normally 
regenerate into peripheral nerve grafts or express GAP-43 or Li, were engineered to 
express Li or GAP-43, they showed an enhanced axonal sprouting response into a 
peripheral nerve graft. Cells expressing both Li and GAP-43 showed more extensive 
sprouting within the weeks after injury and graft implantation (Zhang et al., 2005). 
In vivo studies of spinal cord injury have also supported a role for Li in enhancing nerve 
regeneration. For example, Ll transfected embryonic stem cells injected into the spinal 
cord after compression injury showed greater survival, and extended longer processes, 
increased migration and populated the lesion site (Chen et al., 2005). Another 
interesting study involved intrathecal Li administration for two weeks after spinal cord 
contusion, which resulted in significantly increased locomotory recovery in rats, 
compared with controls. However, regeneration of CST axons was not extensive, and 
the authors concluded that Li promoted locomotory recovery via a different mechanism, 
such as regeneration of non-CST motor-related descending tracts, protection and 
survival of axons, prevention of apoptosis or other changes in the distal cord, including 
the locomotor pattern generator, or even myelination of axons (Roonprapunt et al., 
2003). This study therefore suggests that Li 's role in regeneration may not strictly be 
due to its axon outgrowth promoting properties. In agreement with this study, antisense 
morpholino oligonucleotides used to knockout L1.1 (homolog of human L1) after spinal 
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cord injury in adult zebrafish resulted in impaired functional recovery, regrowth and 
synapse formation, compared with controls, indicating that L1.1 is an important part of 
the regenerative response (Becker et al., 2004). 
Recently, Adcock and colleagues (2004) demonstrated the importance of Li in axon 
guidance during nerve regeneration. At the CNS / PNS interface there is a boundary 
between astrocytes and Schwann cells. Axons will cross from astrocytes to Schwann 
cells, but not vice versa. The authors hypothesised that this may be either due to the 
presence of CSPGs, or because Li is produced by Schwann cells but not astrocytes. 
Abolishing CSPGs did not alter the effect. However, manipulation of Li by transfection 
into astrocytes increased the proportion of axons able to cross the boundary, indicating 
that Li is an important factor in this system. In contrast, a recent report has shown that 
when comparing E9 and EIS brainstem axons, providing the more mature EIS axons 
with an Li substrate after injury did not substantially increase regenerative growth 
(Blackmore and Letourneau, 2006). 
1.3.3.1.1 Laminins 
Positive staining for laminin in the adult CNS is rare (Grimpe and Silver, 2002). 
However, as in the developing nervous system, specific laminin peptides have neurite 
growth promoting ability, and therefore are being considered as useful agents for 
facilitating the same functions in the injured CNS. They may be useful for the repair of 
damaged neurons, such as in tissue engineering strategies, to support directed growth 
across the CNS lesion and glial scar (reviewed by Meiners and Mercado, 2003). 
1.3.3.1.2 Semaphorins 
The semaphorin family of molecular guidance molecules are well known for their potent 
chemorepellent properties during CNS development and recent studies have shown 
Sema 3A to play a predominantly repulsive guidance role in axon regeneration. High 
levels of Sema 3A expression in various CNS injury models have been reported. For 
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example, olfactory bulbectomy, as well as penetrating injuries to the lateral olfactory 
tract, cortex, perforant pathway and spinal cord induce proliferation and migration of 
fibroblasts-like cells expressing high levels of Sema 3A mRNA (Pasterkamp et al., 
1998a; 1999), preventing regenerating axons from entering the scar. In contrast, after 
axotomy of the olfactory nerve there is local and transient increased Sema 3A 
expression, which may induce a molecular boundary for regenerating neuron growth 
rather than inhibiting growth altogether (reviewed by Grimpe and Silver, 2002). 
Interestingly, PNS neurons, which have a much better capability for regeneration than 
CNS neurons, appear to downregulate Sema 3A in response to injury (Pasterkamp et al., 
1998b; reviewed by De Winter et al., 2002), a result which may indicate Sema 3A 
repulsion as a key inhibitor of CNS regeneration. 
1.3.4 Strategies to improve post-injury regeneration 
A comprehensive approach to the restoration of CNS function following injury is a 
complex task, as it would need to include: the rescue of neurons from death; replacement 
of dead and dying neurons; prevention of axonal disruption; promotion of axonal 
regeneration; remyelination of regenerated axons and the restoration of anatomical 
connections to recovered function (Selzer, 2003). Therapeutic approaches that restore 
the extracellular CNS environment of the neuron, characteristic of a more embryonic 
state, increasing axon regeneration and improving functional recovery after injury are 
gaining popularity. 
Current molecular strategies under investigation include the use of neutralising 
antibodies against growth inhibitory molecules, as used to inhibit the action of CSPGs 
(section 1.3.2.2.1), addition of growth promoting factors, such as Li (section 1.3.3.1), 
manipulation of the expression of important growth-promoting cytoskeletal components, 
modification of signalling cascades and preventing or removing the glial scar. Other 
strategies may include transplantation and cellular approaches, such as the use of 
peripheral nerve grafts, or transplantation of foetal tissue, stem cells, or ensheathing 
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cells. Each approach could potentially have a significant contribution and it is 
commonly recognised that a combination of therapies would be required to encourage 
functional regeneration. 
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1.4 PROJECT AIMS 
While the mechanisms of nervous system development are gradually being elucidated, 
much less is understood about how the more mature CNS responds to injury; or what 
therapeutic approaches may successfully promote regeneration. One way to address this 
issue is to identify molecules particularly important to the development of the CNS, and 
their specific mechanisms of action, as they are likely to be highly indicative of the 
requirements for regenerative growth in the more mature nervous system. Relatively 
little is known about the functions of the ERM proteins in the CNS, but they appear to 
mediate many processes that are important for appropriate neuronal development. 
Further, alluding to their developmental significance, their functions are potentially 
mediated by interaction with the crucial neural CAM Ll. Therefore, this thesis will 
investigate the role of ERM proteins in nervous system development and the reactive 
and regenerative response to traumatic injury. 
Aim! 
To investigate the specific expression of ERM proteins, throughout neuronal 
morph ogenesis. 
There has not previously been a comprehensive study that has examined the localisation 
of ERM proteins in CNS neurons throughout their development and maturation. 
Therefore, immunocytochemistry will be utilised to determine the localisation of total 
ERM proteins, as well as the phosphorylated (active) ERM protein pool, particularly in 
relation to Ll. This will be performed in in vitro cultures of primary neurons to 
facilitate observation of their localisation in specific cellular structures and 
compartments. 
Aim 2 
To identify functions of the ERNI proteins in neuronal morphogenesis. 
An ideal method for determining specific cellular functions of a protein is to perturb its 
function. Therefore, a dominant negative form of ezrin will be transfeeted into neurons. 
Neuron behaviour will be observed by time-lapse imaging, followed by quantitation of 
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several aspects of their growth and morphology, compared with neurons not expressing 
the dominant negative ezrin. 
Aim 3 
To investigate the role of ERM proteins and Li in neurite outgrowth, during 
development and in the neuronal response to trauma. 
Evidence has implicated both the ERM proteins Li in neurite outgrowth in developing 
CNS neurons. These experiments will seek to confirm these roles, and subsequently 
determine whether these proteins are similarly involved in the regenerative neurite 
sprouting response that results from injury of more mature neurons. An in vitro model 
of transection of neuronal processes, combined with the application of Li protein as a 
neuronal growth substrate, will be used. 
Aim 4 
To identify the characteristics of a motile neuron population in long-term cortical 
neuron cultures, particularly in relation to potential ERM involvement 
A population of highly motile neurons, observed utilising the in vitro transection injury 
model, translocate into the injury site. In these experiments birth-dating and 
immunocytochemical techniques will be used to further investigate the specific 
phenotype of this neuron population, and to further examine the putative role of ERM 
proteins in neuronal migration. 
Aim 5 
To examine the mechanisms of ERM activation in neurons. 
Studies in non-neuronal cell types have indicated that a number of different enzymatic 
systems are involved in the activation of ERM proteins, and this may be cell-type 
specific as well as dependent on the biological context. Application of an inhibitor of 
Rho kinase will be used to examine the role of Rho kinase in ERM activation. The 
functional outcomes of perturbing ERM activation will be examined. 
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2 MATERIALS AND METHODS 
2.1 CELL CULTURE 
2.1.1 Substrate preparation for neuron culture 
2.1.1.1 L1-Fc chimera protein 
Li -Fe chimera protein was produced according to previously reported methods (De 
Angelis et al., 1999; Dickson et al., 2002). Briefly, COS-7 cells were maintained in 
lOmm tissue culture plates in Dulbecco's Modified Eagle's Medium (DMEM, Gibco) 
supplemented with 10% FCS (Gibco) and 1% penicillin / streptomycin antibiotic 
(Gibco). Prior to transfection, cells were subcultured and transferred to 150mm tissue 
culture plates (IWAKI) and cultured to approximately 70% confluence. To transfect 
four dishes, a transfection solution containing 60ttg Li-Fe DNA (section 2.6), lmL 
Dextran (400mg/mL), lmL Chloroquine (100mM) and 38mL DMEM / 10% FCS 
medium was prepared. Cultures were washed once with medium and 10mL transfection 
solution was added to each plate and returned to the incubator (37°C, 5% CO2). After 
three hours the transfection solution was replaced with 4mL 10% DMSO / PBS solution 
at room temperature for two minutes, while gently swirling. This solution was 
immediately removed and replaced with 20mL DMEM containing 10% low IgG FCS 
(Gibco). 24 hours later the medium was replaced with 25inL DMEM containing 1% low 
IgG FCS (Gibco) and returned to the incubator for six days, to allow Ll-Fe chimera 
protein to accumulate. 
For Ll-Fc protein purification, aliquots containing 0.05g Protein A Sepharose 
(Amersham Biosciences) in lmL 0.01M PBS were pre-swelled overnight on a rocker, at 
4°C. The conditioned media was centrifuged (7 minutes, 1000rpm, 4°C) and the 
supernatants were combined. One aliquot of Protein A Sepharose solution was added to 
each 50mL media, which was then incubated overnight on a rocker, at 4°C. 
Supernatants were applied to a blank chromatography column (Bio-Rad), followed by 
two 0.01M PBS washes. The protein was eluted with 2mL 0.1M glycine (pH 3.0), into a 
tube containing 2001AL 1M Tris-HC1 (pH 9.0). The presence of Li-Fe protein was 
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confirmed by Western Blotting (section 2.5) and protein concentration determined by 
bicinchoninic assay (BCA, Pierce), according to the manufacturers instructions. 
2.1.1.2 Substrate Application 
Glass coverslips (19mm, Marienfeld) were etched with nitric acid (BDH Chemicals) 
overnight, followed by tap water and milli-QTM water washes, dried and heat sterilised 
prior to application of substrates. Coverslips were placed in 12-well tissue culture trays 
(IWAIU). A 0.001% Poly-1-lysine (Sigma) solution was applied to coverslips for three 
hours. Laminin (Sigma, 51..tg/mL) was applied after poly-l-lysine, for three hours. For 
Li substrates, poly-l-lysine treatment was followed by anti-human IgG Fc antibody 
(1:10,000, Sigma), which was incubated on coverslips for three hours. Finally, L 1-Fc 
(4tighnL; Kamiguchi and Yoshihara, 2001) chimera protein was applied and incubated 
overnight. Semaphorin 3A/Fc substrates (R & D Systems; 41.A.g/mL) were prepared by 
the same application sequence as Ll-Fc. After substrate application lmL of 'initial 
medium'; NeurobasalTM (Gibco), supplemented with 10% FCS, 0.5mM L-glutamine 
(Gibco), 25iuM glutamate (Gibco), 2% B27 (Gibco) and 1% penicillin / streptomycin 
antibiotic was applied to tissue culture plate wells. Prepared culture plates containing 
medium were placed in an incubator (37°C, 5% CO 2) overnight, prior to cell culture. 
2.1.2 Dissection 
Time-mated pregnant Hooded- Wistar rats carrying pups of 18 days gestation (E18) were 
sacrificed by carbon dioxide exposure, in accordance with the guidelines stipulated by 
the University of Tasmania Animal Ethics Committee. Rat pups were immediately 
removed, placed on ice and decapitated. Meninges were carefully cut away using fine 
scissors, exposing the dorsal surface of the brain. For cortical neuron culture, tissue was 
dissected from the neocortical region using fine forceps. Hippocampal dissection was 
performed under microscope guidance. The brain was removed from the skull and the 
hemispheres separated by cutting away from the Circle of Willis on the ventral surface. 
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Removal of the meninges and thalamus revealed the hippocampus, which was dissected 
out using fine scissors. 
2.1.3 Tissue processing and culture 
Tissue was collected in 5mL 10mM HEPES (Sigma) buffer, at 37°C. Enzymatic 
digestion of the tissue was facilitated by incubation with 0.125% Trypsin (Sigma), for 15 
minutes. Tissue was washed three times with HEMS and mechanically dissociated 
using a pipette. Staining with trypan blue (Sigma) was used to assess cell viability and 
concentration. Cells were plated onto coverslips in 'initial medium' at 5 x 104 cells per 
coverslip. At 1 day in vitro (DIV), medium was replaced with 2mL 'subsequent media', 
a serum free medium consisting of NeurobasalTM medium supplemented with 0.5mM L-
glutamine, 2% B27 and 1% penicillin / streptomycin antibiotics. Every fourth day lmL 
of 'subsequent media' was replaced with fresh medium. 
2.2 TRANSECTION INJURY OF NEURON CULTURE 
At 21 DIV neuron cultures consist of a dense meshwork of neuronal processes, and 
display characteristics of mature neurons, when developmental protein markers are no 
longer expressed, but markers related to maturity, such as MAP2, synaptic markers and 
the neurofilament triplet proteins, are (de Lima et al., 1997; Chuckowree and Vickers, 
2003; King et al., 2006). At this time, cultures were subjected to transection injury, 
according to methods established in our laboratory (Dickson et al., 2000). Under 
microscope guidance a small goniotomy knife (Kaisers) was used to transect neuronal 
processes in selected regions of the culture. Specifically, injuries were performed in 
areas of high neuronal process density. Several injuries were performed per coverslip, 
each approximately one mm in length. 
2.3 IMMUNOCYTOCHEMISTRY 
2.3.1 Fixation 
Cell cultures were fixed using varied methods depending on requirements of primary 
antibodies. Cells were fixed with either with 4% Paraformaldehyde (PFA, Sigma) for 
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thirty minutes at room temperature, or ice-cold 10% Trichloroacetic acid (TCA, Sigma) 
for twenty minutes at -20°C. TCA fixation was required for immunolabelling with an 
antibody that is specific for phosphorylated ERM proteins (Hayashi etal., 1999). 
Fixation was followed by three ten minute 0.01M PBS washes. Table 2.1 shows 
commonly used primary antibodies and the method of fixation required. Fixation was 
immediately followed by immunocytochemistry. 
2.3.2 Indirect fluorescence immunocytochemistry 
Following fixation, primary antibodies, which recognise and bind to specific epitopes of 
cellular proteins, were applied to specimens at appropriate concentrations (Table 2.1), 
diluted in a 0.3% Triton-X (Fluka) solution, which was used to permeabilise cell 
membranes. Primary antibodies were incubated on an orbital shaker for two hours at 
room temperature, then overnight at 4°C, followed by three 0.01M PBS washes. 
Species and isotype specific Alexa Fluor fluorescent secondary antibodies (Table 2.2) 
were applied at a dilution of 1:1000 and incubated in the dark, on an orbital shaker for 
1.5 hours at room temperature. Specimens were washed three times with 0.01M PBS 
and mounted onto microscope slides using Permafluor (Beckman Coulter) mounting 
medium. 
2.4 MICROSCOPY AND ANALYSIS 
Fixed, fluorescent immunolabelled specimens were examined using a Leica DM LB2 
immunofluorescence microscope, equipped with a cooled CCD Magnafire (Optronics) 
digital camera. Images were acquired using Magnafire (version 1.0) software. Image 
analysis, such as neurite lengths and distance of cell movement, was performed using 
Improvision Openlab (version 4.0.2) software. Images were prepared using Adobe 
Photoshop (version 9.0). Time-lapse microscopy using Normaski Interference Contrast 
optics was performed using a Leica DMB IRB inverted fluorescence microscope, 
Hamamatsu ORCA-ER digital camera and Improvision Openlab software. Statistical 
analysis was performed in Microsoft Excel (Mac Os X); the data was obtained from at 
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Table 2.1. Commonly used primary antibodies for immunocytochemistry 
Antibody Fixation Species Dilution Supplier 
anti-(3-tubulin 4% PFA, 4% 
PFA, 10% 
TCA 
mouse 1:2500 Sigma 
anti-I3-III-tubu1in 4% PFA mouse 1:10000 Promega 
anti-ezrin-radixin- 
moesin 
4% PFA mouse IgM 1:5000 Gift from Dr 
F. Solomon 
anti-microtubule 
associated protein 2 
(MAP2) 
4% PFA mouse 1:1000 Chemicon 
anti-phosphorylated 
ERM 
10% TCA rabbit 1:500 Cell 
Signaling 
anti-tau 4% PFA rabbit 1:10000 DAKO 
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Table 2.2. Secondary antibodies used for immunocytochemistry 
Emission Reactivity Species Supplier 
488 mouse IgG goat Molecular Probes 
594 mouse IgG goat Molecular Probes 
488 mouse IgM goat Molecular Probes 
594 mouse IgM goat Molecular Probes 
488 rabbit goat Molecular Probes 
594 rabbit goat Molecular Probes 
488 guinea pig 	. goat Chemicon 
594 rat goat Molecular Probes 
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least three separate neuronal cultures. Means are reported -±. standard error of the mean 
(SEM). The student's t-test (Microsoft Excel) was performed in order to determine 
significance, and p values less than 0.05 (CI 95%) were considered statistically 
significant. Graphs were prepared in Microsoft Excel or Prism (version 4.0c). 
2.5 IMMUNOBLOTTING 
Initially, proteins were separated by SDS-PAGE using a Mini-PROTEANO H (Bio-
Rad) system. 7.5% or 12% 0.375M Tris-HC1 separating gels were used, depending on 
the molecular weight range of the proteins to be separated. The separating gel was 
overlayed with a 4% 0.125M Tris-HC1, pH 6.8 stacking gel. Samples were prepared by 
dilution in 2x Laemelli sample buffer (1:2), which were then heat treated at 90°C for 
five minutes and incubated on ice for five minutes. A broad range, pre-stained 
molecular weight marker (Bio-Rad) was included in each separation to facilitate protein 
molecular weight determination. The gel was run at 200V for the duration of the 
separation. 
After separation, gels were stained for total protein with Coomassie stain, or used for 
immunoblotting, utilising a Mini Trans-Blot® Electrophoretic Transfer Cell (Bio-Rad). 
Prior to transfer, gels were equilibrated in transfer buffer for 15 minutes at room 
temperature, on an orbital shaker. The gel 'sandwich', containing a nitrocellulose 
membrane (Bio-Rad) and the gel, was inserted into the transfer cell. Protein transfer 
was performed for 1.5 hours at 4°C, 70V. The nitrocellulose membrane was washed 
three times with tris buffered saline with tween (TTBS) for five minutes, before 
blocking with TTBS / 5% skim milk powder /5% FCS. The length of blocking varied 
from thirty minutes to 1.5 hours depending on the primary antibodies used. Blocking 
solution was removed by washing with TTBS. Primary antibodies were diluted in TTBS 
and incubated with the membrane for 2-16 hours at room temperature or 4°C on an 
orbital shaker. Membranes were washed three times with TTBS for ten minutes, then 
incubated with species appropriate horseradish peroxidase (HRP) conjugated secondary 
antibodies (1:1000 to 1:2000, DAM)), diluted in TUBS, for 1.5 hours at room 
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temperature, on a shaker. After this, membranes were washed three times with Tris 
buffered saline (TBS), for ten minutes. 
Protein bands were labelled using an ECLTM chemiluminescence system (Amersham), 
according to the manufacturers instructions. Bands were developed with HyperfilmTM 
(Amersham) using standard darkroom techniques. Briefly, film was exposed to 
developer (ILFORD) for three minutes, placed in the stop bath (tap water) for thirty 
seconds, followed by fixative (Kodak) for five minutes and washed in tap water for five 
minutes. For quantitative analysis, the film was scanned and band intensities analysed 
using Bio-Rad Quantity One software (version 4.5.0). 
2.6 PLASMID DNA PREPARATION 
Plasmid DNA encoding Ll-Fc was a gift from Assoc Prof Deanna Benson. Plasmid 
DNA encoding pEGFP-F was purchased from Clontech, and a truncated form of ezrin, 
encoding only the N-terminus, inserted into the pEGFP-N1 vector, (NEz-GFP) was 
prepared by Dr Tracey Dickson. The vector maps are illustrated in Figure 2.1. 
DNA was transformed using Epicuran coli XL 10 Gold Ultracompetent cells (Stratgene), 
according to manufacturers instructions. Briefly, cells were thawed on ice, and 
incubated with 41AL 13-mercaptoethanol for ten minutes, on ice. 11.1L pure DNA was 
added and incubated for thirty minutes, on ice. The sample was heat pulsed (40-45°C, 
thirty seconds) and placed on ice for two minutes. 2004 NZY + broth was added and 
incubated for one hour at 37°C, on a platform shaker at high speed. Following 
incubation, 50-100RL of the transformation was spread plated onto LB plates containing 
the appropriate selection antibiotic for the vector (ampicillin or kanamycin; 30lig/mL), 
dried and allowed to grow overnight at 37°C. Colonies were inoculated into 5mL LB 
broth containing SRL of the appropriate antibiotic. Broth cultures were incubated 
overnight at 37°C on a platform shaker at maximum speed. Qiagen QIAprep® Miniprep 
purification of DNA was performed according to the manufacturers instructions. 
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Figure 2.1 Vector information for plasmid DNA. A. The pcDNA3 vector (Invitrogen) 
containing DNA encoding LI-Fc was a gift from Assoc Prof Deanna Benson, and has been 
previously described (De Angelis et al., 1999). B. The pEGFP-F vector encoding GFP 
was purchased from Clontech. C. The pEGFP-N1 vector (Invitrogen) containing DNA 
encoding the N-terminus of ezrin, has been previously described (Algrain et al., 1993; 
Dickson et al., 2002). D. pmaxGFPTM was purchased from Amaxa. 
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Gel electrophoresis was used to check purified DNA products. Plasmids were either 
linearised or digested using the appropriate restriction enzymes (New England Biolabs). 
Plasmids were separated on a 0.8% Agarose gel (Invitrogen) containing Ethidium 
Bromide (Sigma), in TAE buffer. A I kb DNA ladder (New England Biolabs) was used 
for identification of plasmid size. Bands were visualised using the UV transilluminator 
of an XRS Chemidoc (Bio-Rad). DNA yield was determined using a spectrophotometer 
(Eppendorf). 
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3 LOCALISATION AND PERTURBATION OF ERM PROTEINS IN 
DEVELOPING CNS NEURONS 
3.1 INTRODUCTION 
The ERM proteins have been implicated in many important cytoskeletal-based 
mechanisms. However, these functions have predominantly been identified in non-
neuronal cell types. For example, they are involved in cell division in NIH-3T3 cells 
(Henry et al., 1995), are crucial for cell-substrate contacts and microvilli formation in 
mouse thymoma cells (Takeuchi et al., 1994), and cell motility in lymphocytes (del Pozo 
et al., 1999; Lee et al., 2004). Initially, ERM proteins were localised to the growth cone 
in developing neurons (Goslin et al., 1989), which was suggestive of roles in 
developmentally regulated growth mechanisms. During the last two decades there has 
been a gradual increase in knowledge of the specific roles of ERM proteins in CNS 
neurons. 
A research group focussed on identifying specific components that control the cell 
cytoskeleton raised an antibody known as 13H9, which recognised a cytoskeletal 
component of the marginal band of erythrocytes (Birgbauer and Solomon, 1989). They 
then used the antibody for immunolabelling in developing cultured hippocampal 
neurons, another system where the precise control of cellular events by the cytoskeleton 
was becoming elucidated. The antibody almost exclusively labelled growth cones, in a 
pattern very similar to phalloidin (F-actin) (Goslin et al., 1989). Therefore, this was 
amongst the first evidence that ERMs were expressed in the nervous system, as the 
antibody was later confirmed to be specific for an epitope found in ezrin, radixin and 
moesin (Winckler et al., 1994). Subsequent investigations of ERM expression, in 
various neuronal phenotypes, have confirmed this expression pattern (Birgbauer et al., 
1991; Gonzalez-Agosti and Solomon, 1996; Castelo and Jay, 1999; Paglini et al., 1998; 
Dickson et al., 2002; Cheng et al., 2005). Furthermore, in vivo studies have suggested 
that ERM proteins are specifically expressed during nervous system development, with a 
rapid decline in their expression coinciding with the final stages of embryonic 
development (Mintz et al., 2003). 
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As with many other proteins, much of what is known about ERM function has been 
learned through the use of genetically modified animals. Essentially, moesin and radixin 
knockout mice appear to be phenotypically normal (Doi et al., 1999; Kikuchi et al., 
2002), which may be due to functional redundancy or compensatory expression of other 
ERM family members. At the cellular level, a number of approaches have been used to 
perturb ERM expression or activity, and therefore dissect the functions of the proteins. 
Perturbation methods used in neurons, in vitro, have included the withdrawal of growth 
factors (Gonzalez-Agosti and Solomon, 1996), microCALI (Castelo and Jay, 1999), 
antisense oligonucleotides (Paglini et al., 1998) and dominant negative transfection 
(Dickson et al., 2002). These studies have identified roles primarily in growth cone 
morphology and motility, neurite outgrowth and most recently axonal morphogenesis. 
The focus of these experiments was to clarify the expression and localisation pattern of 
ERM proteins in hippocampal neurons, as they are a well-characterised neuronal 
phenotype, and their development is thought to correlate well with that observed in vivo 
(Dotti et al., 1988). The developmental expression of total ERM proteins, in relation to 
the phosphorylated (active) form of ERM proteins, and their recently identified neuronal 
binding partner Ll (Dickson et al., 2002) was studied. Next, neurons were transfected 
with DNA encoding either green fluorescent protein (GFP), or a dominant negative form 
of ezrin linked to GFP (NEz-GFP). Transfection, combined withlive cell imaging and 
quantitation studies was used to determine the effects of ERM perturbation on the 
development of primary neurons, in vitro. 
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3.2 MATERIALS AND METHODS 
3.2.1 Substrate preparation and cell culture 
Poly-1-lysine substrates were prepared according to section 2.2.1 (Materials and 
Methods). Primary hippocampal and cortical neurons were harvested from embryonic 
rats and cultured according to procedures outlined in sections 2.1.2 and 2.1.3 (Materials 
and Methods). For developmental (3, 5, 7, 21 DIV) ERM localisation studies, 
hippocampal neurons were fixed for immunocytochemistry with either 4% PFA or 10% 
TCA as described in section 2.3.1 (Materials and Methods). Cortical neurons were used 
rather than hippocampal neurons for ERM perturbation studies utilising transfection 
techniques, due to the high number of cells required for success of the transfection 
protocol. 
3.2.2 Immunocytochemistry 
Neurons were immunolabelled according to the procedures in section 2.3 (Materials and 
Methods). The primary antibodies used are outlined in Table 2.1. Previous studies have 
determined the specificity of the phosphorylated ERM antibody (Mintz et al., 2003). An 
anti-L1 CAM (1:5000) rabbit polyclonal antibody provided by Dr C Lagenaur was used. 
Alexa Fluor fluorescent secondary antibodies are detailed in Table 2.2. 
3.2.3 Transfection studies 
Neurons were transfected with pmaxGFPTM (Amaxa), pEGFP-F, or NEz-GFP (a 
dominant negative form of ezrin encoding the N-terminus of ezrin). pEGFP-F and NEz-
GFP were produced according to standard procedures, in section 2.6 (Materials and 
Methods). Transfection was performed utilising an Amaxa Nucleofector® device and 
the Rat Neuron Nucleofector® Kit for primary rat hippocampal or cortical neurons. In 
some experiments, the data obtained from transfection with pmaxGFPTM was combined 
with pEGFP-F, as there were no significant differences in morphology of the neurons 
observed using the two different GFP vectors. Thus results from transfection with these 
vectors are described as GFP, rather than by their specific vector names. After 
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optimisation of the protocol, including the number of cells required for transfection, the 
amount of DNA and culture plating density (Table 3.1), neurons were transfected 
according to manufacturers instructions at the time of harvest (0 DIV). 
3.2.4 Live Cell Imaging 
Neurons expressing the specific plasmids were transferred to glass imaging dishes 
containing imaging buffer warmed to 37°C. Neurons were imaged at 1, 2 or 3 DIV, for 
various periods (most often 10 minutes, but up to 120 minutes) in order to compare 
behaviour and morphology between NEz-GFP and control GFP transfected neurons. 
For quantitation studies, the measurements were obtained from the final frame in the 
imaging sequence. 
3.2.5 Microscopy and analysis 
Microscopy and quantitation were carried out as described in section 2.4 (Materials and 
Methods). In transfection studies, aspects of neuronal growth and morphology, 
including axon length, dendrite length, number of dendrites, percentage of branched 
axons and dendrites, the maximum number of times axons and dendrites were branched 
and growth cone area were determined using Improvision Openlab software. Movies 
were prepared and annotated using Improvision Openlab and Final Cut Express (version 
1.0) and QuickTime Pro (version 7.1.3) software, respectively. Eleven GFP control 
transfected neurons and nine NEz-GFP transfected neurons, from at least three separate 
neuronal cultures, were included in the analysis. 
Table 3.1. Optimum conditions for transfection using Amaxa Nucleofector® products 
Vector Number of neurons 
per reaction 
DNA (lig) Neuron culture density: 
cells per coverslip 
pEGFP-F 6 x 106 10[tg 1 x 105 
pmaxGFPTM 4 x 106 21,tg 1 x 105 
NEz-GFP 6 x 106 10Rg 1 x 105 
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3.3 RESULTS 
3.3.1 Li and ERM are expressed during early development, in vitro 
It has been established that Li is predominantly expressed during early neuronal 
development (Linnemann et al., 1988; Wong et al., 1995; reviewed in Hortsch, 1996; 
Tsuru et al., 1996). In the current experiments, Li was localised to neuronal soma, 
axons and axonal growth cones, but was absent from dendrites (Figure 3.1 C, F). 
However, Li immunolabelling was not diminished in long-term cultures at 21 DIV, 
when cortical neurons are considered relatively mature (Figure 3.1 L). Li expression 
persists in mature, unmyelinated axons, in vivo (reviewed by Wong et al., 1995). 
Notably, Li labelling specifically co-localised with ERM proteins in axonal growth 
cones. Labelling for total ERM proteins, independent of their phosphorylation state, was 
apparent throughout early development (1-7 DIV), and was localised to axonal and 
dendritic growth cones, as well as more restricted sites along neurites (Figure 3.1 A, D 
and G). ERM labelling was also dispersed within a proportion of growth cones in 
relatively mature cultures (Figure 3.1 J, arrowheads indicate ERM labelling), however 
specific labelling for phosphorylated ERM demonstrated that the proteins were not 
present in their phosphorylated, or active form (Figure 3.1 K). 
Phosphorylated ERM labelling provided more specific information about the expression 
of active ERM proteins during early development. Between 1 and 5 DIV the pattern of 
labelling was similar to that of phosphorylation state independent ERM, and therefore 
concentrated in areas of growth activity, but it was more restricted in its localisation 
(Figure 3.1 B, E and H). That is, while labelling for total ERM proteins was observed in 
all growth cones, active ERM was limited to specific areas, often only a subset of 
filopodia (compare figure 3.1 G and H). At 21 DIV active ERM was not evident within 
any neurites, filopodia or growth cones (Figure 3.1 K). Cultures were expanded to 28 
DIV to determine if the total ERM labelling was maintained in more mature neurons. 
Immunolabelling showed a complete absence of both phosphorylation state independent 
and phosphorylated ERM in these neurons at 28 DIV. In contrast to the specific, 
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Figure 3.1 ERNI and Li localisation during hippocampal development, in 
vitro. Hippocampal neurons were fixed at 3, 5, 7 and 21 DIV and 
immunolabelled with antibodies to determine protein localisation during 
development. A, D, G and J. Immunolabelling with antibodies to 
phosphorylation state independent ERM (green) and 13-tubulin (red). ERM 
proteins were localised to axonal and dendritic growth cones, as well as 
occasional filopodia emanating from neurite shafts, which may correspond to sites 
of new branch formation (arrowheads). B, E, H and K. Phosphorylated, or 
active ERM (green) and 13-tubulin (red) labelling. Phosphorylated ERM was more 
restricted in its localisation (arrowheads) than phosphorylation state independent 
ERM. Phosphorylated ERM was completely diminished from cultured 
hippocampal neurons at 21 DIV (K). C, F, I and L. Ll (red) and 
phosphorylation state independent ERM (green) labelling. L 1 was localised to the 
axon (C and F, arrows) and soma, and persisted throughout in vitro development. 
ERM labelling was localised to growth cone and neurite filopodia (arrowheads), 
and remained localised to some small growth cones at 21 DIV (J, L, arrowheads). 
• ERM and Li specifically co-localised in the axonal growth cone. Scale bar: A-C, 
F, G, and J = 40m; D, E, H, I, K and L = 461tm. 
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restricted localisation of ERM proteins in neurons, glial cells widely expressed ERM 
proteins, including phosphorylated ERMs. 
In summary, labelling for active ERM proteins in in vitro neuronal development peaked 
at approximately 3 DIV and was diminished by 21 DIV, whereas a pool of inactive 
ERM remained in neuronal processes and growth cones until it also diminished between 
21 and 28 DIV. This hnmunolabelling pattern is indicative of developmental ERM 
functions. Li and ERM proteins specifically co-localised in axonal growth cones, which 
is suggestive of specific functions resulting from their binding, such as growth cone 
morphogenesis, axon outgrowth and pathfinding. In addition, they may participate in 
modulating the neuronal response to molecular guidance cues. 
3.3.2 Perturbation of ERM function in early development results in alterations in 
neuron morphology 
Initially, neurons transfected with either NEz-GFP or GFP were observed by time-lapse 
imaging at 1-3 DIV, to identify morphological and behavioural differences in neurons 
over-expressing the truncated form of ezrin. At 1 DIV (Movie 3.1) GFP transfected 
neurons were developing normally, with lamellipodia becoming more defined in their 
localisation, representing the beginning of neurite formation. Lamellipodia and 
filopodia were very active, extending and retracting as the neuron began to establish 
neurites. In contrast, neurons transfected with NEz-GFP at 1 DIV (Movie 3.2) appeared 
to be slightly lagging behind their GFP control transfected culture counterparts, with 
respect to neurite formation. Many neurons remained rounded, without the presence of 
large lamellipodia that is characteristic of the initial stages of development in culture. 
However, it was noted that in NEz-GFP transfected neurons, filopodia emanating from 
the cell body were highly active, extending and retracting comparably to GFP 
transfected control neurons. 
By 3 DIV GFP transfected neurons had developed multiple dendrites, and a defined 
axon, which possessed a highly motile distal growth cone (Movie 3.3). Some NEz-GFP 
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Movie 3.1 The development of GFP transfected control neurons at 1 DIV. A 
primary cortical neuron transfected with the vector encoding GFP at the time of 
harvest (0 DIV), then time-lapse imaged at 1 DIV. The sequence contains images 
obtained every 10 seconds for 1 hour. The first image in the sequence was 
obtained under fluorescence, to demonstrate that the neuron was expressing the 
plasmid DNA. The neuron was undergoing the early developmental process of 
neurite initiation, as evidenced by large, active lamellipodia (arrows). These 
lamellipodia are likely to correspond to the development of neurites within the 
next day in vitro. Scale bar = 25Rm. 
Movie 3.2 The development of NEz -GFP transfected neurons at 1 DIV. A 
primary cortical neuron transfected with the vector encoding NEz-GFP at 0 DIV, 
then time-lapse imaged at 1 DIV. The sequence contains images obtained every 
10 seconds for 1 hour, and the first image was obtained under fluorescence. 
Compared with GFP transfected neurons (Movie 3.1), the development of NEz-
GFP expressing neurons often appeared to be delayed. While the neuron 
possessed highly active, long filopodial protrusions (small arrows), it had not 
established lamellipodia around the cell body, which is a preceding stage to 
•neurite formation. Untransfected neurons in the same culture displayed more 
characteristic morphology of this stage of development in vitro, with established 
lamellipodia and in some cases, neurites (large arrow). Scale bar = 25tim. 
Movie 3.3 GFP transfected neuron at 3 DIV. A primary cortical neuron 
transfected with the vector encoding GFP at the time of harvest (0 DIV), then 
time-lapse imaged at 3 DIV. The sequence contains images obtained every 5 
seconds over a 10 minute period, with the first image obtained under 
fluorescence. The sequence shows that the transfected neuron had established 
multiple, short neurites (small arrows) as well as one longer neurite, which is 
likely to be the axon. The axonal growth cone (large arrow) possessed highly 
motile filopodia and lamellipodia. Filopodia located along the axon and 
associated with the new dendrites were also motile. Scale bar = 25Rm. 
Movie 3.4 NEz-GFP transfected neuron at 3 DIV. A primary cortical neuron 
transfected with a vector encoding NEz-GFP at 0 DIV, then time-lapse imaged at 
3 DIV. The movie sequence is comprised of images obtained ever 10 seconds for 
1 hour, and the first image was obtained under fluorescence. The neuron 
progressed through development with respect to the formation of a single axon 
and multiple dendrites (compare with Movie 3.3), however the axonal growth 
cone (large arrow) was small and lacked lamellipodia. Furthermore, rather than 
defined dendrites, multiple long filopodia emanated from the cell body (small 
arrow). In addition, the axon was branched (arrowheads), which was not 
normally observed in GFP control transfected neurons at this age. Scale bar = 
25pm. 
Movie 3.5 NEz-GFP transfected neuron at 3 DIV. A primary cortical neuron 
transfected with the vector encoding NEz-GFP at 0 DIV, then time-lapse imaged 
at 3 DIV. Images were obtained every 5 seconds over a 10 minute imaging 
period, and the first image was obtained under fluorescence. This neuron 
displayed further abnormal morphology (compared with Movie 3.4), such as the 
lack of an axonal growth cone (large arrow). Also neurites appeared slightly 
flattened, with "blebbing" (arrowhead). Dendrites were short and lacked 
filopodia and growth cones (small arrows), and filopodia were short and inactive. 
Scale bar = 25txm. 
Movie 3.6 NEz-GFP transfected neuron at 3 DIV. Under the same conditions 
as Movie 3.5, a primary cortical neuron transfected with a vector encoding NEz-
GFP at 0 DIV, then time-lapse imaged at 3 DIV. Images were obtained every 5 
seconds over a 10 minute imaging period, and the first image was obtained under 
fluorescence. The neuron displayed many characteristics of poor health including 
flattening of neurites and "blebbing" (also observed in Movie 3.5). This neuron 
also lacked an active axonal growth cone (large arrow). Filopodia associated with 
the branched primary dendrite (arrow) were inactive (arrowhead). Scale bar = 
25tim. 
Note: Movies supplied in QuickTime format on DVD affixed to the back cover. 
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transfected neurons displayed relatively similar morphology and behaviour (Movie 3.4). 
However, a subset of NEz-GFP neurons displayed abnormal morphology, including 
"blebbing" along the neurites, flattened neurites and small growth cones (Movies 3.5 
and 3.6). Due to the robust expression and health of neurons transfected with the two 
different GFP constructs, it was unlikely that the transfection process caused the 
abnormal morphology, which suggests that it was specifically the expression of 
dominant negative ezrin that caused the morphological abnormalities. Interestingly, 
NEz-GFP transfected neuron filopodia were active (Movie 3.6). 
Therefore, live cell imaging studies did not uncover obvious differences in the 
behaviour, particularly with respect to filopodial and lamellipodial activity, between 
neurons transfected with GFP or NEz-GFP, at any of the timepoints observed. 
Therefore, aspects of neuron morphology and outgrowth were quantitatively assessed at 
3 DIV (Figure 3.2), a timepoint at which neurite outgrowth is well established and 
neurons are polarised (de Lima et al., 1997; Dotti et al., 1988). NEz-GFP transfected 
neurons showed no significant difference in axon length (181[im ± 22) compared with 
GFP transfected neurons (15212m ± 22) (p = 0.39) (Figure 3.2 A). Similarly, dendrite 
length in neurons transfected with NEz-GFP (47Rm ± 6), compared with GFP 
transfected controls (371.tm ± 3) were not significantly different (p = 0.09) (Figure 3.2 
B). Notably, there were tendencies for the NEz-GFP transfected neurons to have longer 
axons and dendrites, but this did not reach statistical significance. 
The number of dendrites was counted in order to examine a role for ERM proteins in 
neurite initiation (Paglini et al., 1998). NEz-GFP and GFP transfected neurons at 3 DIV 
both had an average number of three dendrites (NEz-GFP 2.5 ± 0.42; GFP 2.9 -«- 0.31, p 
= 0.46) (Figure 3.2 C). ERM proteins have also been proposed to play a role in axon 
branching (Dickson et al., 2002), and so the amount of branching in both axons and 
dendrites was examined. 57% (± 20%) of NEz-GFP transfected neuron axons were 
branched, while 25% (± 16%) of GFP transfected neurons had branched axons, a 
difference that was not statistically significant (p = 0.23) (Figure 3.2 D). The results 
were similar for branched dendrites; 33% (± 13%) of dendrites were branched in 
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Figure 3.2 Perturbation of ERM function in developing primary cortical 
neurons. Cortical neurons were transfected with plasmid DNA encoding GFP or 
NEz-GFP at 0 DIV, using the Nucleofector® system. At 3 DIV, neurons were 
time-lapse imaged and then aspects of their morphology were quantitated. * 
represent p values less than 0.05. Error bars are ± SEM. 
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neurons transfected with NEz-GFP, in comparison with 9% (± 5%) dendrites branched 
in neurons transfected with GFP, which did not reach statistical significance (p = 0.09) 
(Figure 3.2 E). Of the axons that were branched, NEz-GFP transfected neuron axons 
were branched a maximum of two times (± 0.38), compared with GFP transfected 
neurons, which were branched once (± 0.16; p = 0.08) (Figure 3.2 F). Similarly, 
dendrites belonging to NEz-GFP transfected neurons that were branched, were branched 
an average number of three times (± 0.16), compared with once in GFP control 
transfected neurons (± 0.09; p = 0.13) (Figure 3.2 F). 
ERM proteins have been implicated in growth cone morphology, particularly 
lamellipodial formation (Castelo and Jay, 1999); therefore axonal growth cone area was 
quantitated. NEz-GFP transfected neuron growth cones were an average area of 49t.tm 2 
(± 17Rm2), compared with GFP transfected neuronal growth cones, which were an 
average of 130Rm2 (± 321Am 2). While the variation in growth cone size was large, it was 
not statistically significant (p = 0.08) (Figure 3.2 G). 
In summary, compared with control, GFP transfected neurons, NEz-GFP transfected 
neurons showed a trend towards increased axon and dendrite outgrowth, increased axon 
and dendrite branching and decreased growth cone size, but none reached statistical 
significance. 
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3.4 DISCUSSION 
These experiments have shown that the ERM proteins are developmentally expressed in 
long-term primary neuron cultures. In particular, phosphorylated (active) ERIVI 
expression was diminished by 21 DIV, which coincides with the time at which neurons 
are considered relatively mature (de Lima et al., 1997; Dickson et al., 2000; Chuckowree 
and Vickers, 2003; King et al., 2006). Furthermore, transfection experiments, in which 
neurons were stimulated to over-express a truncated, and thus inactive form of ezrin, 
alluded to many potentially important functions in neuron development. 
Initial studies demonstrated that Li was localised to the soma, axons and axonal growth 
cones of neurons early in development. This pattern of labelling persisted in relatively 
mature cultures (21 DIV), although it is well documented that Li exerts its most vital 
roles early in development (for review see Hortsch, 2000). Li and ERM proteins co-
localised in axonal growth cones, which might indicate specific roles for the binding 
relationship in processes such as axon guidance and outgrowth. It was imperative for 
subsequent studies pertaining to ERM protein function in CNS neurons to precisely 
characterise their temporal and spatial localisation, in neuronal cultures. The ERM 
proteins were predominantly localised to axonal and dendritic growth cones during early 
development, which agrees with previous data (Goslin et al., 1989; Birgbauer et al., 
1991), but were also often observed in fine filopodia along the neurites. In contrast with 
other previous studies, in these experiments neuron cultures were extended to later 
timepoints, to determine ERM expression patterns in more mature neurons. 
Phosphorylation state independent ERM labelling persisted in relatively mature cultures 
(21 DIV), but by 28 DIV was diminished. In contrast, phosphorylated, or active, ERM 
was more highly restricted in its localisation throughout development, and diminished 
by the time maturation occurred (21 DIV). These studies therefore confirm that ERM 
proteins are specifically expressed during development and are thus likely to have 
important developmental functions. 
Perturbation studies also supported the likelihood of developmental functions of the 
ERM proteins. While no significant differences between morphology in control GFP or 
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NEz-GFP treatment were observed, the data showed clear trends towards deviations 
from normal growth and morphology. Some notable changes included the increase in 
axon and dendrite length, an increase in axon and dendrite branching, as well as a 
decrease in growth cone size, all demonstrated in NEz-GFP neurons at 3 DIV. 
A pioneering study by Gonzalez-Agosti and Solomon (1996) examined the role of 
radixin in growth cone morphogenesis. Experiments showed that withdrawal of nerve 
growth factor (NGF) from chick sympathetic neurons resulted in growth cone collapse, 
with a concomitant decrease in radixin immunolabelling. When NGF was reapplied, the 
growth cone was re-established, as was radixin labelling. In the same set of 
experiments, a less dramatic approach to growth cone perturbation, the application of an 
electrical field, was used. This resulted in growth cone turning, which showed 
asymmetrical radixin labelling localised to the side of the growth cone that turned 
(Gonzalez-Agosti and Solomon, 1996). In another study, abolishing radixin in the 
growth cone of DRG neurons using microCALI techniques reduced the area of growth 
cone lamellipodia by 30%, compared with controls (Castelo and Jay, 1999). Antisense 
oligonucleotide double suppression of radixin and moesin resulted in a number of 
deleterious effects on growth cones of primary hippocampal neurons, including a 
reduction in growth cone size and the loss of lamellipodia (Paglini et al., 1998), both of 
which were also observed in the current transfection experiments. Interestingly, the 
same study also observed a decrease in the number of filopodia, but the remaining 
filopodia were increased in length (Paglini et al., 1998). 
In these transfection studies increased axon and dendrite branching was observed in 
NEz-GFP neurons compared with GFP controls. Increased axon branching was 
previously observed in hippocampal neurons transfected with the same NEz-GFP 
construct (Dickson et al., 2002). More specifically, the increased branching was 
observed when the transfected neurons were grown on a substrate containing Li, a 
membrane binding partner of the ERM proteins in neurons, which strongly suggested 
that the Li-ERM-actin relationship is involved in mediating appropriate axonal 
morphogenesis during neuronal development (Dickson et al., 2002). The experiments 
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presented here now implicate ERMs in dendrite branching, in addition to axon 
branching. In a recent study, transfection of cerebellar granule neurons with two 
separate truncated forms of Li, without the RSLE or juxtamembrane regions (which are 
both sites for ERM binding) disrupted the L 1-ERM linkage, resulting in reduced 
branching (Cheng et al., 2005). The opposite effects on neurite branching, compared to 
the study by Dickson and colleagues (2002), were attributed to different sites of action 
(Cheng et al., 2005). 
Live imaging studies performed at 1 DIV suggested that neurons transfected with NEz-
GFP were lagging behind control neurons with respect to neurite initiation and 
establishment of polarity. This has been observed in experiments using oligonucleotide 
suppression of radixin and moesin (Paglini et al., 1998). However, in the current 
experiments, the more gradual initiation of neurites was followed by increased neurite 
outgrowth in both the axon and dendrites at 3 DIV. ERM proteins have long been 
postulated to be involved in neurite outgrowth, however direct evidence is scarce in the 
literature. Others have shown that suppression of radixin and moe sin leads to a decrease 
in the rate of axonal outgrowth (Paglini et al., 1998). In contrast with these findings, 
Castelo and Jay (1999) showed that even when perturbation of radixin in growth cones 
dramatically changed their morphology, neurite extension was not affected. The 
increased outgrowth observed in these experiments is highly suggestive of a function in 
regulating neurite growth, perhaps by mediating neurite retraction. 
In conclusion, these studies have shown that the localisation of ERM proteins, 
particularly phosphorylated ERM, declines in more mature neurons in long-term 
cultures. Phosphorylated ERM is more restricted in its localisation than total ERM 
proteins, and ERMs co-localise with Ll, particularly in axonal growth cones of polarised 
neurons. Perturbation of ERM function in cultured neurons supports important roles in 
neurite outgrowth, growth cone morphology and neurite branching. 
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4 THE ROLE OF ERM PROTEINS AND Li IN DEVELOPMENTAL AND 
POST-INJURY REGENERATIVE NEURITE OUTGROWTH 
4.1 INTRODUCTION 
Encouraging the adult CNS to regenerate following injury remains at the forefront of 
neurobiology research and is an issue of clinical significance. Regeneration of the 
nervous system potentially requires the re-expression of developmentally significant 
molecules, since neuron re-growth is likely to involve cellular mechanisms in common 
with development. These developmentally important molecules may include 
cytoskeletal-associated proteins implicated in processes such as neurite outgrowth, 
which makes the ERM proteins potential candidates. 
ERM proteins are expressed during neuronal development in dynamic cellular structures 
such as neuronal growth cones (for example, Goslin et al., 1989; Birgbauer et al., 1991; 
Dickson et al., 2002; Mintz et al., 2003; Chapter 3), and are therefore thought to be 
intricately involved in mediating growth cone morphology and motility (Paglini et al., 
1998; Castelo and Jay, 1999), processes related to neurite outgrowth. ERMs function by 
binding to plasma membrane proteins and the underlying cytoskeleton, providing a 
linkage between these important components of the cell. 
Li is a nervous system specific plasma membrane binding partner of the ERM proteins 
(Dickson et al., 2002). Neuronal Li is predominantly membrane-associated, localised 
specifically to the axon during early development (Persohn and Schachner, 1987; 
Linnemann et al., 1988), and participates in key developmental processes including cell 
adhesion, neurite outgrowth, axon pathfinding and fasciculation (Hortsch, 1996). The 
vital nature of Li is demonstrated by mutations to the human Li gene (Wong et al., 
1995; Fransen et al., 1997), which results in distinct neurological deficits, known as 
CRASH syndrome (corpus callosum agenesis, retardation, adducted thumbs, shuffling 
gait and hydrocephalus) (Fransen et al., 1995). Ll knockout mice show very similar 
abnormalities, including increased ventricle size, impaired axon decussation in major 
tracts, weakness in the hind limbs and reduced survival (Cohen et al., 1997; Dahme et 
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al., 1997; Demyanenko et al., 1999; reviewed by Kamiguchi et al., 1998). Therefore, Li 
is known to be essential for development, but in addition, it has been demonstrated to 
also promote neuronal regeneration after trauma (see recent examples Roonprapunt et 
al., 2003; Becker et al., 2005; Chen et al., 2005; Zhang et al., 2005). 
Therefore, in the present study the role of ERM proteins and Li was investigated in 
developmental growth and regenerative re-growth of mature neurons following trauma. 
More specifically, whether the mechanism by which Li aids regeneration involves 
binding with the ERM proteins was examined. An in vitro experimental model that 
involves transection of neuronal processes (Dickson et al., 2000; Chuckowree and 
Vickers, 2003; Chung et al., 2003) was utilised. Neurite transection was performed at 
21 DIV when neurons in culture are relatively mature, as defined by the absence of 
developmental proteins and presence of proteins related to maturity (de Lima et al., 
1997; Chuckowree and Vickers, 2003; King et al., 2006). Immunolabelling for ERM 
proteins was used to investigate whether they are involved in the regenerative response. 
Furthermore, Li was supplied as a growth substrate to quantitatively determine whether 
Li facilitated the post-injury regenerative neurite sprouting response. In another aspect 
of this investigation, two different neuronal populations were examined, those derived 
from the cortex and the hippocampus, to investigate potential variation in their 
regenerative capacities. 
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4.2 MATERIALS AND METHODS 
4.2.1 Substrate preparation and cell culture 
Cell culture substrates containing 0.001% poly-l-lysine or L 1-Fc (41.1g/mL), and primary 
dissociated cortical or hippocampal neuron cultures were prepared according to the 
procedures outlined in sections 2.1.1 to 2.1.3 (Materials and Methods). To determine 
the neurite outgrowth promoting ability of Ll-Fc, neuron cultures grown on Li-Fe 
substrates were fixed with 4% PFA at 2, 3 and 4 DIV. In vitro injuries were performed 
at 21 DIV, as described in section 2.2 (Materials and Methods). For post-injury studies, 
neurons were fixed (at 1, 6, 12, 24, 30 and 72 hours) with 4% PFA for 
immunocytochemistry, details are provided in section 2.3.1 (Materials and Methods). 
Scanning Electron Microscopy (SEM) studies required 2.5% glutaraldehyde fixation as 
described in subsequent sections. 
4.2.2 Immunocytochemistry 
Immunocytochemistry was performed using standard procedures in section 2.3 
(Materials and Methods). For developmental studies of the effect of the L 1-Fc substrate 
on neurite outgrowth, neurons were double immunolabelled with antibodies to MAP2 
and tau. Mature injured neurons fixed via the 4% PFA method were labelled with 
antibodies to phosphorylation state independent ERM and either 13-tubu1in or tau. 
Further antibody details are provided in Table 2.1. To visualise antibody localisation, 
isotype and species appropriate fluorescent secondary antibodies were used (Table 2.2). 
4.2.3 Microscopy and analysis 
Microscopy and image acquisition was performed according to section 2.4 (Materials 
and Methods). Improvision Openlab software was used to determine axon length in 
developmental neurite outgrowth studies, where 75 individual axon lengths were 
measured at each timepoint of 2, 3 and 4 DIV. For injury studies, the length of the 
regenerating neurites from the border of the injury site to the tip of the growth cone, as 
well as growth cone area, were quantitated. One hundred individual neurites were 
66 
Chapter 4 - Results 
examined for each experimental condition. The data was obtained from at least three 
separate neuronal cultures. 
4.2.4 Scanning Electron Microscopy 
Both early developmental (1, 3, 5 and 7 DIV) and mature hippocatnpal neurons (21 
DIV) at 6 hours post-injury were prepared for SEM as previously described 
(Chuckowree et al., 2003). Briefly, cells were fixed in 2.5% Glutaraldehyde / 0.1% 
phosphate buffer (pH 7.4) and post-fixed with 0.1% osmium tetraoxide. Specimens 
were dehydrated by progression through an ethanol series, critical point dried and sputter 
coated with gold prior to examination under a Jeol JSM-840 scanning electron 
microscope. Digital images were captured using ImageSlave software. 
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4.3 RESULTS 
4.3.1 Li substrate promotes neurite outgrowth during in vitro development 
To determine the ability of Ll-Fc protein to promote neurite outgrowth, axon lengths of 
hippocampal neurons grown on Li and poly-l-lysine at 2, 3 and 4 DIV were compared. 
By 2 DIV hippocampal neurons had reached Stage 3 of growth, having a defined axon 
(Dotti et al., 1988), therefore axon lengths could be compared from 2 DIV onwards 
(Figure 4.1). At each time-point assessed, hippocampal neurons grown on the Li 
substrate had longer axons than those grown on poly-l-lysine (Figure 4.1 A). At 2 DIV, 
the mean axon length on poly-l-lysine was 115[tm, compared with 123[tm on L 1 (p = 
0.206). At 3 DIV the average axon length on poly-l-lysine was 120tim, compared with 
135Rm on Li (p = 0.052), and at 4 DIV, the mean length on poly-l-lysine was 125[1,m, 
versus 143[trn on Li (p = 0.057). As the neurons developed in vitro, the divergence in 
rate of axon outgrowth on the different substrates became more pronounced. However, 
the differences did not reach statistical significance, and examination beyond 4 DIV was 
not possible due to the formation of contacts between neurites of different neurons. This 
data primarily confirmed that Li protein, applied as a growth substrate, was biologically 
active and capable of promoting neuronal growth in culture, in accordance with previous 
investigations (for example, Esch et al., 1999). 
4.3.2 ERM proteins are re-expressed in the neuronal response to trauma 
Initially, cultured cortical and hippocampal neurons grown on poly-l-lysine or Li 
substrates were injured at 21 DIV, returned to normal incubator conditions, then fixed at 
varying timepoints post-injury (1, 6, 12, 24, 30 and 72 hours; Figure 4.2) an 
immunolabelled with antibodies to the MAP tau and the ERM proteins. At 1 hour post-
injury there were no changes evident at the injury site. By 6 hours post-injury new 
regenerative neurite sprouts entered the injury site. At the later timepoints (particularly 
24 - 72 hours) neurons had established a robust regenerative response, in which neurites 
had extended across the injury site. Therefore, later timepoints were not suitable for 
neurite length quantitation studies, and these experiments determined that the most 
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Figure 4.1 Hippocampal neuron growth on Li and poly-l-lysine substrates. 
Neurons were immunolabelled with an antibody to tau during early in vitro 
development and axon lengths were measured at 2, 3 and 4 DIV. A. Quantitation 
demonstrated that at each developmental timepoint axons on the Ll substrate 
were longer than those grown on poly-l-lysine, however this difference was not 
statistically significant (p > 0.05). B. A representative hippocampal neuron at 2 
DIV. C. A neuron at 3 DIV. D. A neuron at 4 DIV. In B, C and D arrowheads 
identify the axon. Scale bar: B and C = 20Rm; D = 261..tm. 
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Figure 4.2 Time course of regenerative neurite sprouting following 
transection. Cortical neurons were cultured on poly-1-lysine in vitro to relative 
maturity (21 DIV), and transection injury was performed. Neuron cultures were 
fixed at 1, 6, 12, 24, 30 and 72 hours post-injury, and immunocytochemistry was 
utilised to label for tau and the ERM proteins. Arrows indicate the injury site. At 
timepoints after 6 hours post-injury regenerative neurite sprouts crossed the injury 
site, therefore 6 hours post-injury was subsequently used for quantitation of 
regenerative neurite length and growth cone area. Scale bar: 1, 6, 24 and 30 hours 
= 4811m; 12 and 72 hours = 701.tm. 
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appropriate timepoint for quantitation of regenerative neurite characteristics was 6 hours 
post-injury. 
Following injury at 21 DIV, neurons were fixed at 6 hours post-injury and labelled with 
antibodies to the ERM proteins. Previous experiments demonstrated that ERM 
immunolabelling is more abundant during early development (1-7 DIV), and particularly 
phosphorylated ERM is diminished at 21 DIV (Chapter 3). In these experiments, ERM 
labelling was observed specifically localised to the growth cones of regenerative neurites 
that entered injury sites (Figure 4.3 A and B), demonstrating that injury stimulated the 
re-expression, or changes in the localisation, of the ERM family of proteins. 
Phosphorylated ERM was also present in the growth cones of post-injury neuritic 
sprouts. In contrast, the uninjured areas of the culture displayed no active ERM 
immunolabelling. 
This re-expression of the ERM proteins was observed in neurons grown on both Ll and 
poly-l-lysine substrates. However, a clear difference in some aspects of regenerative 
neurite morphology was observed when the substrates were compared. 
4.3.3 The neuronal response to injury on Li substrate results in longer 
regenerative neurites, compared to poly-l-lysine 
In order to establish the role of Ll in the response to trauma, specifically in this neuronal 
culture model, regenerative neurite growth of injured neurons grown on Li substrate or 
poly-l-lysine was compared. Ll has previously been shown to influence neurite 
outgrowth in vivo (for example, Honig et al., 2002). In the current study regenerative 
neurite lengths from parallel cultures was compared, with the single variable being 
growth substrate. Both hippocampal and cortical derived neurons had significantly 
longer neurites, 6 hours post-injury, when grown on Ll (cortical neurons 58[tm ± 5.17; 
hippocampal neurons 4411m ± 2.84) than when grown on poly-l-lysine alone (cortical 
neurons 401im ± 1.92; hippocampal neurons 341.1m ± 1.81) (Figure 4.4; p < 0.05 for both 
neuronal populations). 
69 
Figure 4.3 Growth cones of hippocampal neurons grown on Li and poly-1- 
lysine substrates. Neurons were grown in culture until 21 DIV, then subjected to 
transection injury. A. Immunocytochemistry of regenerative neurite sprouts 
grown on poly-l-lysine, with antibodies to 13-tubulin (red) and phosphorylation 
state independent ERM (green), showed that growth cones were typically small, 
'bell-shaped' structures with few distinct filopodia (arrows). B. Regenerative 
neurite growth cones on Li substrate immunolabelled with tau (red) and 
phosphorylation state independent ERM (green). Growth cones showed a more 
filopodial morphology and were larger (arrows). SEM was utilised to further 
investigate the morphology of growth cones. C. This confirmed the morphology 
of growth cones on poly-l-lysine (arrow). D. Growth cones on Ll were much 
larger and filopodial (arrow). E. A hippocampal neuron grown on poly-l-lysine 
at 3 DIV. F. A hippocampal neuron at 3 DIV on Ll. G. A higher magnification 
of boxed areas shown in E. H. A higher magnification of boxed area shown in F. 
Growth cone morphology of regenerative neurite sprouts (A-D) reflects that of 
early development (E-H). Scale bar: A, B, E - H = 10Rm; C = 1[tm; D = 21./m. 

Figure 4.4 Quantitation of regenerative neurite sprouting. Cortical and 
hippocampal neuron cultures were injured at 21 DIV, then fixed 6 hours post-
injury for quantitation of characteristics of regenerative neurite sprouts. A. 
Regenerative neurite lengths, which were significantly longer on Li than poly-1- 
lysine for both cortical and hippocampal neurons. B. Regenerative neurite 
growth cone areas, which were significantly larger on Li than poly-l-lysine for 
hippocampal neurons but not cortical neurons. * represent p values less than 0.05. 
Error bars are ± SEM. 
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4.3.4 Regenerative neurite growth cone morphology differs depending on growth 
substrate 
There was a distinct difference in the growth cone morphology of post-injury 
regenerative neurites on the Li substrate compared with neurons grown on a substrate of 
poly-l-lysine. Although there was variability in growth cone appearance on each 
substrate, the Li substrate was more often associated with larger, fan shaped growth 
cones with obvious lamellipodia and numerous filopodia (Figure 4.3 B and D). In 
contrast, injury-induced regenerative neurite growth cones from neurons grown on poly-
1-lysine were characterised by fewer filopodia, and were smaller, 'bell-shaped' structures 
(Figure 4.3 A and C). This observation was further investigated in two ways, firstly by 
quantitation of growth cone area, and secondly by closer examination using SEM, as 
illustrated in Figure 4.3 (C - H). 
Quantitation of growth cone area of both hippocampal and cortical regenerative neurites 
after injury revealed that those on the Li substrate had greater mean area (cortical 
neurons 1551Am2 ± 7.77; hippocampal neurons 2151Arn 2 ± 12.44) than those grown on 
poly-l-lysine (cortical neurons 152[1m2 ± 8.25; hippocampal neurons 1171.im2 ± 8.11) 
(Figure 4.4 B). This was statistically significant for hippocampal neurons (p <0.05), but 
not for cortical neurons (p = 0.827). SEM was used to compare post-injury growth 
cones with developing axonal growth cones at 3 DIV, grown on poly-l-lysine and Li 
substrates. Results showed that developing and post-injury neurite growth cones shared 
similar morphology for both substrates (Figure 4.3 C and D, compared with E-H). Thus, 
SEM studies confirmed that Li supplied as a growth substrate influenced neuronal 
growth cone morphology, in development, and similarly in the neuronal response to 
trauma. 
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4.3.5 Neurons derived from the cortex show more advanced regenerative neurite 
growth than those from the hippocampus, at 6 hours post-injury 
Comparison of the regenerative abilities of hippocampal and cortical derived neurons 
revealed that cortical regenerative neurites reached greater lengths by 6 hours post-injury 
than those from hippocampal neurons grown on both poly-l-lysine (p < 0.05) and Li (p 
<0.05) substrates (Figure 4.4 A). This result indicates that neurons taken from the 
cortex mount a more robust, or at least more rapid, regenerative sprouting response 
following in vitro injury. Immunocytochemistry did not clearly define a correlation 
between ERM expression and the differing ability of these neurons to regenerate. 
Interestingly, when the growth cone area of neurons originating from the hippocampus 
and cortex on poly-1-lysine and Li substrates in the post-injury response was compared, 
hippocampal growth cones were found to be significantly larger on Li (p < 0.05), but in 
contrast, cortical growth cones were significantly larger on poly-l-lysine (p <0.05; 
Figure 4.4 B). These data suggest that Li promotes different morphology of cortical and 
hippocampal growth cones, which may account for the variation in regenerative 
responses between the neuronal populations. 
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4.4 DISCUSSION 
The recently characterised binding relationship between the ERM cytoskeletal-linker 
proteins and Ll is likely to have a significant contribution to neuronal development, 
based on the previously elucidated roles of the individual proteins. Thus, it was 
hypothesised that involvement in developmental processes would make the ERM 
proteins and Li probable candidates for participation in the regenerative neuronal 
response to trauma, which was examined using an in vitro model of transection. Data 
showed that, like during neuron development, providing neurons with a growth substrate 
containing Li increased regenerative neurite outgrowth after injury. Furthermore, ERM 
proteins were re-expressed after injury, localised specifically to regenerative neurite 
growth cones. These experiments also revealed differences in growth cone morphology 
of neurons grown on an Li substrate, compared with poly-l-lysine, and showed that 
cortical neurons potentially possess a more robust regenerative ability than hippocampal 
neurons. 
The ERM proteins are predominantly localised to axonal and dendritic growth cones 
during early development. ERM labelling persists in relatively mature cultures (21 
DIV), albeit restricted to a few growth cones. In contrast, phosphorylated, or active, 
ERM is more highly restricted in its localisation throughout development, and is 
diminished by the time maturation occurs (Chapter 3). Regenerative neurite growth 
cones of injured cultured neurons at 21 DIV were positively labelled for the ERM 
proteins. Since ERMs are not expressed by uninjured cultures of this age, it could be 
concluded that ERM proteins were either re-expressed, or re-localised from the soma or 
other part of the neuron, to the regenerative neurite growth cone. This suggests that a 
recapitulation of developmental events involving the ERM proteins is a component of 
the neuronal response to injury, a role for ERMs that has not previously been reported. 
The involvement of the ERM binding partner Li in the neuronal response to trauma was 
also assessed. An effective method for studying Li in in vitro systems involves 
providing neurons with purified Li as a growth substrate (Lagenaur and Letnmon, 
1987). Substrate-bound or soluble Li facilitates Li mediated processes such as neurite 
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outgrowth (Doherty et al., 1995) when compared with neuron growth on regular culture 
substrates such as poly-l-lysine. This was confirmed in these experiments, where axon 
lengths measured during early hippocampal development demonstrated longer axons of 
neurons grown on the Li substrate. Furthermore, previous studies suggest that in both 
in vitro and in vivo models, upregulation or experimentally applied Li following 
neuronal injury may aid the regenerative response, (Poltorak et al., 1993; Aubert et al., 
1998; Brook et al., 2000; Becker et al., 2001; Mason et al., 2003) although the exact 
mechanism is unknown. Indeed, in the current investigation, Li facilitated the 
outgrowth of regenerative neurites in injured hippocampal and cortical neuron cultures, 
as regenerative neurites of neurons from both origins grown on the Ll substrate were 
significantly longer than those grown on poly-l-lysine alone. Taken together, these 
results implicate both Li and the ERM proteins in the post-injury regenerative response. 
The present study also demonstrated the influence of growth substrate on growth cone 
morphology. This has been documented for developing neurons (Payne et al., 1992; 
Brittis et al., 1995; Burden-Gulley et al., 1995; Burden-Gulley and Lemmon, 1996; 
Burden-Gulley et al., 1997), where poly-l-lysine, laminin and Li offered as growth 
substrates resulted in strikingly varied growth cone morphology. This study has now 
demonstrated that growth cones of hippocampal and cortical regenerative neurites from 
relatively mature, injured neurons displayed different morphologies on the Li substrate 
when compared with poly-l-lysine. Growth cones on the Li substrate were larger and 
appeared to have more filopodia. This indicates that Li substrate promotes growth cone 
morphology likely to be linked to neurite outgrowth. 
Unexpectedly, post-injury data indicated that relatively mature cultured cortical and 
hippocampal neurons also differed in their post-injury neurite growth response, since 
cortical regenerative neurites were significantly longer than hippocampal regenerative 
neurites at 6 hours post-injury, when grown on both poly-l-lysine and Li substrates. 
This suggests the possibility that neurons taken from the cortex and hippocampus have 
differing abilities to mount a post-injury regenerative sprouting response, and / or that 
the rate of regenerative sprouting differs between neuron types. The latter is likely given 
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that by 72 hours post-injury, hippocampal and cortical neurons had comparable patterns 
of neurite sprouting. Comparisons between the regenerative abilities between different 
neuronal populations have not previously been widely reported. 
Furthermore, hippocampal neurite growth cones were significantly larger than cortical 
growth cones when the growth substrate was Li, whereas the reverse was true for the 
poly-l-lysine substrate. In combination, this indicates that hippocampal neurons may be 
more responsive to the Li substrate, which resulted in significantly longer sprouting 
neurites on the Li substrate than their counterparts grown on poly-l-lysine substrate and 
significantly larger growth cones than those from cortical regenerative neurites grown on 
Ll. Also, cortical regenerative neurite sprout growth cones shared similar morphology 
and area on both substrates, suggesting they were less responsive to the Li substrate. In 
interpreting these results it must also be considered that the differences in cortical and 
Ilippocampal regenerative responses and growth cone morphology may be due to 
differences in their relative maturity. At E 18, when the neurons were harvested for 
culture, cortical development is more complete than hippocampal development, much of 
which occurs post-natally. 
Therefore, this data illustrates that the ERM proteins, and their binding partner Li, are 
involved in both developmental processes and the neuronal regenerative response to 
trauma. Active ERM was localised to areas of re-growth by injured neurons during 
regenerative attempts, and Li facilitated this response resulting in a more robust neurite 
sprouting response. These experiments have shown that growth characteristics after 
injury are influenced by growth substrate, and suggest that neurons of hippocampal and 
cortical origin cultured in vitro may differ in their response to injury. These data 
implicate ERMs, as well as Li, in the adult CNS response to trauma, information that 
will contribute to avenues of investigation into interventions for improvement of 
outcomes following many forms of neuronal injury. 
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5 IDENTIFICATION AND CHARACTERISATION OF A POPULATION OF 
MOTILE NEURONS WHICH EXPRESS ERM PROTEINS, IN LONG-
TERM CORTICAL CULTURE 
5.1 INTRODUCTION 
During cerebral cortical development, post-mitotic neurons generated in the proliferative 
ventricular zones migrate towards the pial surface in order to reach their correct position 
in the neocortex, a distance of several thousand micrometers in some species (reviewed 
by Tsai and Gleeson, 2005). Neurons cease migration when they receive the appropriate 
stop signals, and then settle into their position in the horizontal laminar organisation of 
the neocortex (reviewed by Bielas et al., 2004). They then develop an axon and 
dendrites, which form synaptic connections with other cells. From this point, neurons of 
the cortex are considered to become relatively immobile in the environment that is 
densely packed with neurons, their supporting cells, and the extracellular components. 
However, some neurons are able to migrate through regions of the more mature brain. 
For example, neural precursors are continually produced in the subventricular zone 
(Luskin, 1993) and migrate through the RMS to replace neurons of the olfactory bulb 
throughout life (Lois and Alvarez-Buylla, 1994; Doetsch and Alvarez-Buylla, 1996). 
There is also evidence suggesting that multiple forms of CNS injury induce 
neurogenesis in the mature brain (reviewed by Parent, 2003; Kulbatski et al., 2005), and 
cells can migrate toward cortical lesions (Sundholm-Peters et al., 2005). This has 
particular implications for brain injury and healing in the mature nervous system, since it 
has previously been assumed the adult CNS has a limited capacity for plasticity 
(reviewed by Chuckowree et al., 2004). 
Developmental neuron migration is partially influenced by directional guidance cues. 
These cues may exist in the form of ECM molecules and CAMs, as well as the more 
classically defined chemo-attractive and -repellent molecular guidance cues. While 
there has been a great deal of investigation into the roles of guidance cues in axonal 
outgrowth and pathfinding, much less is understood about how those same molecules 
influence neuron migration (see reviews by Park et al., 2002; Ward et al., 2003), and 
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whether they are similarly effective in modulating the behaviour of more mature 
neurons. Guidance cues interact with their specific receptors on the surface of neurons, 
which activates intracellular signalling cascades (for review see Song and Poo, 2001), in 
turn modulating microtubule and actin cytoskeleton components (reviewed by Meyer 
and Feldman, 2002; Tsai and Gleeson, 2005) and their associated molecules, to bring 
about the structural changes required for a neuron to undergo translocation. 
Doublecortin (DCX), a MAP-like protein (Feng and Walsh, 2001), has received 
increasing attention due to its crucial role in developmental neuron migration, which is 
evidenced by disorders of migration resulting from mutation in the gene encoding DCX 
(reviewed by Gleeson, 2000). 
The ERM proteins are also potentially important for neuron migration, as they function 
in mechanisms important for motility, including cell-substrate adhesion, and the 
localisation of surface adhesion molecules (for example, Lee et al., 2004). They have 
also been shown to be important for migration in a number of cell types, including 
lymphocytes, epithelial cells and tumour cells (for example, Sahai and Marshall, 2003; 
Nijhara et al., 2004; Borm et al., 2005). This, combined with their expression in regions 
of migration in the developing brain (Mintz et al., 2003), ideally places them as 
important for neuron migration, although this role has not been fully investigated. 
In vitro neuron cultures derived from the embryonic neocortex are a heterogeneous 
population of neuronal phenotypes, which correlate well with in vivo neuronal 
phenotypes (Fletcher and Banker, 1989; Banker and Goslin, 1998). When cortical 
neurons are maintained in long-term culture, they develop characteristics comparable to 
mature neurons in vivo, including polarisation (de Lima et al., 1997), the loss of 
developmental markers (Chuckowree and Vickers, 2003), expression of specific protein 
markers related to maturity (de Lima et al., 1997; Chuckowree and Vickers, 2003) and 
formation of synapses (Ichikawa et al., 1993; de Lima et al., 1997), as well as exhibiting 
electrophysiological properties, including the generation of potentials (Dichter, 1978; 
Brodie et al., 1986). Furthermore, in vitro techniques have been used successfully to 
study neuron migration (for example, Behar et al., 2001; Kholmanskikh et al., 2003), 
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and have particular merit in facilitating the observation of individual cells (BeIlion et al., 
2005; Nobes and Hall, 1999). 
The current experiments have utilised the previously described in vitro transection 
model (Chapter 4) to observe the motile capacity of neurons in primary cortical cultures. 
This model bears similarity to the wound-healing assays used to observe motility in 
other cell types, such as fibroblasts (Nobes and Hall, 1999). A highly motile population 
of neurons in long-term culture was observed after transection injury. To establish 
specific phenotypic characteristics, their cytoskeletal profile was examined. 
Furthermore, whether ERM proteins play a role in this in vitro translocation, and 
migration in the embryonic brain, was examined. Cytoskeletal disrupting 
pharmacological agents were used to determine the role of the microtubule cytoskeleton 
in mediating the observed motility, and the motile neurons' response to isolated 
guidance cues including Li, laminin and Sema 3A was observed. 
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5.2 MATERIALS AND METHODS 
5.2.1 Substrate preparation and cell culture 
Laminin, L 1-Fc protein, poly-1-lysine and Sema 3A/Fc were applied as substrates, 
described in section 2.1.1 (Materials and Methods). A range of Sema3A/Fc 
concentrations were tested, and at 4tag/mL showed inhibitory effects, while supporting 
adhesion and neuron growth. Laminin was the standard culture substrate in these 
experiments. Primary dissociated cortical neuron cultures were prepared as described in 
sections 2.1.2 and 2.1.3 (Materials and Methods). 
5.2.2 In vitro neuronal transection injury 
Post-injury motility assays were performed on cortical neurons in long-term culture (21 
DIV) by subjecting them to transection injury, according to procedures described in 
section 2.2 (Materials and Methods). Coverslips were photographed to produce a time-
lapse imaging sequence (images obtained every 4 hours over a 24 hour period post-
injury), then fixed with 4% PFA, or in all other experiments, fixed at 24 hours post-
injury with 4% PFA or 10% TCA for immunocytochemistry. For cytoskeletal disruption 
studies, taxol (Sigma), a microtubule stabilising agent (Schiff and Horwitz, 1980), was 
initially reconstituted with 20% DMSO / 0.01M PBS, then applied to neuron cultures at 
a final concentration of 1 Otig/mL (Chuckowree and Vickers, 2003). Nocodazole 
(Sigma), a microtubule destabilising agent (Samson et al., 1979), was reconstituted with 
50% DMSO / 0.01M PBS, then applied at a final concentration of l[tg/mL 
(Chuckowree, 2005). Drugs were applied immediately after the injuries were 
performed. Vehicle control treated cultures were processed concurrently. 
5.2.3 5-Bromo-2'-deoxyUridine (BrdU) incorporation 
To assay the approximate birth date of neurons in the current in vitro model, cortical 
neuron cultures were incubated with 51kM  or lORM of the thymidine analogue BrdU 
(Sigma) at 1, 7 and 17 DIV for 72 hours, or applied at 21 DIV, at the time of transection 
injury. Injuries were performed on cultures at 21 DIV and fixed 24 hours post-injury. 
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Dividing cells within the time frames of application were identified by immunolabelling 
with an antibody with immunoreactivity to BrdU (Table 5.1). 
5.2.4 Immunocytochemistry 
Cortical neuron cultures were immtmolabelled with a range of primary antibodies 
(details are provided in Tables 2.1 and 5.1) using standard protocols described in section 
2.3 (Materials and Methods). Isotype and species appropriate Alexa Fluor secondary 
antibodies were used to visualise antibody localisation (Table 2.2). To visualise cell 
nuclei, Nuclear Yellow (0.01%) was applied for ten minutes following completion of 
secondary antibody incubation. 
5.2.5 Immunohistochemistry 
Sections from E 18 rat cortex were examined to determine the localisation of ERM 
proteins in vivo, a developmental stage when cortical migration is not yet completed 
(Ignacio et al., 1995). Brains were removed, immersion fixed with 4% PFA, and 
cryoprotected with sucrose solutions. 4011m coronal sections were prepared using a 
cryostat. Sections were immunolabelled with an antibody to DCX (1:2000; Table 5.1), 
and an antibody to phosphorylated ERM (1:100; Table 2.1), and stained with Nuclear 
Yellow (0.01%). Isotype and species appropriate Alexa Fluor secondary antibodies 
(1:500) were used to visualise antibody localisation (Table 2.2). 
5.2.6 Microscopy and analysis 
A Leica DM IRB inverted microscope equipped with a heated stage (37°C) was used for 
time-lapse microscopy and immunofluorescence analysis was performed using a Leica 
DM LB2 microscope, as described in section 2.4 (Materials and Methods). For 
cytoskeletal disruption studies and assessment of the role of guidance cues in motility, 
Improvision Openlab software was used to determine the average number of neurons 
located within lesion sites, per mm of lesion length, was determined and the distance of 
translocation was measured as the minimum distance from the edge of the lesion to the 
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Table 5.1 Primary antibodies for immunocytochemistry 
Antibody Species Dilution Supplier 
anti-BrdU mouse 1: 1000 BD 
anti-GFAP mouse 1: 2000 Chemicon 
anti-ferritin rabbit 1: 2000 DAKO 
anti-GAD 65 mouse 1: 500 Chemicon 
anti-GAD 67 mouse 1: 1000 Chemicon 
anti-calretinin rabbit 1: 5000 Chemicon 
anti-nestin mouse 1: 2000 BD 
anti-a-internexin mouse 1: 1000 Chemicon 
anti-NeuN mouse 1: 1000 Chemicon 
anti-NF-L rabbit 1: 500 Novus 
anti-NF-M rabbit 1: 1000 Serotec 
anti-NF-H rabbit 1: 1000 Serotec 
anti-NCAM-L 1 rat 1: 1000 Santa Cruz 
anti-DCX guinea pig 1: 10000 Chemicon 
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neuron cell body. Fifteen to twenty injury sites from three separate neuronal cultures 
were included in the statistical analysis. 
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5.3 RESULTS 
5.3.1 Motile neurons infiltrate the injury site following transection in primary 
cortical neuron cultures 
The well-established in vitro transection injury model based on neurons in long-term 
culture (21 DIV; Dickson et al., 2000) results in a typical progression of changes, 
beginning with retraction of the injury site edges (Chuckowree and Vickers, 2003), and 
then a cell free injury site (Figure 5.1 A). The model has been successfully used to 
observe the regenerative neurite sprouting response (for example, Dickson et al., 2000; 
Chuckowree and Vickers, 2003; Chapter 4). The sprouting response is robust, with 
injury sites almost completely covered with regenerative neurites by 48 to 72 hours post-
injury (Chapter 4). In the current experiments, time-lapse microscopy was performed 
over the 24 hours following transection injury, and has shown that accompanying 
regenerative neurite spouting is a phenomenon in which a distinct population of motile 
neurons enter the injury site (Figure 5.1). This response was initiated within the first 4 
hours of injury and by 24 hours was well established (Figure 5.1 A). The cells 
positively immunolabelled with the neuronal marker 13-III-tubulin (Figure 5.1 B), but 
were not immunolabelled with an antibody to the astrocyte marker GFAP (Figure 5.1 C), 
the principle glial cell phenotype in cortical neuron cultures. 
Particular aspects of the morphological characteristics of the motile neuron population 
are indicative of their motile ability. They are small, multipolar neurons that, in many 
cases, did not appear to be polarised (Figure 5.1 B). Furthermore, they had not 
developed the long neurites characteristic of other neurons at 21 DIV, such as pyramidal 
neurons, nor did they appear to synapse with other neurons in culture. In combination, 
these characteristics initially suggested that they might be a neural progenitor 
population. However, in contrast to this hypothesis, previous studies from our 
laboratory have shown that at 21 DIV all neurons are at least 14 days of age in cortical 
neuronal cultures (Chuckowree and Vickers, 2003), due to the inability of post-mitotic 
neurons to undergo any further divisions. Therefore, further studies were performed to 
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Figure 5.1 Identification of a distinct population of motile neurons in long-
term cortical neuron cultures. Cortical neurons were grown in culture until 21 
DIV, when they were subjected to transection injury. A. The response to injury 
was examined by time-lapse microscopy. Injury sites were photographed from 0 
hours (immediately after the injury) to 24 hours post-injury, at 4 hour time 
intervals. Within 4 hours post-injury, neurons had entered the injury site (arrow, 
inset is a magnification of the neuron), a phenomenon that increased over the 24 
hours post-injury. Immediately after the 24 hour post-injury timepoint the neuron 
cultures were fixed and immunolabelled, to identify whether the motile cells were 
neurons (13-III-tubulin labelling) or glial cells (GFAP labelling). B. 13-III-tubulin 
immunolabelling, a magnification of the boxed area in A, demonstrated that the 
motile cells were neurons. The neurons were small, multipolar neurons, only a 
subset of which appeared to be polarised (arrows). C. Co-immunolabelling with 
GFAP demonstrated that none of the cells within the injury site (in B) were a glial 
phenotype (arrows). Dashed lines outline the injury border. Scale bar: A = 
100[1m, inset = 501..tm; B-C = 50Rm. 
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identify the neurons based on their neurochemical characteristics, with a particular focus 
on determining their phenotype and stage of maturation. 
5.3.2 Motile neurons do not incorporate BrdU, indicating that they are 21 days 
old 
To assay the approximate birth date of neurons in culture, the thymidine analogue BrdU 
was applied to cultures at a range of time-points, including 1-4 DIV, 7-10 DIV, 17-20 
DIV and immediately after injury at 21 DIV, to detect dividing cells within those time-
frames. Neuron cultures were then injured at 21 DIV, and immunolabelled 24 hours 
post-injury to examine when the motile neuron population emerges. 
Interestingly, the motile neuron population did not incorporate BrdU at any of the 
timepoints tested (Figure 5.2 A-D), indicating that these neurons were present at the 
beginning of the culture period and therefore at least 21 days old. However, this motile 
ability does not fit with the traditional view of more mature neurons in long-term 
culture. The possibility that the cells resulted from proliferation in response to the injury 
was unlikely because BrdU applied at the time of injury was not incorporated into the 
motile neurons (Figure 5.2 D). 
BrdU application to cell cultures at a concentration of 101LiM, at 1 DIV (Figure 5.2 A) for 
72 hours may have had a toxic effect, therefore resulting in an observed decreased 
amount of incorporation into cells compared to other timepoints. This possibility was 
recognised because more proliferating cells at earlier timepoints would have been 
expected. Therefore, to account for any toxic effect a lower concentration of BrdU, 
541A was employed as comparison with the 10[tM concentration, and all of the 
representative cultures shown in Figure 5.2 were treated with the lower concentration. 
The continued efficacy of BrdU incorporation to identify dividing cells at the lower 
concentration is demonstrated in Figure 5.2, with immunolabelling often observed in the 
nuclei of cells with glial morphology rather than neurons (for example, Figure 5.2 D). 
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Figure 5.2 BrdU incorporation in cortical neuron cultures. To determine the 
approximate birth date of the motile neuron population, cultures were incubated 
with BrdU at various timepoints throughout the culture period and then injured at 
21 DIV. 24 hours post-injury, cultures were fixed and immunolabelled with NF-
M, to identify neurons, and an antibody to BrdU, to detect dividing cells. A. 
BrdU applied at 1 DIV and removed after 72 hours. Very few cells were BrdU 
labelled at this early timepoint. B. BrdU applied at 7 DIV for 72 hours. C. 
BrdU applied at 17 DIV for 72 hours. D. BrdU added immediately after injury. 
The large arrow indicates a cell of glial morphology that incorporated BrdU. A to 
D show that the motile neuron population (arrows) did not immunolabel with the 
antibody to BrdU (arrowheads) at any of the timepoints tested. Scale bar = 50um. 
BrdU 
Chapter 5 - Results 
5.3.3 The cytoskeletal profile of motile neurons indicates they are differentiated, 
but not mature 
In order to determine the specific phenotype and stage of maturation of the motile 
neuron population after injury, cortical neuron cultures were grown until 21 DIV, 
subjected to transection injury, fixed at 24 hours post-injury and immunolabelled with a 
range of antibodies. The results are summarised in Table 5.2 and illustrated in Figure 
5.3. The neurons did not positively immunolabel with antibodies with reactivity to 
GFAP (Figure 5.3 A), a marker of astrocytes, or ferritin (Figure 5.3 A), a marker for 
microglia, but as previously discussed the cells were immunolabelled with an antibody 
to the neuron-specific type III (3-tubulin (Figure 5.1 B, Figure 5.3 D). 13-III-tubulin is a 
component of microtubules and often considered a marker of immature neurons, 
however in long-term cultures neurons were observed to continue to uniformly express 
P-III-tubulin throughout the cell (for example, Figure 5.3 D). 
Due to the morphology of motile neurons, it was initially hypothesised that they might 
be an interneuron phenotype. However, the motile neuron population did not 
immunolabel with the GABAergic neuron markers GAD 65 and GAD 67 (for example, 
Ogoshi and Weiss, 2003; Figure 5.3 B and 5.3 C, respectively), nor were they positive 
for calretinin (Figure 3D), a calcium binding protein localised to a subset of GABAergic 
neurons (for example, Pappas and Parnavelas, 1998). Therefore, the motile neurons did 
not display common neurochemical characteristics of interneurons. 
The expression of markers related to development and maturity was examined in the 
motile neuron population. The neurons did not immunolabel with an antibody to nestin 
(Figure 5.3 E), which is an intermediate filament protein expressed by neural precursors 
(recently reviewed by Michalczyk and Ziman, 2005), which suggested that they had 
differentiated into neurons. The motile neurons did, however, express a-internexin 
(Figure 5.3 F), an intermediate filament protein that starts to be expressed during 
neuronal differentiation (Shea and Beermann, 1999), and shows compartmentalised 
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Table 5.2 The cytoskeletal profile of motile neurons 
Antibody Immunoreactivity 
anti-GFAP astrocytes — 
anti-ferritin microglia — 
anti-13-III-tubulin microtubules, neuron specific + 
anti-GAD 65 GABAergic interneurons — 
anti-GAD 67 GABAergic interneurons — 
anti-calretinin a subset of GABAergic interneurons — 
anti-ne stin neural progenitor cells — 
anti-a-internexin neuronal intermediate filament + 
anti-NeuN post-mitotic neurons — 
anti-NF-L neuronal intermediate filament, marker of 
early neurons 
+ 
anti-NF-M neuronal intermediate filament, marker of 
early neurons 
+ 
anti-NF-H neuronal intermediate filament, marker of 
more mature neurons 
— 
anti-MAP2 microtubule associated protein — 
anti-tau microtubule associated protein + 
anti-NCAM-L 1 polarised neurons + 
anti-DCX migrating neurons — 
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Figure 5.3. Characterisation of the motile neuron population by examination 
of the cytoskeletal profile. Neurons were grown in culture until 21 DIV, when 
they were injured. 24 hours post-injury they were fixed and immunolabelled with 
a range of antibodies to facilitate identification of the phenotype of the motile 
neuron population. Refer to Table 5.2 for specific immunoreactivity details. A. 
Neurons within the injury site did not immunolabel with antibodies to either 
GFAP (green) or ferritin (red). B. Motile neurons were immunopositive for NF-
M (red), but not GAD 65 (green). C. Neurons were immunolabelled with the 
MAP tau (red), but not GAD 67 (green). D. 13-III-tubulin (green) is uniformly 
expressed in cortical neurons at 21 DIV (arrowhead) and was similarly expressed 
by motile neurons, but they did not label with calretinin (red). E. Tau (red) 
labelled motile neurons did not immunolabel for nestin (green). F. The motile 
neurons were labelled with both a-internexin (green) and NF-M (red). G. Tau 
(red) labelled motile neurons were not immunopositive for NeuN (green), which 
labelled only a subset of neuronal nuclei in cultures (arrowhead). H. p-III-
tubulin (green) co-immunolabelling with NF-L (red). I. 13-III-tubulin (green) 
positive motile neurons were in some cases very weakly labelled with NF-H (red - 
arrow). J. Tau (red) labelling was more intense in the axon of polarised neurons 
(arrow), but motile neurons did not immunolabel with MAP2 (green). K. In 
many areas P-III-tubulin (green) co-localised with Ll (red), but Li labelling was 
more notable in the axon of polarised neurons (arrow). L. 13-III-tubulin (green) 
labelled motile neurons were not labelled with DCX (red). Dashed lines in B, C, 
E and J-L outline the injury border. Scale bar = 50Rm. 
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localisation in the axon and, particularly dendrites (Benson et al., 1996), of a sub-
population of neurons in long-term culture (Dickson et al., 2005). In contrast, the 
neurons did not immunolabel with the post-mitotic neuronal marker NeuN (Figure 5.3 
G), but it was noted that this marker only labelled a small population of neurons 
throughout the cultures. Motile neurons were labelled with NF-L (Figure 5.3 H) and 
NF-M (Figure 5.3 F), but NF-H was either absent, or alternatively showed very weak 
immunolabelling confined to the soma (Figure 5.3 I). NFs are neuron-specific 
cytoskeletal intermediate filament proteins expressed by distinct neuron populations 
(Vickers and Costa, 1992; Kirkcaldie et al., 2002), predominantly in the axon (Benson et 
al., 1996). Neuronal labelling with NFs is indicative of their level of maturity, because 
NF-L and NF-M are expressed earlier than NF-H (Benson et al., 1996; reviewed by 
Lariviere and Julien, 2004). NF-H expression is often associated with more mature 
neurons, which might imply that the motile neurons had not reached full maturity. The 
motile neurons also did not express MAP2 (Figure 5.3 J), which increases in dendrites 
with maturation (de Lima et al., 1997) and persists in long-term cortical cultures. Thus, 
these data indicate that the neurons were differentiated, but perhaps not mature. 
In contrast to MAP2 immunolabelling, motile neurons did express the MAP tau (Figure 
5.3 J). Tau is involved in the establishment of polarity in neurons (Caceres and Kosik, 
1990). Tau was localised to the cell body of motile neurons, with weaker localisation in 
neurites. Occasionally there was more distinct localisation in one neurite, which was 
likely to be the axon (Figure 5.3 J). The NCAM-L1 antibody immunolabels the axon 
specific, developmentally expressed, CAM Ll (Persohn and Schachner, 1987; 
Linnemann et al., 1988). Motile neurons showed weak positive cellular distribution of 
LI, with more intense labelling in one neurite, the axon, in some motile neurons (Figure 
5.3 K). Therefore, most motile neurons had not yet become polarised. 
Quite surprisingly, the motile neurons did not immunolabel with DCX (Figure 5.3 L), a 
marker of migrating immature neurons (Gleeson et al., 1999) that is strongly associated 
with microtubule function. DCX expression is most often associated with cell bodies 
and the leading processes of migrating neurons and the axons of axons of differentiating 
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neurons (Francis et al., 1999; Friocourt et al., 2003). Therefore, the current results 
suggested that DCX expression is not required for motility per se in the motile neuron 
population. In contrast, other larger neurons with more highly extended and elaborate 
processes within the same culture were strongly itrununopositive for DCX (Figure 5.4). 
5.3.4 ERM proteins are localised to the motile neuron population, in vitro and 
immature neurons of the embryonic cortex, in vivo 
As previously described, under normal culture conditions, by 21 DIV phosphorylated 
ERM is not expressed (Chapter 3). However, immunocytochemical analysis of the 
motile neurons that had undergone translocation into the injury site revealed a striking 
expression of phosphorylated ERM localised in neurite filopodia and growth cone-like 
structures (Figure 5.5 A). While other elements of the cytoskeletal profile suggested that 
the motile neurons had not reached the same level of maturity as other neurons in 
culture, examination of uninjured cultures did not reveal any obvious neuron populations 
that continued to express phosphorylated ERM at 21 DIV (Figure 5.5 B). Thus, it was 
unlikely that this population had continually expressed phosphorylated ERM throughout 
the culture period. Therefore, phosphorylated ERM might have been specifically re-
expressed for translocation, which strongly supports a role for ERM proteins in 
migration. 
Due to the expression of phosphorylated ERM in the motile neuron population, ERM 
expression was assessed in a well-characterised stage of migration in the embryonic 
cortex during brain development to determine whether ERMs are also involved in 
migration of immature neurons in vivo. Analysis of brain sections from E 18 rats 
revealed extensive DCX labelling, which identified immature migrating neurons, in the 
cortical plate and intermediate zone, regions also known to be strongly immunopositive 
for the ERM proteins at the same stage of development (Mintz et al., 2003). In 
agreement with that study, double labelling revealed that axons labelled with DCX were 
co-labelled for the ERM proteins (Figure 5.6 A-D). In addition, a subset of neurons 
located within the intermediate zone, at the border of the ventricular zone, also 
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Figure 5.4 DCX immunolabelling in cortical neuron cultures at 21 DIV. 
Primary cortical neurons in culture were injured at 21 DIV, and immunolabelled 
with antibodies to 13-III-tubulin (green) and DCX (red). While the motile neuron 
population did not express DCX (Figure 5.3), a subset of neurons in the cultures 
did co-immunolabel with antibodies to 13-III-tubulin and DCX (arrows). Scale bar 
= 301.1.m. 

Figure 5.5 Phosphorylated ERM expression in the motile neuron population. 
Neurons were grown in culture until 21 DIV, when they were injured. 24 hours 
post-injury they were fixed and immunolabelled with antibodies to 13-tubulin (red) 
and phosphorylated ERM (green). A. Immunocytochemical analysis of the 
motile neurons that underwent translocation into the injury site revealed a striking 
expression of phosphorylated ERM, localised in neurite filopodia and growth 
cone-like structures (arrows). B. In contrast, examination of uninjured areas of 
the cultures did not reveal any obvious neuron populations that continued to 
express phosphorylated ERM at 21 DIV. Neurons in uninjured areas displaying 
similar morphology to the motile neuron population did not express 
phosphorylated ERM (arrows), which suggested phosphorylated ERM was 
expressed specifically by translocating neurons in the response to injury. Scale 
bar = 50p.m. 

Figure 5.6 Phosphorylated ERNI and DCX immunolabelling in migrating 
neurons of the embryonic neocortex. The embryonic (El 8) cortex was 
examined by immunohistochemistry to determine whether migrating neurons, 
identified by DCX immunolabelling (red), also expressed phosphorylated ERM 
(green). A. The cortical plate of El 8 neocortex contained neurites 
immunopositive for phosphorylated ERM proteins (arrow). B. DCX 
immunolabelling of the same region as shown in A, the arrow indicates the same 
neurite was also labelled with DCX. C. A composite image of phosphorylated 
ERM and DCX immunolabelling demonstrates co-localisation, as indicated by the 
arrow. D. An increased magnification of A, to show specific ERM labelling 
(arrowhead). E. An increased magnification of B, to show specific DCX 
immunolabelling (arrowhead). F. Neuronal cell bodies at the border of the 
intermediate and subventricular zones were often labelled for phosphorylated 
ERM (arrow). G. DCX immunolabelling of the same area in E demonstrated 
labelling with DCX, as indicated by the arrow. H. A composite image of 
phosphorylated ERM and DCX immunolabelling demonstrates the somal co-
localisation (arrow). I. An increased magnification of F, to show specific ERM 
localisation (arrow). J. An increased magnification of G, to show specific DCX 
localisation (arrow). Scale bar: A — C, F — H = 20iim; D - E, I, - J = 10gm. 
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expressed both DCX and ERM proteins (Figure 5.6 E-J). These data further implicate 
the ERM proteins as contributing to the specific mechanisms underpinning neuronal 
migration. 
5.3.5 Microtubule destabilisation induced by nocodazole significantly increases 
neuron motility 
The cytoskeletal altering agent's taxol and nocodazole were used to examine the role of 
the microtubule cytoskeleton in translocation in the motile neuron population. The 
agents were applied immediately after transection injury, then 24 hours post-injury 
cultures were fixed and immunolabelled to facilitate observation of changes in motile 
ability, compared with vehicle controls. 
Interestingly, microtubule stabilisation through taxol application resulted in no 
significant changes in the number of neurons that entered the injury site (3 ± 0.83 
neurons/mm injury) comPared with the vehicle control treated cultures (7 ± 1.93 
neurons/mm injury; p = 0.08; Figure 5.7 A). Similarly, nocodazole treatment, which is 
used to destabilise microtubules, resulted in no significant changes in the number of 
neurons that entered the injury site in the treated cultures (5 ± 1.99 neurons/mm injury) 
compared with vehicle controls (9 ± 2.34 neurons/mm injury; p = 0.08; Figure 5.7 B). 
Taxol caused no changes in the distance of neuron translocation into the injury site (25 ± 
1.69m), compared with controls (28 ± 1.38m; p = 0.15; Figure 5.7 C). In contrast, 
nocodazole treatment resulted in significantly increased distance of translocation into the 
injury site (33 ± 1.88pm), compared with controls (25 ± 0.96Rm; p < 0.05; Figure 5.7 
D). It was also observed, particularly in nocodazole treated cultures, that neurons which 
had entered the injury site were often rounded, with no neurites observed by 
immunolabelling. Therefore, it is possible that the neurites were lost in response to 
treatment, although simultaneous labelling of nuclei did not suggest that the health of 
neurons was compromised by either taxol or nocodnzole treatment. 
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Figure 5.7 The effect of microtubule altering agents on the motile neuron 
population. Primary cortical neuron cultures were grown until 21 DIV, when 
they were subjected to transection injury. Immediately after injury they were 
treated with taxol (10tig/mL) or nocodazole (1p,g/mL), or their vehicle controls. 
24 hours post-injury cultures were fixed and analysed for the effect of 
microtubule disrupting agents on the motility of the neuron population. A. The 
number of neurons per mm of lesion after taxol treatment, compared with vehicle 
controls. B. The number of neurons per mm of lesion after nocodazole treatment, 
compared with vehicle controls. C. The mean distance of neuron translocation 
into the lesion after taxol treatment, compared with vehicle control treated 
cultures. D. The mean distance of neuron translocation into the lesion after 
nocodazole treatment, which was significantly greater than vehicle control treated 
cultures. * represent p values less than 0.05. Error bars are -± SEM. 
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5.3.6 Motile neurons are significantly influenced by substrate bound molecular 
guidance cues 
The effect of molecular guidance cues on neuron motility has not been widely studied, 
although it is thought that the same molecules important for axon guidance are probably 
involved in neuron migration (reviewed by Song and Poo, 2001). Therefore, the effects 
of poly-l-lysine, laminin, Li and Sema 3A on motility in this neuron population were 
studied. Neurons were grown on substrates containing each of the guidance cues until 
21 DIV, injured and then 24 hours post-injury the number of neurons and their distance 
of translocation into the injury site were examined. 
Culturing cortical neurons on substrates of the different guidance cues resulted in 
significant changes in aspects of neuron motility. This primarily demonstrates that post-
mitotic neurons in long-term culture are responsive to guidance cues. Laminin 
substrates promoted the greatest neuron motility, with significantly more neurons 
entering the injury site (17 neurons/mm ± 1.41) than on any other substrate, including 
poly-l-lysine (11 neurons/mm ± 1.42), Li (9 neurons/mm ± 0.93) and Sema 3A (5 
neurons/mm ± 1.3) (p < 0.05; Figure 5.8 A). Figure 5.8 B shows that a similar pattern 
was observed with respect to the distance of movement, in response to the guidance 
cues. Therefore, the laminin substrate promoted the greatest average distance of 
translocation (37Rm ± 0.94), which was significantly greater than poly-l-lysine (34pm ± 
1.01), Li (291im ± 1.0) and Sema 3A (26[tm ± 1.06) (p <0.05). The poly-l-lysine 
substrate promoted the next greatest mean distance of translocation, which was 
significantly greater than the distance of translocation on Li (p < 0.05) and Sema 3A (p 
<0.05). Li also promoted a significantly higher mean distance of neuronal translocation 
when compared with Sema 3A (p < 0.05). Therefore, these results confirm that 
developmental guidance cues potentially influence the motility of neurons after their 
differentiation. 
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Figure 5.8 The effect of molecular guidance cues on the motile neuron 
population. Primary cortical neurons were grown on substrates containing 
laminin, Li, poly-l-lysine or Sema 3A until 21 DIV, when they were subjected to 
transection injury. 24 hours post-injury cultures were fixed and analysed for 
differences in aspects of the motility of the neuron population. A. The number of 
neurons per mm of lesion when grown on the four different substrates. B. The 
average distance of neuron translocation in response to substrate bound guidance 
cues. * represent p values less than 0.05. Error bars are -±- SEM. 
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5.4 DISCUSSION 
These experiments have demonstrated the existence of a highly motile population of 
neurons in long-term primary cortical neuron cultures, identified because they rapidly 
infiltrate the injury site following transection. They did not incorporate BrdU at any of 
the timepoints tested throughout the culture period. Immunolabelling with a range of 
markers indicated that the neurons were differentiated, but had possibly not reached the 
maturity of other neurons in culture. Motile neurons specifically expressed 
phosphorylated ERM proteins, which suggested a role in neuron translocation and 
migration. The role of the microtubule cytoskeleton in motility was examined, namely 
by application of taxol or nocodazole, which showed that microtubule destabilisation 
significantly enhanced aspects of neuron motility. The motile neurons were responsive 
to molecular guidance cues, in a similar manner to that expected of neural precursors or 
immature neurons, with laminin substrates promoting significantly greater motility than 
those containing Li or Sema 3A. 
The transection injury model facilitated the novel observation that a population of highly 
motile neurons infiltrates the injury site. BrdU incorporation studies initially indicated 
that the neurons were present from the beginning of culture; therefore they were at least 
21 days old. Neurons at 21 DIV are considered long-term cultures and most individual 
neurons displayed morphological and neurochemical characteristics of maturity, but this 
did not apply to the motile neuron population. Examination of the motile neurons' 
cytoskeletal profile suggested that they were not neural precursor cells, because they 
were not immunolabelled with nestin. Instead, they were post-mitotic and differentiated 
into a neuronal phenotype, as indicated by their immunoreactivity to markers including 
f3-III-tubulin, a-internexin, NF-L and NF-M. In addition, a subset of the motile neurons 
was polarised, identified by specific axonal inununolabelling with the markers tau and 
Ll. 
Factors that indicated the motile neurons had not matured included their lack of 
immunolabelling with antibodies to MAP2 and NF-H. Multiple MAP2 isoforms and 
phosphorylation states (Riederer and Innocenti, 1992) make the exact expression profile 
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of MAP2 complicated, but it appears that expression is conserved amongst all neuronal 
phenotypes of the cortex in vivo, except in aging neurons an eventual decrease in MAP2 
mRNA and protein expression occurs (Riederer and Innocenti, 1992). Furthermore, 
while the NF triplet is only expressed in a specific subset of cortical neurons (Vickers 
and Costa, 1992; Kirkcaldie et al., 2002), the motile neurons expressed NF-L and NF-M, 
which indicated they would also eventually express NF-H. NF-L is the first NF 
expressed, followed by NF-M and then NF-H (reviewed by Lariviere and Julien, 2004), 
a pattern that is also observed in culture (Benson et al., 1996). Therefore, the virtual 
absence of NF-H immunolabelling was another indicator that the neurons had not 
reached maturity. However, a very weak expression of NF-H immunolabelling in the 
cell bodies of some motile neurons was observed, but it was not possible to decipher 
whether this represented the initial stages of NF-H production in the perikaryon 
(Lariviere and Julien, 2004). 
The motile neuron population did not express DCX, which is proposed to function in 
microtubule stabilisation. DCX is most predominantly expressed by migrating immature 
neurons during development (Gleeson et al., 1999), and is thus commonly used as a 
marker of neuron migration. DCX is also expressed by newly generated neurons in the 
adult brain (Brown etal., 2003) migrating along the RMS (Gleeson et al., 1999; 
Koizumi et al., 2006). The lack of DCX expression in the motile neuron population may 
be related to the fact that these neurons appear to have completed differentiation and in 
some cases were polarised, which might mean they are more mature than the neurons 
commonly identified by this marker. It may also be that the actin cytoskeleton might be 
the predominant system used in this motility, perhaps due to their phenotype or stage of 
maturity. The expression of DCX by some clearly differentiated neurons in non-injured 
areas of the culture was unexpected, but confers with an immunohistochemical study by 
Nacher and colleagues, which identified differentiated cells immunoreactive for DCX in 
a number of areas of the adult rat brain not related to neuronal migration (Nacher et al., 
2001). 
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The observation that phosphorylated ERM immunolabelling was specific for the motile 
neuron population in in vitro experiments strongly implied a role in neuron migration. 
Previous immunohistochemical studies support this conclusion. For example, ezrin is 
localised to migrating neurons of the intermediate zone in the prenatal human cerebrum 
(Johnson et al., 2002), and in another study, phosphorylated ERM was localised to 
processes throughout the intermediate zone of the embryonic (E17) rat cortex (Mintz et 
al., 2003). Therefore, this study sought to extend on this information by specifically 
examining phosphorylated ERM expression in the embryonic cortex in relation to DCX, 
which is localised to immature migrating neurons. DCX immunolabelling co-localised 
with phosphorylated ERM in axons and cell bodies of neurons within migratory zones of 
the cortex. This provides further evidence that ERMs are not only involved in in vitro 
translocation, but developmental migration, in vivo. Their associations with both the 
actin and microtubule cytoskeleton make them likely candidates for multiple functions 
in neuron migration. 
To further understand the role of the microtubule cytoskeleton in neuron motility the 
microtubule stabilising agent taxol, and the microtubule destabilising agent nocodazole 
were used. Both agents have been used extensively to study microtubule dynamics in 
functions such as neurite initiation (Smith, 1994; Dehmelt et al., 2003), neurite 
outgrowth (Ruthel and Banker, 1998; Gallo and Letourneau, 1999; Chuckowree and 
Vickers, 2003), growth cone morphology and behaviour (Mansfield and Gordon-Weeks; 
1991; Williamson et al., 1996; Rajnicek and McCaig, 1997; Gallo, 1998; Buck and 
Zheng, 2002) and axonal transport (Thies and Meller, 2000; Francis et al., 2005), but 
have only rarely been used in studies of neuron motility and migration (Schaar and 
McConnell, 2005). Schaar and McConnell (2005) showed that the application of 
nocodazole (1[1,M) resulted in no difference in the velocity or the distance of nuclear 
translocation of neurons isolated from the anterior subventricular zone, in vitro, which 
suggested that another cytoskeletal system controls nuclear movement. Indeed, the actin 
cytoskeleton is strongly implicated in migration in many cell types. In contrast, in these 
experiments nocodazole significantly increased the distance of Iranslocation into the 
injury site. The sensitivity of neurons to nocodazole treatment in this model might be 
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related to their lack of DCX expression, because Yoshiura et al., (2000) demonstrated 
that in some cases DCX stabilises microtubules against nocodazole treatment. 
In these experiments, the identified motile neuron population was affected by molecular 
guidance cues, which is promising for reasons related to post-injury regenerative 
responses in the mature brain. Various forms of CNS insult have been shown to induce 
neurogenesis in both the subventricular zone and hippocampal dentate gyms (reviewed 
by Parent, 2003). There is also an increasing interest in the possibility of implanting 
stem cells to assist in functional recovery after CNS trauma and in neurological 
disorders (recently reviewed by Lindvall and Kokaia, 2006). Cell therapies, utilising 
endogenous or exogenous cells, are potentially feasible approaches, however unless the 
cells can migrate to areas of the brain where they are needed to replace lost neurons and 
are able to integrate into the neuronal circuitry they are not useful, and potentially 
detrimental. One approach to guiding migration of cells to their appropriate positions 
involves the manipulation of the expression patterns of guidance cues to patterns more 
like those observed during CNS development. These experiments show that post-
mitotic cortical neuron motility is effected by each of the guidance cues tested in a 
manner similar to their previously determined roles in axon guidance (for example, 
Bixby et al., 1989; Doherty et al., 1995; Polleux et al., 1998) and neuron migration (for 
example, Persohn and Schachner, 1987; Kearns et al., 2003; Tamamald et al., 2003), 
which indicates that the same developmental cues may be useful for guiding neurons at 
varying stages of maturity. 
Therefore, these analyses suggest that the motile neurons were committed to a neuronal 
fate, but had not matured at the same rate as other neurons typically observed in cortical 
neuron cultures. There may be as many as ten thousand different types of neuron 
(Muotri and Gage, 2006), and the neurochemical profile described here may be a 
reflection of the great diversity of neuronal phenotypes, rather than a product of culture 
conditions on developing neurons. Indeed, it is entirely possible that this population 
may never mature, or perhaps the onset of changes toward maturity was initiated by the 
injury itself. An interesting recent study has demonstrated that a population of 
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hippocampal precursor cells, under similar culture conditions, can be induced to 
differentiate into neuron-like cells by injury (Tseng et al., 2006). In a similar way, the 
motile neuron population in these cultures may be stimulated to mature by factors 
related to the injury. 
Therefore, these experiments identified a neuron population in long-term cortical 
cultures that does not fit the traditional view of mature neurons, with respect to their 
expression of cytoskeletal proteins, such as the ERM proteins, morphology and their 
motile ability. There are likely to be many yet undescribed neuronal phenotypes that 
may be of potential importance in the mature brain, perhaps after traumatic injury. We 
may be able to further manipulate their individual characteristics in therapeutic strategies 
to assist in functional regeneration in the adult brain. 
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6 RHO KINASE ACTIVATES ERM PROTEINS AND MEDIATES THEIR 
FUNCTION IN CORTICAL NEURON GROWTH, MORPHOLOGY AND 
MOTILITY 
6.1 INTRODUCTION 
ERM proteins exist in the cytosol in an inactive state that, upon activation, undergo a 
conformational change which allows binding to both plasma membrane proteins and 
actin filaments of the cytoskeleton (see review by Ramesh, 2004), resulting in a 
physical, and signal transduction link between the plasma membrane and cytoskeleton. 
The mechanisms underlying ERM activation and function are so far unresolved, and 
their stimulation and resulting cellular actions may be cell type specific as well as 
dependent on biological context. 
Like many cytoskeletal proteins, ERM protein activity is regulated by conformation. 
When inactive, the N- and C-terminal domains of the protein self-associate, masking the 
actin binding site (Gary and Bretscher, 1995). PIP 2 binding to an un-identified site in 
the N-terminal domain brings about activation (Hirao et al., 1996), while sequential 
phosphorylation (Fievet et al., 2004) of a specific C-terminal threonine (ezrin Thr 567, 
radixin Thr 564 and moesin Thr 558) stabilises ERM proteins in their active 
conformation, probably by preventing interaction of the N- and C-terminal domains 
(Matsui et al., 1998; Tsukita et al., 1999). Several kinases capable of phosphorylating 
the ERM C-terminal threonine have been identified, including PIP2 (Matsui et al., 1999; 
Fievet et al., 2004), PKC (PKCa and PKCO) (Ng et al., 2001), MRCK (Nakamura et al., 
2000) and Rho kinase (Matsui et al., 1998; Yonemura et al., 1999). Matsui and 
colleagues (1998) first identified that Rho kinase is capable of phosphorylating the ERM 
C-terminal threonine, but later the same group demonstrated that Rho kinase inhibition 
using the inhibitor Y27632 did not suppress Rho-dependent ERM activation (Matsui et 
al., 1999). However, in the rat hippocampal progenitor cell line, H19-7/1GF-IR, 
glutamate stimulates RhoA and Rho kinase dependent phosphorylation of moesin (Jeon 
et al., 2002). These data are indicative of a complex relationship between Rho signal 
transduction and ERM activation. 
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In the present study, the specific outcomes of Rho kinase activation of ERM proteins in 
neurons was investigated, both in previously elucidated ERM functions such as 
developmental neuronal growth and morphology and post-injury regeneration, as well as 
examining the potential role in neuronal translocation. 
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6.2 MATERIALS AND METHODS 
6.2.1 Substrate preparation and cell culture 
Poly-l-lysine, laminin, Li and Sema 3A substrates were prepared as described in section 
2.1.1 (Materials and Methods). Poly-l-lysine was the standard culture substrate for these 
experiments. Primary cortical neuron cultures were established according to procedures 
described in sections 2.1.2 to 2.1.3 (Materials and Methods). 
B35 neuroblastoma cells (ATCC®) were maintained in DMEM containing 10% FCS and 
1% penicillin/streptomycin. Prior to experimental use, cells were differentiated using a 
combined serum deprivation and incubation with dibutryrl cyclic AMP (cAMP) 
approach (Schmid et al., 1999). Cells were gown in DMEM containing 1% 
penicillin/streptomycin and 1mM dibutryrl cAMP (Sigma), but not FCS, for 
approximately 16 hours. Following this, the medium was replaced with fresh DMEM / 
1% penicillin/streptomycin. For experiments, Rho kinase inhibitor was applied to cells 
approximately 24 hours following differentiation. 
6.2.2 Rho kinase inhibitor 
In these experiments, a highly specific inhibitor of Rho lcinase, Rho kinase inhibitor II 
(Calbiochem) was utilised, which is abbreviated RKI II. RKI II shows little activity 
towards Erk, PKA or PKC, PDGFR or c-Kit/SCFR (1050> lORM to > 301..IM) (Takami 
et al., 2004). It was initially reconstituted to 5mg/mL with sterile DMSO and stored at - 
20°C. 
6.2.3 Rho kinase inhibition of phosphorylated ERM in primary cortical neurons 
To determine whether the Rho kinase inhibitor would effect the phosphorylation of 
ERM proteins in primary cortical neurons early in culture (0-2 DIV), preliminary 
experiments tested a range of concentrations (5 - 25011M), time-points post-plating for 
addition (0 hours to 1 DIV) and time-points for fixation (15 minutes —24 hours) and 
immunolabelling, to observe the effects of inhibition (data not shown). Based on this 
preliminary analysis, the effect of treatment with 'low' (50IAM) and 'high' (250RM) 
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concentration RKI II was compared in detail, with their respective DMSO vehicle 
controls. The 'low' concentration lies within the expected specificity range, and is 
comparable to the concentrations used for other inhibitors of Rho kinase, such as 
Y27632 (for example, Borisoff et al., 2003; Monnier et al., 2003). Therefore, the 'high' 
concentration represents the upper limit of this range, and the possibility of reduced 
specificity at the highest concentrations must be considered. RKI II was diluted 1:10 in 
NeurobasalTM medium and added to lmL culture medium at 24 hours post-plating (1 
DIV) and then 24 hours after addition (2 DIV) cultures were fixed with 10% TCA, as 
described in section 2.3.1 (Materials and Methods). Parameters of phosphorylated ERM 
expression and neuronal development were analysed, including axon length, axon 
phosphorylated ERM positive filopodia, growth cone phosphorylated ERM positive 
filopodia, dendrite number, dendrite length and dendrite phosphorylated ERM positive 
filopodia. 
6.2.4 Immunoblot analysis of RKI II activity 
To determine the efficacy of RKI II and confirm its effect on the levels of 
phosphorylated ERM in developing primary cortical neurons in the presence or absence 
of inhibitor, quantitative immunoblotting was utilised. Differentiated B35 
neuroblastoma cells were treated with 250RM RKI II or DMSO vehicle control for 24 
hours. For immunocytochemistry, B35 cells were fixed with 10% TCA. For 
immunoblotting, cells were washed once with ice cold 0.01M PBS and harvested using a 
lysis buffer containing 1% Triton, 500mM Sodium Fluoride (NaF, Sigma), 1mM 
Orthovanadate (Na3VO 4, Sigma), 1mM Phenylmethanesulfonyl fluoride (PMSF, 
Sigma), 11.A.M Calyculin A (a serine/threonine phosphatase inhibitor, Sigma) and one 
complete protease inhibitor tablet per 10mL buffer (Roche). Equal amounts of total 
protein, determined by BCA assay, were separated by SDS- PAGE, and then transferred 
to membranes, according to standard procedures detailed in section 2.5 (Materials and 
Methods). Membranes were probed with a primary antibody specific for phosphorylated 
ERM (anti-rabbit; 1:1000; Chemicon), and a moesin antibody that recognises total ERM, 
independent of phosphorylation state (anti-mouse; 1:1000; BD Transduction 
Laboratories). A GAPDH antibody acted as a loading control (anti-mouse; 1:5000; 
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Chemicon). HRP conjugated secondary antibody (1:1000-1:2000) incubation was 
followed by detection using an ECLTM chemiluminescence system. 
6.2.5 Transection injury of relatively mature neurons for regenerative neurite 
growth and neuron motility assays 
For post-injury regenerative neurite growth and motility assays primary cortical neurons 
were cultured until relative maturity (21 DIV), when developmental markers are no 
longer expressed, but those related to maturity, including MAP2 and synaptic markers 
are (de Lima et al., 1997; Chuckowree and Vickers, 2003; King et al., 2006). Areas of 
high neuronal density were subjected to transection injury using methods described in 
section 2.2 (Materials and Methods). To assess regenerative neurite sprouting, cultures 
were immediately treated with either 50RM or 2501AM RKI II or their DMSO vehicle 
controls, then fixed at 6 hours post-injury, the optimum time-point for quantitation of the 
regenerative neurite sprouting response as previously determined (Chapter 4). For 
neuron movement assays, cultures were immediately treated with 250RM RKI II or 
DMSO vehicle control, then fixed at 24 hours post-injury, when neuron translocation 
into the injury site was well established (Chapter 5). Cultures were fixed with 10% 
TCA. 
6.2.6 Immunocytochemistry 
Inununocytochemistry was performed according to standard procedures in section 2.3.2 
(Materials and Methods). Cultures were immunolabelled with primary antibodies to 13- 
tubulin and phosphorylated ERM (Table 2.1) and Alexa-fluor fluorescent secondary 
antibodies were used to visualise antibody localisation (Table 2.2). 
6.2.7 Microscopy and analysis 
All microscopy and analysis was performed as described in section 2.4 (Materials and 
Methods). For developmental studies, where parameters of phosphorylated ERM 
expression and neuronal development were analysed, 80 neurons from four neuronal 
cultures were included in the analysis. Regenerative neurite lengths were measured 
from the border of the injury site to the growth cone tip, and 100 neurites from four 
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neuronal cultures were included in the analysis. The number of post-injury regenerative 
neurites was expressed as neurites/nun of lesion, and twenty lesions from four neuronal 
cultures were included in the analysis. The net distance of neuron movement was 
measured as the minimum distance from the edge of the lesion to the centre of the cell 
body. The number of neurons that had undergone movement into the injury site was 
expressed as neurons/mm of lesion. For RKI II analysis on poly-l-lysine only, 15 injury 
sites from three neuronal cultures were included in the analysis. For RKI II inhibition 
on poly-l-lysine, laminin, Li and Sema 3A substrates, twenty injury sites from three 
neuronal cultures were analysed. Quantity One software (Bio-Rad) was used to perform 
intensity analysis of bands on immunoblots. Individual lanes were selected for 
comparison. The X axis of the graph is the Rf value and the Y axis is the pixel intensity 
value at each point along the lane. Background subtraction was not required. The area 
under the intensity plot curve is a measure of the size of the protein band. 
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6.3 RESULTS 
6.3.1 Rho kinase inhibition reduces the number of phosphorylated ERM positive 
filopodia and alters cortical neuron growth and morphology during early 
development, in vitro 
In developing CNS neurons in vitro, phosphorylated ERM proteins are localised to areas 
of high motility and growth, including growth cones and filopodia emanating from 
neurite shafts (Chapter 3). Therefore, a number of aspects of phosphorylated ERM 
localisation and neuronal growth and morphology, in response to RKI II treatment 
during development, were examined (Figures 6.1 and 6.2). There was a tendency for 
axons to be slightly longer in neurons treated with the 'low' (50RM) concentration of 
RKI II compared with controls (vehicle control 117Rtn ± 4.29, 50RM RKI II 127Rm ± 
4.80, p = 0.17), while the 'high' (250RM) concentration of RKI II caused significantly 
reduced axon lengths (vehicle control 97ium ± 4.25, 250RM RKI II 66Rm ± 3.65, p < 
0.05) (Figure 6.1 A-B, Figure 6.2 A). Similarly, dendrite length was significantly 
increased by the 'low' (50RM) concentration RKI II (vehicle control 19pm ± 0.63, 
50RM RKI II 20tim ± 0.56, p < 0.05), but significantly decreased when treated with the 
'high' (250RM) concentration (vehicle control 18Rm ± 0.55, 250[AM RKI II 16Rtn ± 
0.48, p < 0.05) (Figure 6.1 A-B, Figure 6.2 B). Also, the number of dendrites was 
significantly decreased both at the 'low' (50RM) (vehicle control 2.96 ± 0.09, 50RM 
RKI II 2.71 ± 0.09, p < 0.05) and 'high' (250RM) RKI II concentrations (vehicle control 
2.9 ± 0.09, 250RM RKI II 2.29 ± 0.08, p < 0.05) (Figure 6.1 A-B, Figure 6.2 C). 
The specific effect of Rho kinase inhibition on cellular phosphorylated ERM was 
quantitated, by determining the number of phosphorylated ERM positive filopodia, 
compared with controls. Representative neurons immunolabelled with phosphorylated 
ERM and 13-tubulin treated with the vehicle control or RKI II are shown in Figure 6.1. 
Observations showed that treatment with 'high' (250RM) RKI II decreased the amount 
of phosphorylated ERM filopodia, for example, at the distal tips of dendrites (Figure 6.1 
A-B), as well as along the axon (Figure 6.1 C-D). Figure 6.1 E and 6.1 F demonstrate 
the decrease in phosphorylated ERM positive filopodia of the axonal growth cone as a 
101 
Figure 6.1 The effect of Rho kinase inhibition on neuronal morphology and 
phosphorylated ERNI localisation. Primary cortical neurons were treated with 
'high' (250RM) concentration of RKI II, or vehicle control, from 1 to 2 DIV, then 
fixed and immunolabelled with primary antibodies to 13-tubulin (red) and 
phosphorylated ERM (green). Large images are composites of the 13-tubulin and 
phosphorylated ERM insets. A. Vehicle control treated neurons exhibited normal 
developmental morphology; a long axon (large arrow) and multiple dendrites. 
Filopodia at the distal tips of dendrites were often immunolabelled with 
phosphorylated ERM (small arrows and pERM inset). B. RKI II treated neurons 
possessed axons of similar length to vehicle treated control (large arrow), but had 
significantly reduced phosphorylated ERM labelling, only at the distal tip of the 
axon in the example shown (large arrow and pERM insert). The number and 
length of dendrites were significantly decreased (small arrow). C. Vehicle 
control treated neurons characteristically displayed numerous phosphorylated 
ERM positive filopodia emanating from the axon and dendrite shafts (arrows and 
pERM inset). D. RKI II treated neurons showed significantly fewer neurite 
filopodia immunolabelled with phosphorylated ERM (arrows). E. Axonal 
growth cones treated with the vehicle control were large, displaying typical 
lamellipodial morphology (large arrow) and numerous phosphorylated ERM 
positive filopodia (small arrows and pERM inset). E. In contrast, the axonal 
growth cones of neurons treated with RKI II were smaller, less likely to have 
lamellipodial structures and significantly fewer filopodia immunolabelled with 
phosphorylated ERM (arrows and pERM inset). Scale bar: A-C = 20t.tm, insets 
401..tm; D = 131.1m, inset 2611m; E = 8[1,m, inset 16vm; F = 51.1m, inset 1011m. 
13-tubuli 
41 
• 
pERM 
Figure 6.2 Quantitative analysis of the effect of Rho kinase inhibition on 
neuronal morphology and phosphorylated ERM localisation. Primary cortical 
neurons were treated with 'low' (501i1V1) or 'high' (250[tM) concentration RKI II, 
or their vehicle controls, from 1 to 2 DIV, fixed and immunolabelled with 
antibodies to I3-tubulin and phosphorylated ERM prior to analysis. * represent p 
values less than 0.05. Error bars are ± SEM. 
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result of 'high' (250RM) RKI II treatment, compared with controls. Quantitatively, 
when treated with the 'low' (50RM) concentration of RKI II, the number of 
phosphorylated ERM positive filopodia of the axon (vehicle control 1.64 ± 0.18, 50RM 
RKI II 0.61 ± 0.09), dendrites (vehicle control 1.45 ± 0.08, 50RM RKI II 0.93 ± 0.06) 
and the axonal growth cone (vehicle control 1.19 ± 0.12, 501.1.M RKI 11 0.56 ± 0.1) were 
all significantly reduced (p <0.05) when compared with vehicle treated controls (Figure 
6.2 D-F). In addition, the number of phosphorylated ERM positive filopodia was 
significantly decreased (p <0.05) in neurons treated with 'high' (250RM) concentration 
of RKI II, along both the axon (vehicle control 1.08 ± 0.13, 250RM RKI II 0.23 ±. 0.07) 
and dendrites (vehicle control 0.98 ± 0.06, 250RM RKI II 0.45 ± 0.05) and of the axonal 
growth cone (vehicle control 0.96 ± 0.13, 250RM RKI II 0.59 ± 0.1) (Figure 6.2 D-F). 
Concomitant with the reduced number of phosphorylated ERM positive growth cone 
filopodia were notable alterations in growth cone morphology, often exhibiting a spikier, 
less lamellipodial morphology (Figure 6.1 E-F). 
These data indicate that RKI II treatment has significant negative effects on the number 
of phosphorylated ERM positive filopodia, as well as aspects of neuronal growth and 
morphology, including axon and dendrite outgrowth and the number of dendrites 
formed. 
6.3.2 Rho kinase inhibition reduces the amount of phosphorylated ERM protein 
Immunoblotting was used to determine the amount of phosphorylated ERM in B35 
neuroblastoma cells, in the presence and absence of RKI II, in order to quantitatively 
correlate protein levels with immunocytochemical observations. The B35 
neuroblastoma cell line was used because primary neuron cultures are invariably a 
mixed population containing glial cells (<5% within the first 7 DIV), which also express 
phosphorylated ERM proteins more abundantly than neurons (Figure 6.3 A). Thus, 
using immunoblotting, it would not be possible to separate neuronal and glial 
phosphorylated ERM expression. Also, interestingly, glial cells in culture appear to be 
minimally affected by RKI II (Figure 6.3 B). Initially, immunocytochemistry was used 
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Figure 6.3 Phosphorylated ERM localisation in glial cells, primary cortical 
neurons and B35 neuroblastoma cells in the presence or absence of 'high' 
(25ORM) concentration of RKI II. A. Cultures derived from the embryonic 
neocortex are a mixed population of cells that also contain glial cells. Vehicle 
control treated cultures were immunolabelled with 13-tubulin (red) and 
phosphorylated ERM (green), which showed that glial cells widely express 
phosphorylated ERM (large arrow), compared with neurons (small arrow). B. This 
phosphorylated ERM (green) localisation was not affected in RKI II treated cultures 
(arrow), compared with control cultures shown in A. Therefore, rather than primary 
cortical neuron cultures, a pure population of B35 cells was utilised for 
immunoblotting analysis. Undifferentiated or cAMP differentiated B35 cells were 
treated with 'high' (2501./M) concentration RKI II or vehicle control for 24 hours, 
comparable to primary cortical neuron treatment regimes. Cells were 
immunolabelled with primary antibodies to f3-tubulin (red) and phosphorylated ERM 
(green). C. In the absence of RKI II, vehicle treated control cortical neurons 
showed phosphorylated ERM immunolabelling in numerous filopodia, particularly 
at the distal tips of neurites (arrows). D. The number of phosphorylated ERM 
positive filopodia was significantly reduced in 'high' (25ORM) concentration RKI II 
treated neurons, as previously discussed. E. In vehicle control treated 
undifferentiated 835 cells phosphorylated ERM labelling was abundant and 
localised around the entire cell in spiky filopodial protrusions (arrows). F. 
Phosphorylated ERM localisation did not appear markedly affected by RKI II 
treatment in undifferentiated B35 cells (arrows). G. In vehicle treated controls, the 
morphology and phosphorylated ERM labelling in cAMP differentiated B35 cells 
was comparable to neuronal localisation patterns, thus more restricted to peripheral 
filopodial structures and concentrated at growing tips (arrows). H. Phosphorylated 
ERM localisation was reduced in differentiated B35 cells after RKI II treatment 
(arrow). Scale bar = 201tm. 
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to observe the localisation of phosphorylated ERM proteins in undifferentiated and 
differentiated B35 cells, compared with cortical neurons, in the absence or presence of 
'high' (250RM) concentration RKI II (Figure 6.3 C-I-1). As previously described, 
application of 'high' (250uM) concentration RKI II markedly reduced phosphorylated 
ERM labelling in primary cortical neurons (Figure 6.3 C-D). Phosphorylated ERM 
labelling in undifferentiated B35 cells was very abundant and localised around the entire 
cell in spiky filopodial protrusions (Figure 6.3 E), and was not markedly affected by 
'high' (250RM) concentration RKI II (Figure 6.3 F). In contrast, phosphorylated ERM 
labelling in cAMP differentiated B35 cells was more comparable to patterns of 
localisation observed in neurons and was more restricted to peripheral filopodial 
structures and concentrated at growing tips (Figure 6.3 G), and phosphorylated ERM 
labelling appeared to be diminished after 'high' (250[1M) concentration RKI II treatment 
(Figure 6.3 H). 
Immunolabelling of the proteins harvested from vehicle control treated B35 cells with 
the phosphorylated ERM antibody resulted in two distinct bands (Figure 6.4 A), which 
are likely to correspond to ezrin/radixin (approximately 8010a) and moesin 
(approximately 75kDa). Treatment with the 'high' 250RM RKI II concentration resulted 
in a decrease in phosphorylated ERM immunolabelling, particularly diminished 
immunolabelling was notable in the ezrin/radixin band. This is further demonstrated by 
the intensity plot shown in Figure 6.4 B. The vehicle control treated intensity plot (red) 
shows two peaks, representing the ezrin/radixin and moesin bands. The RKI II treated 
intensity plot (blue) shows one peak of reduced intensity. The single peak in the RKI II 
treated sample corresponds to the lower molecular weight band (moesin); therefore the 
higher molecular weight band (ezrin/radixin) was more negatively affected by RKI II 
treatment. An antibody that detects all three ERM proteins, independent of 
phosphorylation state, was used to immunolabel the total ERM protein pool, and also 
resulted in two distinct bands (Figure 6.4 A). However, there was no marked difference 
between the vehicle control and RKI II treated samples, either in the bands (Figure 6.4 
A) or the intensity plot (Figure 6.4 C), indicating that RKI II affected only the amount of 
phosphorylated ERM and not total ERM. These results were observed in two separate 
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Figure 6.4 Immunoblotting analysis demonstrating the effect of Rho kinase 
inhibition on the amount of phosphorylated ERM in B35 neuroblastoma cells. 
A. Protein harvested from differentiated B35 cells treated for 24 hours with either 
vehicle control or 'high' (250RM) concentration RKI II, were separated by SDS-
PAGE and probed with a phosphorylation specific ERM antibody, an antibody that 
recognises the total ERM protein pool, and an antibody to GAPDH. Using the 
phosphorylated ERM specific antibody, in vehicle control samples two distinct 
bands were detected, a weaker band of higher molecular weight, and a more strongly 
labelled one of lower molecular weight, which are likely to correspond to 
ezrin/radixin and moesin, respectively (red arrows). Blots of the RKI II treated B35 
cells probed with the phosphorylated ERM antibody showed a notable decrease in 
intensity of both bands (blue arrow) compared with the vehicle control. In contrast, 
labelling with the antibody directed to ERM proteins, irrespective of 
phosphorylation state, did not show any marked changes in intensity. B. Intensity 
plots of phosphorylated ERM immunoblots of vehicle control treated cultures show 
two peaks of intensity (red arrows), which correspond to the two bands identified in 
A. In contrast, protein harvested from cultures treated with RKI II show a single 
peak of immunolabelling with decreased intensity (blue arrow). The higher 
molecular weight band (ezrin/radixin) was more notably affected by RKI II 
inhibition, with a single intensity peak remaining after treatment, corresponding to 
the moesin band (blue arrow). C. Intensity plots of total ERM immunoblots show 
that vehicle control and RKI II treated cultures exhibit bands of comparable 
intensity, demonstrating that Rho kinase inhibition does not affect the amount of 
total ERM protein, but does decrease the amount of phosphorylated ERM. 
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cell harvests, and confirm that Rho kinase is involved in the phosphorylation of ERM 
proteins in B35 neuroblastoma cells, as well as neurons. 
6.3.3 Rho kinase inhibition significantly inhibits the number of regenerative 
neurites following transection injury 
ERM proteins are re-expressed by more mature neurons exhibiting regenerative neurite 
sprouting after injury, in particular localised to regenerative neurite growth cones 
(Chapter 4). In addition, there is increasing evidence that inhibition of Rho kinase is 
beneficial for neurite outgrowth during attempted regeneration (recent examples include 
Dergham et al., 2002; Fournier et al., 2003; Monnier et al., 2003; Bertrand et al., 2005; 
Chan et al., 2005). Therefore, the effect of RKI II on the expression of phosphorylated 
ERM in regenerative neurites and on the amount of regenerative regrowth of relatively 
mature cortical neurons was investigated. 
Interestingly, phosphorylated ERM expression in regenerative neurites was variable 
between all experimental conditions, including the 'low' (501tM), 'high' (2501.1M) RKI 
II concentrations and vehicle control preparations. Figure 6.5 A and 6.5 B demonstrate 
examples of regenerative neurites with variable phosphorylated ERM expression after 
treatment with the 'high' (2501iM) concentration of RKI II. Application of RKI II after 
injury at the 'low' (501.1M) concentration resulted in no significant difference in the 
length of regenerative neurite sprouts at 6 hours post-injury (vehicle control 37t.tm ± 2.7, 
5011M RKI II 36t.tm ± 1.9, p = 0.77) (Figure 6.5 C). The 'high' (250RM) concentration 
also did not significantly influence regenerative neurite length (vehicle control 331Am ± 
2.18, 2501AM RKI II 291Arn ± 1.53, p = 0.13) (Figure 6.5 C). Rho kinase inhibition 
slightly, but not significantly, increased the number of regenerative neurite sprouts that 
formed at the 'low' 501AM RKI II (vehicle control 13 ± 3.84, 501AM RKI 11 16 ± 4.91, p 
= 0.45), but significantly decreased the number of regenerative neurites at the 'high' 
25011M concentration of RKI II (vehicle control 14 ± 3.77, 25011M RKI II 5 ± 1.38, p = 
0.01) (Figure 6.5 D). Thus, RKI II did not significantly affect the expression of 
phosphorylated ERM during regenerative responses in these experiments, but the 
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Figure 6.5 The role of Rho kinase and phosphorylated ERM in post-injury 
regenerative neurite sprouting. Primary cortical neurons were maintained in 
culture until 21 DIV, when they were subjected to transection injury. Six hours 
post-injury, neuron cultures were fixed and immunolabelled with primary 
antibodies to 13-tubulin (red) and phosphorylated ERM (green). A. Following 
treatment with 'high' (2501.1M) concentration RKI II, many regenerative neurite 
sprout growth cones did not express phosphorylated ERM (arrows). B. However, 
in neuronal cultures subjected to the same treatment ('high' (250[A,M) 
concentration RKI II) there were regenerative neurite sprout growth cones that 
expressed phosphorylated ERM (arrows). Thus, A and B demonstrate the 
variable expression of phosphorylated ERM in regenerative neurite growth cones 
after RKI II treatment. C. The average length of regenerative neurites was not 
significantly affected when treated with 'low' (5ORM) or 'high' (25011M) 
concentration RKI II, compared with their vehicle controls. D. The number of 
regenerative neurites was significantly affected by treatment with 'high' (25ORM) 
concentration RKI II. Scale bar: A-B = 201.1m. * represent p values less than 0.05. 
Error bars are ±SEM. 
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number of regenerative neurite sprouts was significantly decreased following 'high' 
250RM RKI II treatment. 
6.3.4 Rho kinase inhibition reduces phosphorylated ERM and neuronal motility 
in an in vitro assay 
Neurons in culture at 21 DIV are capable of undergoing movement across the 
substratum (Chapter 5). More specifically, in the hours after injury, neurons identified 
by P-III-tubulin immunolabelling, move into the injury site (Figure 6.6 A). Whether the 
neurons specifically move into the cell-free injury site in an attempt to heal the wound is 
thus far unknown. Irrespective of this, the motility assay provided an ideal opportunity 
to investigate the potential role of ERM proteins in neuron movement and thus 
potentially migration. Utilising the assay, immunolabelling demonstrated that cells that 
underwent movement into the injury site express phosphorylated ERM in peripheral 
growth cone-like structures and filopodia (Chapter 5; Figure 6.6 B), whereas cortical 
neurons in culture at 21 DIV do not normally express phosphorylated ERM (Chapter 3). 
This suggests that ERM proteins were re-expressed specifically by motile neurons, and 
therefore may have a role in the cytoskeletal processes involved in mediating this 
process. 
Next, it was hypothesised that if phosphorylated ERM proteins are re-expressed in 21 
DIV neurons undergoing movement, and Rho kinase phosphorylates ERM proteins in 
neurons, inhibition of Rho kinase may inhibit neuronal movement. Thus, RKI II was 
applied at 250uM to cortical neurons subjected to transection injury at 21 DIV. The Rho 
kinase inhibitor caused a marked reduction in neuronal phosphorylated ERM, identified 
by immunocytochemistry (Figure 6.6 B). Addition of the inhibitor significantly 
decreased the number of neurons that underwent movement into the injury site (vehicle 
control 7 neurons/mm ± 1.28, 250uM RKI Ill neuron/mm ± 0.15; p <0.05) (Figure 6.6 
C), but did not significantly affect the distance moved by individual neurons (vehicle 
control 251..tm ± 3.03, 250uM RKI II 21um ± 4.32; p = 0.21) (Figure 6.6 C). Combined, 
these data suggest that Rho kinase and ERM function are important for neuron motility. 
105 
Figure 6.6 The effect of Rho kinase inhibition on phosphorylated ERM and 
post-injury neuron motility. Primary cortical neuron cultures were grown until 
21 DIV, when they were subjected to transection injury. A. A post-injury 
timecourse showed that in the 24 hours after injury, neurons immunolabelled with 
13-III-tubulin had moved into the injury site (arrows). B. In vehicle treated 
controls, motile neurons immunolabelled with 13-tubulin (red) and phosphorylated 
ERM (green) showed abundant phosphorylated ERM along neurites and in 
growth cone-like structures (arrows). After 'high' (250W) concentration RICE II 
treatment, neurons showed more restricted expression of phosphorylated ERM 
(arrow). C. After treatment with 'high' (250p,M) concentration RICI II, 
significantly fewer neurons had moved into the lesion, 24 hours post-injury. In 
contrast, the distance moved into the lesion was not significantly affected. Scale 
bar: A Oh = 100Rm; 6h = 901.tm; 16h = 65[1m; 24h = 80Rm. B = 201..tm. * 
represent p values less than 0.05. Error bars are ± SEM. 
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6.3.5 Rho kinase inhibition differentially effects motility on substrates containing 
molecular guidance cues 
RKI II was applied at the 'high' 250RM concentration to cortical neurons injured at 21 
DIV grown on poly-l-lysine, laminin, Li and Sema 3A substrates to investigate whether 
Rho kinase is differentially involved in mediating translocation in response to various 
guidance cues. Addition of the inhibitor significantly decreased the number of neurons 
that underwent translocation on substrates of poly-l-lysine (vehicle control 7 
neurons/mm ± 1.28, 250RM RKI III neuron/mm ± 0.15; p < 0.05, an 86% reduction), 
laminin (vehicle control 9 neurons/mm ± 0.43, 250RM RKI Ill neuron/mm ± 0.35; p < 
0.05, an 89% reduction) and Li (vehicle control 4 neurons/mm ± 0.44, 250tiM RKI II 2 
neurons/mm ± 0.55; p < 0.05; a 50% reduction). The reduction was not significant for 
the Sema 3A substrate (vehicle control 4 neurons/mm ± 1.10, 250RM RKI II 1 
neuron/mm ± 0.36; p = 0.10; a 75% reduction) (Figure 6.7 A). In contrast, RKI II did 
not significantly decrease the mean distance translocated for neurons cultured on any of 
the substrates, including poly-l-lysine (vehicle control 25Rm ± 3.03, 250RM RKI II 
211.1m ± 4.32; p = 0.21), laminin (vehicle control 20Rm ± 3.69, 250RM RKI II 18pm ± 
2.93; p = 0.22), Li (vehicle control 241..tm ± 3.08, 250RM RKI II 27Rm ± 4.08; p = 0.19) 
and Sema 3A (vehicle control 231.1m ± 4.65, 2501AM RKI II 181Am ± 10.93; p = 0.50) 
(Figure 6.7 B). Interestingly, RKI II treatment slightly increased the mean distance of 
translocation on the Li substrate. 
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Figure 6.7 The effect of RKI II on neuron motility in response to molecular 
guidance cues. Cortical neurons grown on substrates of poly-l-lysine, laminin, 
Ll or Sema 3A were injured at 21 DIV, then treated with 2501./M RKI II. 24 
hours post-injury they were fixed and immunolabelled for quantitation of the 
effect of RKI II on post-injury motility on each substrate. A. The number of 
neurons per mm of lesion when grown on the four different substrates, in the 
presence of RKI II (black), or DMSO control (white). RKI II treatment resulted 
in significantly less neurons per mm of lesion on poly-l-lysine, laminin and Ll. 
B. The average distance of neuron translocation in response to substrate bound 
guidance cues, in the presence of RKI II (black), or DMSO control (white). * 
represent p values less than 0.05. Error bars are ± SEM. 
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6.4 DISCUSSION 
Several kinases have been implicated in the activation of ERM proteins by 
phosphorylation in various cell types, and these experiments have examined the specific 
role of Rho kinase in ERM activation in CNS neurons. The relationship between Rho 
pathway members and ERM activation was identified when stimulation of RhoA activity 
in NIH 3T3 cells resulted in the phosphorylation of ERM proteins and the formation of 
cell surface structures (Shaw et al., 1998), and transfection of NIH 3T3 cells with 
constitutively active RhoA, but not Racl or Cdc42, increased the level of 
phosphorylated ERM proteins (Matsui et al., 1998). However, in subsequent 
investigations a constitutively active form of Rho kinase did not increase ERM 
phosphorylation, and the Rho kinase inhibitor Y27632 did not suppress ERM activation 
(Matsui et al., 1999). This suggested Rho kinase was not directly involved in ERM 
phosphorylation, which contrasted with a report indicating Rho kinase phosphorylation 
of moesin was essential for microvilli formation in COS7 cells (Oshiro et al., 1998). 
More recently, it has been demonstrated that in some types of kidney-derived cells, 
ERM proteins can be activated in the absence of Rho, suggesting that a Rho-independent 
activation mechanism also exists (Yonemura et al., 2002). 
These experiments have shown that Rho kinase is involved in the activation of ERM 
proteins in primary cortical neurons. Application of RKI II caused a significant decrease 
in phosphorylated ERM positive filopodia of the axonal growth cone and along the axon 
and dendrites in developing primary cortical neurons, a result that was confirmed by a 
reduction in the amount of phosphorylated ERM protein in response to RKI II by 
quantitative immunoblotting, in B35 neuroblastoma cells. However, these data also 
support the proposal that there are Rho-independent mechanisms of ERM activation 
(Yonemura et al., 2002), due to the inability of RKI II to abolish phosphorylated ERM 
immunolabelling in each of these experiments. Furthermore, the inability of RKI II to 
completely inhibit ERM phosphorylation may be related to the suggestion that moesin is 
phosphorylated by PKC, while ezrin and radixin are phosphorylated by Rho kinase 
(reviewed by Louvet-Vallee, 2000). This observation was supported by the current 
immunoblotting investigations, where bands corresponding to moesin appeared to be 
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less affected by RKI II. This suggests that the individual ERM proteins are controlled 
via different activation pathways and may be responsible for specific functions in 
neurons, rather than acting as a family with completely overlapping functions (for 
example, Paglini et al., 1998). 
These investigations have identified ERM proteins as targets of Rho kinase in primary 
cortical neurons. However, other targets of Rho ldnase include adducin, myosin light 
chain, myosin light chain phosphatase, collapsin response mediator protein-2, LIM 
kinase (which in turn phosphorylates cofilin), intermediate filament and the Na +-H±- 
exchanger (reviewed by Bishop and Hall, 2000; Fukata et al., 2001; Giniger, 2002). 
While RKI II therefore does not exclusively act on ERMs, there are some striking 
similarities between many of the proposed roles of Rho kinase and ERM proteins in 
neurons, including neurite initiation, neurite outgrowth and branching, axon guidance, 
neuronal polarisation and growth cone morphology (Paglini et al., 1998, Dickson et al., 
2002; reviewed by Luo, 2000; Govek et al., 2005), which this data supports. 
This data is particularly indicative of a link between Rho kinase, ERM activity and 
neurite outgrowth because RKI II decreased neurite outgrowth, and was concomitant 
with decreased phosphorylated ERM filopodia of the axonal growth cone, and along the 
axon and dendrites. By inhibiting Rho kinase and phosphorylated ERM in developing 
neurons, in vitro, 'low' RKI II treatment resulted in increased axon and dendrite length, 
whereas 'high' RKI II decreased axon and dendrite length. It has previously been shown 
that application of a Rho kinase inhibitor increases neurite outgrowth on inhibitory 
substrates (Dergham et al., 2002; Borisoff et al., 2003; Fournier et al, 2003), while the 
effect on more permissive substrates was examined less often and has appeared to be 
minimal (Borisoff et al., 2003). Data also shows that ERM proteins are involved in 
neurite outgrowth, although the specific mechanisms are yet to be identified. For 
example, when radixin and moesin were suppressed in hippocampal neurons using 
antisense oligonucleotides, the rate of growth cone advance was significantly decreased 
(Paglini et al., 1998). Furthermore, interestingly these experiments showed opposing 
effects of 'low' and 'high' concentrations of RKI II on neurite outgrowth, which may be 
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a reflection of the importance of growth-associated cellular molecules like the ERMs 
existing in a tightly controlled balance of activated and inactivated forms in order to 
exert their appropriate effects on the cell. 
The number of primary cortical neuron dendrites was significantly decreased at both 
'low' and 'high' concentrations of RKI II. In contrast with our results, inhibition of Rho 
kinase either with a dominant negative or the inhibitor Y27632 was found to promote 
neurites in neuroblastoma cell lines (Hirose et al., 1998). ERMs are thought to be 
involved in neurite initiation, as suppression of radixin/moesin slows hippocampal 
neurite formation and establishment of polarity (Paglini et al., 1998). In numerous non-
neuronal cells ERMs have been implicated in the formation of cell surface structures, 
such as microvilli and filopodia (Bretscher, 1989; Takeuchi et al., 1994; Amieva and 
Furthmayr, 1995; Yonemura et al., 1999; Nakamura et al., 2000; Scherer et al., 2001), 
some of which also showed that ERM activation in this function was under control of 
Rho signalling (Shaw et al., 1998; Nakamura et al., 2000; Yonemura et al., 2002; 
Nijhara et al., 2004), evidence which may support a role for Rho kinase activation of 
ERMs in neurite formation in primary neurons. 
Rho kinase inhibition resulted in a significant decrease in phosphorylated ERM positive 
growth cone filopodia, which was accompanied by a smaller, spiky, less lamellipodial 
morphology. Others have also reported that Rho kinase inhibition results in growth 
cones lacking lamellipodia (Borisoff et al., 2003). Loss of ERM function has also been 
correlated with reduced lamellipodia (Paglini et al., 1998; Castelo and Jay, 1999), as 
well as decreased growth cone size (Paglini et al., 1998) and growth cone collapse 
(Gonzalez-Agosti and Solomon, 1996). Identification of an interaction between Rho 
kinase and ERM proteins in lamellipodial formation would be complementary to the 
finding that constitutively active Cdc42 expression in NIH 3T3 cells leads to the 
formation of filopodia and localisation of phosphorylated ERM at the filopodial tips 
(Nakamura et al., 2000). 
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Interestingly, in these studies Rho kinase inhibition at 'low' and 'high' concentrations 
resulted in similar effects on neurite outgrowth in developing neurons and those 
undergoing a post-injury regenerative growth response. Rho kinase has been identified 
as a target for manipulation in the regenerative response to injury, with numerous reports 
linking Rho kinase inhibition with increased post-injury regrowth (Dergham et al., 2002; 
Fournier et al., 2003; Monnier et al., 2003; Bertrand et al., 2005; Chan et al., 2005). In 
using Rho kinase inhibitors to modulate regenerative neurite growth, dose selection 
appears to be of primary importance. In these experiments, 'low' RKI II concentration 
slightly increased the number of regenerative neurites, while 'high' RKI II 
concentrations resulted in a significant decrease in the number of regenerative neurites. 
In another recent study, it was shown that application of a low dose of the Rho kinase 
inhibitor Y27632 was detrimental to spinal cord regeneration, while a higher dose 
significantly increased the number of axonal sprouts (Chan et al., 2005). The current 
experimental results demonstrate that RKI II concentrations sufficient for interrupting 
ERM activation are also detrimental to regenerative neurite formation. ERM proteins 
are involved in regenerative attempts of cortical neurons after transection injury, as 
regenerative neurite growth cones expressed ERM proteins, which are not normally 
expressed in more mature neurons (Chapters 3 and 4). Application of RKI II at 'low' 
and 'high' concentrations resulted in variable expression of phosphorylated ERM in 
regenerative neurite growth cones, which might indicate that some neurites and their 
growth cones were affected by the inhibitor but not others, which raises the possibility 
that the different neuronal types in cortical cultures may be differentially dependent on 
ERM protein function, and therefore be differentially sensitive to the effects of Rho 
kinase inhibition. Or, it may simply be a reflection of the rapid cyclic nature of ERM 
phosphorylation and de-phosphorylation in the neuronal growth cone. 
Using the model of transection injury, the function of ERMs in neuronal motility was 
examined. Transection injury resulted in a cell and debris free lesion, but within 24 
hours a population of motile neurons had moved into the injury site. These neurons 
expressed phosphorylated ERM in their peripheral, growth-cone like structures, and RKI 
II inhibition significantly and dramatically decreased the number of neurons that 
110 
Chapter 6 - Results 
underwent movement into the lesion. This is indicative of a potential Rho dependent 
function in neuronal migration (Kholmanskikh et al., 2003; Yoshiz.awa et al., 2005). 
ERMs are also involved in migration, in endothelial cells (Simoncini et al., 2006), 
lymphocytes (Nijhara et al., 2004), neutrophils (Yoshinaga-Ohara et al., 2002) and 
tumour cells (Sahai and Marshall, 2003). For example, ERM proteins are responsible 
for re-localising surface cell adhesion molecules to the trailing edge of the cell to reduce 
its adhesiveness to the substrate (reviewed by Lee et al., 2004). Immunohistochemical 
analyses of the embryonic brain have indicated ERMs might also be involved in neuron 
migration during early development of the cerebral cortex, as ERMs are expressed by 
neurons in the intermediate zone during late embryonic development, a region highly 
concentrated with migrating neurons (Johnson et al., 2002; Mintz et al., 2003; Chapter 
5). It has also been shown that ERM involvement in lymphocyte migration is under the 
control of Rho kinase (del Pozo et al., 1999), which supports evidence that Rho kinase 
activation of ERM proteins is required for neuron movement, in vitro. 
In addition, the capacity for neuron motility after RKI II treatment was substrate 
dependent, with an 86% reduction in the number of motile neurons cultured on poly-1- 
lysine, 89% on laminin, 50% on Ll and 75% on Sema 3A. An interesting possibility is 
that neuronal translocation is mediated via different intracellular signal transduction 
pathways and cytoskeletal effectors, in a guidance cue dependent manner. For example, 
the decrease in translocation was least remarkable on an Ll substrate, and previous 
investigations into Ll signalling in neuron migration have implicated MAP kinases 
(Schmid et al., 2004; Thelen et al., 2002), rather than Rho GTPases. In contrast, Rho 
signalling appears to mediate Sema 3A effects (reviewed by Skaper etal., 2001; Tang, 
2003). The current data suggests that intracellular signalling in laminin mediated neuron 
migration is likely to involve the Rho signalling pathway, due to the marked inhibition 
of translocation in response to inhibitor application. Previous studies have identified 
PKC (Bixby et al., 1989), PKA and myosin light-chain kinase (MLCK) (Freire et al., 
2002) in laminin induced neuritogenesis, but there is little data relating to intracellular 
signalling associated with laminin induced neuron migration. 
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Therefore, these studies suggest that Rho kinase mediated ERM activation is important 
for specific aspects of neuronal development, nerve cell motility and regenerative 
growth. The current data also indicates that alternative kinases are involved in ERNI 
activation. Further identifying these kinases, and the specific biological functions they 
mediate, will be important for our understanding of the complex functions coordinated 
by the ERM proteins and the cytoskeleton in general. 
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7 DISCUSSION 
This thesis has utilised multiple experimental approaches to investigate the functional 
significance of the ERM proteins in CNS neurons. These proteins have previously been 
understudied in the nervous system, especially given that earlier investigations have 
indicated they are associated with crucial CNS developmental processes, such as 
neuronal morphogenesis (Gonzalez-Agosti and Solomon, 1996; Castelo and Jay, 1998; 
Paglini et al., 1998; Dickson et al., 2002). The most compelling evidence of their 
significance in CNS development was provided when ezrin was identified as an 
intracellular binding partner of the nervous system specific CAM Ll (Dickson et al., 
2002). Ll is vital for normal development of the nervous system (Wong et al., 1995; 
Fransen et al., 1995), and it is likely that many Li functions are mediated by its 
relationship with the ERM proteins. Therefore, this thesis provides experimental data to 
clarify some previously proposed roles for the ERM proteins, and in addition, has 
elucidated novel functions for this family of cytoskeletal linker proteins in neurons. 
7.1 ROLES OF THE ERM PROTEINS IDENTIFIED IN CNS NEURONS 
Initially, the expression of ERM proteins throughout development and maturation of 
individual CNS neurons was examined. Previous studies have demonstrated that ERMs 
are specifically localised to axonal and dendritic growth cones in developing CNS 
neurons (Goslin et al., 1989). The current studies extended on this, by comparing the 
localisation of the total ERM protein pool, with that of the phosphorylated, or active, 
ERM protein pool. These aspects were also examined specifically to correlate ERM and 
Ll expression during development, beyond the early developmental timepoints 
examined in earlier investigations. Studies confirmed the growth cone localisation of 
total ERM in developing hippocampal neurons, but also showed they are also localised 
to fine filopodia emanating from neurite shafts. Phosphorylated ERM showed a similar, 
but more restricted localisation pattern compared with total ERM protein, demonstrating 
that at any given developmental timepoint not all cellular ERMs exist in their active 
state. Perhaps the most notable finding was that, at 21 DIV, when prior investigations 
have identified that neurons display characteristics of maturity (de Lima et al., 1997; 
Chuckowree and Vickers, 2003; King et al., 2006), phosphorylated ERM was no longer 
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expressed. Combined, this temporal and spatial localisation data strongly indicated roles 
in developmental neurite outgrowth, as well as neurite outgrowth related functions, such 
as modulating growth cone morphology and motility, axon pathfinding, as well as a 
potential role in the intracellular response to guidance cues. Finally, L 1 and ERM 
proteins were co-localised specifically in axonal structures, most notably the growth 
cone, which is indicative of function in the aforementioned developmental growth 
processes. Thus, the specific ERM localisation in cultured hippocampal neurons was 
highly suggestive of their contribution to mechanisms of neuronal morphogenesis. 
ERM protein function in developing cortical neurons was assessed by transfection 
techniques, utilising a dominant negative construct of ezrin. The dominant negative 
form of the protein is capable of N-terminal binding, but as it is truncated, C-terminal 
binding to the cytoskeleton is not possible (Crepaldi et al., 1997; Dickson et al., 2002). 
Compared with GFP transfected controls, perturbation of ERM function resulted in a 
number of characteristics divergent from normally developing neurons, including 
slightly increased axon and dendrite outgrowth, increased axon and dendrite branching 
and decreased axonal growth cone size, particularly due to the loss of lamellipodia. 
Further examination of the role of ERM proteins in neurite outgrowth, in particular 
regenerative neurite outgrowth in relation to the binding partner Ll, showed that both 
proteins are involved in regenerative neurite sprouting in response to trauma. ERM 
proteins were specifically re-expressed in regenerative neurite sprout growth cones, and 
supplying regenerating neurons with a substrate containing Li resulted in significantly 
longer regenerative neurites. These studies also demonstrated the roles of Li and 
neuronal phenotype in growth cone morphology, as growth cones on the Li substrate 
were significantly larger and more elaborate than on poly-l-lysine substrates, and 
hippocampal neurons had significantly larger growth cones than cortical neurons on Ll. 
Furthermore, results demonstrated that hippocampal and cortical neurons differed in 
their abilities to mount a regenerative response, an important finding since comparisons 
in regenerative ability between neurons originating in varied cortical areas have rarely 
been investigated (for example, Becker et al., 2005; Verma et al., 2005). 
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In an intriguing aspect of this study, a population of highly motile neurons in long-term 
(21 DIV) cortical neuron cultures was identified. The neurons translocated into the 
injury site, within 24 hours after transection injury was performed. They were small, 
multipolar neurons and their morphology, motile ability and cytoskeletal profile did not 
appear to fit that of a previously described neuronal phenotype. BrdU incorporation and 
immunocytochemical investigations confirmed that they were differentiated neurons, 
some of which were polarised. However, they did not express NF-H or MAP2, which 
might suggest they had not reached the maturity of some other neurons in culture. 
Interestingly, these post-mitotic neurons' motility was modulated by extracellular 
guidance cues, in a similar manner to that expected in axon guidance and migration of 
immature neurons. Perhaps most notable though, was that the motile neurons strongly 
expressed phosphorylated ERM in their peripheral neurites and growth cone-like 
structures, while no neurons in other areas of the cultures at that age expressed 
phosphorylated ERM. This strongly suggested that the neurons specifically expressed 
phosphorylated ERM as a part of the cytoskeletal mechanisms required for the neurons 
to undergo translocation. 
Due to this novel finding, the expression of phosphorylated ERM, in relation to the 
migration marker DCX, was examined in the embryonic brain, which revealed co-
localisation between ERMs and DCX in neurons of the developing neocortex, in vivo. 
This further implicated ERM proteins in translocation, and more specifically migration 
in in vivo neocortical development. This finding is a valuable addition to the limited 
previous data implicating ERMs in neuron migration (Johnson et al., 2002; Mintz et al., 
2003). 
Finally, ERM activation has not previously been examined in primary neurons, and 
confusing data exists on the mechanisms of activation of ERM proteins in non-neuronal 
cell types. This may be because the mechanisms vary depending on the cell type and the 
biological outcomes of activation. Specifically, the role of Rho kinase in ERM 
activation was examined, by application of an inhibitor of Rho kinase. Data showed that 
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indeed, Rho kinase is involved in the activation of ERM proteins in neurons. Inhibition 
of this mechanism significantly perturbed a number of ERM related functions, including 
aspects of development such as axon and dendrite outgrowth, as well as the number of 
dendrites formed, which was concomitant with a significant decrease in phosphorylated 
ERM immunolabelling in growth cones and in filopodia along axons and dendrites. Rho 
kinase inhibition also perturbed aspects of regenerative neurite outgrowth, and 
significantly disrupted post-injury neuron motility, including the motility observed on 
different molecular guidance cue containing substrates. However, this data also supports 
the hypothesis that other kinases are involved in the activation of ERM proteins, because 
inhibition at high concentrations did not completely abolish phosphorylated ERM 
immunolabelling, nor were all ERM functions investigated significantly perturbed. 
Furthermore, glial cell phosphorylated ERM labelling did not appear to be affected by 
inhibition of Rho kinase. 
These findings will significantly contribute to understanding the mechanisms of both 
nervous system development and the regenerative response to injury. 
7.2 IMPLICATIONS OF ERM PROTEIN FUNCTION IN CNS 
DEVELOPMENT 
Many molecules are involved in orchestrating nervous system development, and the data 
presented in this thesis suggests that the ERM proteins are involved in important and 
specific developmental CNS functions. Two different methods of ERM perturbation 
resulted in abnormal neuron morphogenesis. Neuron transfection studies using a 
dominant negative ezrin construct resulted in morphological changes, particularly by 
decreasing the number of neurites, increasing neurite outgrowth and branching, and 
causing reduction in the growth cone size. Interestingly, utilising an inhibitor of Rho 
kinase to perturb ERM function resulted in similar outcomes, in particular resulting in a 
significant decrease in the number of dendrites formed and significantly altering neurite 
outgrowth. 
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Both experimental approaches to perturbation of ERM proteins caused changes in 
neurite outgrowth, in that increased axon and dendrite outgrowth was observed in 
transfection studies, as well as following 'low' dose application of RKI II. This suggests 
that the ERM proteins are involved in neurite outgrowth, but potentially more 
specifically in mediating retraction. A growing neurite utilises its growth cone 
structures, the filopodia and lamellipodia, to seek out and then consolidate growth in the 
appropriate direction. Thus, interrupting normal processes of growth cone or neurite 
retraction would result in longer neurites. This was also investigated in a study by 
Paglini and colleagues (1998), where individual filopodia in control neuronal growth 
cones persisted for no more than ten minutes. In contrast, double suppression of radixin 
and moesin caused most filopodia to persist longer than thirty minutes. These neurons 
also showed a significantly increased rate of elongation, and a more than threefold 
slower rate of retraction (Paglini et al., 1998). 
Both perturbation approaches resulted in a decrease in the number of dendrites formed, 
adding to the previous evidence of a role for ERM proteins in neurite initiation (Paglini 
et al., 1998). Transfection data also provided further evidence of ERM function in 
neurite branching, which is an important process for neurite targeting and the 
establishment of appropriate cellular connections. Transfection with the dominant 
negative resulted in increased branching of both axons and dendrites. This has 
previously been reported for axons in hippocampal neurons (Dickson et al., 2002) and 
cerebellar granule neurons (Cheng et al., 2005), specifically as a result of disrupting the 
Ll-ERM-actin linkage. 
It is interesting that the current studies and others have identified striking and significant 
changes in aspects of growth and morphology following perturbation of one or more 
ERM proteins at the cellular level, when to date, knockout studies have identified 
minimal phenotypic effects at the whole animal level. For example, moesin knockout 
mice showed no morphological abnormalities in any of the tissues examined, nor were 
ERM related cellular functions affected, including aggregation of platelets, formation of 
stress fibres in fibroblasts, or microvilli formation in mast cells (Doi et al., 1999). In 
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addition, Kikuchi and colleagues (2002) generated a radixin deficient mouse, which was 
normal at birth, but developed some liver problems within the first eight weeks. More 
recently, radixin deficient adult mice were shown to be deaf, due to the degeneration of 
stereocilia, the large microvilli of cochlea hair cells (Kitajiri et al., 2004). Ezrin 
knockout mice showed retardation in photoreceptor development and microvilli defects 
of the retina (Bonilha et al., 2006). 
The lack of severity of outcomes of knockouts of individual ERM proteins, combined 
with the demonstration that loss of one protein is not compensated by upregulation of 
others (Doi et al., 1999) suggests that the individual proteins might be redundant at the 
tissue level. However, the fact remains that there is specific tissue expression of the 
individual proteins, which should be interpreted that ERMs are not necessarily 
interchangeable in all contexts (Mintz et al., 2003). The generation of a knockout of all 
three ERM proteins, or indeed tissue specific knockouts, may help to answer some of 
these questions. 
Prior to the current investigations, very little was known about ERM protein function in 
developing CNS neurons, as they have more regularly been the subject of investigation 
in non-neuronal cells, where their elucidated roles have provided a foundation for 
investigation of their function in neurons. For example, they are involved in the 
formation of cell surface microvilli in epithelial and thymoma cells (Takeuchi et al., 
1994), and then in subsequent investigations, including this study; ERMs have been 
implicated in neuron filopodia establishment and dynamics (for example, Paglini et al., 
1998). ERMs are also involved in cell adhesion in thymoma cells (Takeuchi et al., 
1994), and were subsequently shown to be intracellular components of adhesion systems 
in neurons (Dickson et al., 2002). Therefore, there are likely to be other neuronal 
functions that remain to be investigated. For example, ERM proteins are involved in 
mechanisms of migration in many non-neuronal cell phenotypes, which incited 
investigation into potential roles in neuronal migration in the present study. 
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As a result, this thesis has provided evidence that ERMs are involved in developmental 
neuron migration, particularly shown by their co-localisation with the microtubule-
associated, migratory marker DCX, in the embryonic neocortex. There are many 
identified cytoskeletal associated proteins important for migration (recently reviewed by 
Bielas and Gleeson, 2004; BeIlion et al., 2005; Gressens, 2006). Mutation to the genes 
encoding these proteins frequently results in disrupted migration, clinically termed 
lissencephaly disorders. For example, mutation of the DCX gene (encoding DCX) 
results in an X linked double cortex syndrome, where radial migration is interrupted, and 
results in a second layer of cortical neurons abnormally gathering under the normal outer 
cortex (reviewed by Gleeson, 2000). Mutation in the LISI gene can have more severe 
manifestations, such as cobblestone lissencephaly, where the outer layers of the cortex 
do not form the normal horizontal layered organisation, along with other symptoms 
including hydrocephalus and cerebellar hypoplasia (Gleeson, 2000). These disorders 
suggest that perturbing the function of individual proteins involved in neuron migration 
can have drastic morphological effects. Clinically, they can result in epilepsies, and 
more subtle alterations may contribute to disorders such as dyslexia and schizophrenia 
(reviewed by LoTurco and Bai, 2006). Therefore, it would be highly valuable to revisit 
the ezrin, radixin and moesin knockout mice with the specific focus being to examine 
the organisation of the cortex. This would be an ideal way to elucidate their more 
specific functions in developmental neuron migration. 
7.3 IMPLICATIONS OF ERM PROTEIN FUNCTION FOR CNS 
REGENERATION 
Previously, very little was known about the role of ERM proteins in neuronal 
development, and therefore the participation of ERMs in regenerative responses of the 
adult CNS have not been investigated. The current studies have shown that in an in vitro 
model of injury of more mature neurons, ERM proteins are re-expressed, both in 
regenerative neurite sprout growth cones, and in a population of motile neurons that 
translocate into the site of injury. Furthermore, ERM perturbation by inhibition of Rho 
kinase was detrimental to aspects of regenerative neurite outgrowth and post-injury 
neuron motility. 
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Traditionally there has been pessimism surrounding the capability of the nervous system 
to undergo regenerative growth. Factors such as an intrinsic loss of the components 
required for neuronal growth, formation of the glial scar and the presence of inhibitory 
molecules in the adult CNS contribute to the failure of regeneration (reviewed by 
Fawcett and Asher, 1999; Morgenstern et al., 2002; Chuckowree et al., 2004; Matsui and 
Oohira, 2004). However, many of the requirements for developmental growth have 
been identified in more recent years and then further investigated in injury models and 
as a result, the goal of functional regeneration now does not seem so unattainable. 
One strategy for promoting re-growth after injury might be to use genetic manipulation 
to upregulate gene expression, and thus protein production, of the cytoskeletal 
components required for new neurite growth. This thesis has shown that the ERM 
proteins are involved in aspects of both developmental and regenerative growth, which 
makes them ideal candidates for manipulation after trauma. Furthermore, their plasma 
membrane binding partner Li has been shown in these experiments, and others, to 
promote regeneration after trauma (Aubert et al., 1998; Brook et al., 2000; Jones et al., 
2003; Becker et al., 2004; Chen et al., 2005; Zhang et al., 2005) and, in some cases, has 
even been associated with functional recovery (Roonprapunt et al., 2003). These are just 
two developmentally significant proteins that could potentially aid regeneration, and 
with the discovery of the roles of other proteins, a combined approach to manipulation 
of the adult injured CNS environment to more closely resemble aspects of development 
remains a viable and exciting strategy for promoting brain repair. 
Another approach to promoting regeneration is the application of pharmacological 
inhibitors of Rho kinase to promote post-injury neurite growth, because it appears that 
the signalling mechanisms of many inhibitory molecules converge on the Rho pathway 
(for example, Wahl et al., 2000; Monnier et al., 2003; Jain et al., 2004). Studies have 
shown that after injury, levels of Rho kinase are elevated (Dubreuil et al., 2003; 2006), 
and application of a Rho kinase inhibitor, in numerous different experimental models, 
has been shown to promote regenerative growth (Borisoff et al., 2003; Dergham et al., 
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2002; Fournier et al., 2003; Monnier et al., 2003; Bertrand et al., 2005). However, the 
data presented in this thesis serves as a caution that molecules such as Rho kinase exist 
in a controlled balance and their inhibition does not necessarily always translate to better 
outcomes, and dose selection appears to be of primary importance (Chan et al., 2005). 
This was demonstrated in the current investigation because addition of RKI II at both the 
'low' and 'high' concentrations slightly reduced the average length of regenerative 
neurites, compared with controls. Furthermore, application of RKI II at the 
concentration that effectively blocked ERM activation resulted in a significant decrease 
in the number of regenerative neurites. These studies did, however, demonstrate that 
Rho kinase inhibition during developmental and regenerative periods causes similar 
outcomes, particularly with respect to formation of neurites and neurite length, which is 
evidence that the signalling pathways involved in the mechanisms of growth in more 
mature neurons are similar to those of growth during development. 
Identification of the phosphorylated ERM expressing motile neuron population in long-
term cortical cultures after transection injury was both novel and potentially relevant to 
post-injury regeneration. These neurons were approximately 21 days old, and their 
characteristics suggested they had progressed through several post-mitotic 
developmental stages. Therefore, their motile ability does not fit with the traditional 
view of neuron migration, which has previously only been reported in precursor and 
early post-mitotic neurons. In fact, the potential for more mature neurons to undergo 
translocation has not previously been widely considered. Indeed it seems highly 
unlikely that neuron phenotypes which posses long axons and elaborate dendritic 
networks could become motile, however this data suggests that there are small, more 
mature neurons with short processes that could potentially migrate through brain 
regions. Identification of such populations in vivo may potentially provide a new avenue 
for exploration with respect to regenerative strategies. 
These experiments also observed the role of molecular guidance cues in the motility 
observed after injury. Molecular guidance cues including laminin, Ll and Sema 3A 
significantly effected neuron motility, which showed that post-mitotic neurons remain 
121 
Chapter 7 - Discussion 
responsive to guidance cues, which in turn modulated their behaviour in a similar 
manner to that which has been elucidated in developmental migration (for example, 
Persohn and Schachner, 1987; Liesi, 1990; Mann et al., 2001). Furthermore, Rho kinase 
inhibition reduced motility differentially depending on the molecular guidance cue. This 
was indicative of the signalling pathways that mediate the actions of guidance cues, 
therefore it would be interesting to now determine whether ERM proteins are a 
downstream constituent of specific molecular guidance signalling pathways, in relation 
to nerve cell migration, as well as neurite outgrowth. 
Whether the motile neuron population identified in these experiments has the same 
characteristics in vivo is still uncertain, but the possibility of using molecular guidance 
cues to attract the neurons to the injury site for regenerative purposes is an exciting 
possibility that warrants future investigations. Manipulation of the pattern of expression 
of guidance cues in the adult CNS after injury has been suggested for promoting 
regrowth and establishing correct targets (reviewed by Koerberle and Bahr, 2004), but 
less widely considered as a method for guiding implanted stem cells or progenitor 
neurons produced in the ventricular zone to sites of injury in the adult brain. Implanting 
stem cells may provide more promising results, as whether neural progenitors are even 
produced throughout life in human's remains controversial (reviewed by Au and Fishell, 
2006). Finally, the ability of the motile neuron population at 21 DIV to respond to 
guidance cues provides additional evidence that neurons in the developing and more 
mature nervous system share the same intrinsic properties. 
The idea that aspects of CNS development must be recapitulated in order for 
regenerative growth to occur in the more mature nervous system has received 
widespread support (for example, Doucet and Petit, 2002; Emery et al., 2003; 
Chuckowree et al., 2004; Koerberle and Bahr, 2004; Filbin, 2006; Harel and Strittmatter, 
2006). However, there appears to be few reports providing direct evidence that aspects 
of regeneration recapitulate development. For example, the re-expression of growth-
associated cytoskeletal components, such as GAP-43 (Bisby et al., 1988; Li et al., 1996; 
Christman et al., 1997; Avwenagha et al., 2003; Zhang et al., 2005; Ikegami et al., 2005) 
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has been demonstrated, but for many other aspects this still appears to be speculative, 
such as the expression of molecular guidance cues in the mature CNS. Therefore, this 
study contributes greatly to this theory, as it has provided many examples of common 
mechanisms in development and regeneration of the more mature injured nervous 
system. Examples include; that ERM proteins were expressed in the growth cones of 
developing neurons and then re-expressed in regenerative neurite growth cones, and that 
Li promoted developmental and regenerative neurite outgrowth. In addition, 
regenerative neurite growth cones and developmental neurite growth cones displayed the 
same morphology when grown on poly-1-lysine and Li substrates. Phosphorylated 
ERM was expressed by migrating neurons in the developing neocortex, as well as by a 
motile neuron population at 21 DIV. Furthermore, post-mitotic neurons at 21 DIV 
responded to guidance cues in the same way that has been reported for more immature 
neurons, and finally, inhibition of Rho kinase in developing neurons and more mature 
neurons post-injury resulted in decreased neurite formation, as well as similar, dose 
dependent effects on neurite outgrowth. In summary, data relating to the commonality 
of mechanisms of development and regeneration encompasses multiple steps of neuron 
growth, including molecular guidance, intracellular signal transduction and cytoskeletal-
associated protein expression. 
7.4 CONCLUSIONS 
• ERM proteins mediate a number of aspects of neuronal morphogenesis, including 
neurite initiation, outgrowth and branching. 
• ERNI proteins and their binding partner Li are involved in developmental and 
regenerative neurite outgrowth. 
• ERMs are localised to translocating neurons, in development and post-injury, 
suggesting a role in neuron migration. 
• The regenerative response of more mature neurons to injury induces 
recapitulation of development, including the mechanisms of cytoskeletal proteins, 
intracellular signalling pathways and molecular guidance cues. 
• Neurons derived from the neocortex and hippocampus may vary in their ability to 
undergo regenerative growth. 
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• ERM proteins are ideal candidates for manipulation in therapeutic strategies to 
promote recovery following CNS trauma. 
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9 APPENDIX — SOLUTIONS 
GENERAL SOLUTIONS 
0.01M PBS, pH 7.4 
100mL 	9% NaC1 (90g of NaC1 (Sigma) per 1L Milli-QC) water) 
40mL 	Na2HPO4(BDH) (28.4g per 1L Milli-Q8 water) 
10mL 	NaH2PO4.2H20 (Sigma) (31.2g per 1L Milli-Q® water) 
850mL 	Milli-Q® water 
CELL CULTURE SOLUTIONS 
0.001% poly-1-lysine 
450mL 	sterile 0.01M PBS 
50mL 	0.01% poly-l-lysine (Sigma) 
10mM HEPES buffer 
1.19g 	HEPES (BDH) 
500mL 	0.01M PBS 
Combine and heat sterilise 
Imaging buffer 
15.5mL 	4M NaC1 (23.4g per 100mL Milli-Q® water) 
2.5mL 	2M KCI (Sigma; 7.46g per 50mL Milli-Q® water) 
50mL 	2M CaC12 (BDH; 14.7g per 50mL Milli-Q® water 
250mL 	2M MgC12 (Sigma; 20.33g per 50mL Milli-Q8 water) 
7.5mL 	2M Dextrose (D-glucose) (Sigma; 18.02g per 50mL Milli-Q® water) 
6.25mL 	2M HEPES (26.03g per 50mL Milli-Q® water) 
Adjust to pH 7.3 with 2M NaOH, make up to 500mL with Milli-Q® water, filter 
sterilise and store at 4°C. 
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IMMUNOCYTOCHEMISTRY SOLUTIONS 
4% Paraformaldehyde (PFA) 
40g 	PFA (Sigma) 
40g 	Sucrose (Sigma) 
100mL 	9% NaC1 
400mL 	Na2HPO4 
500mL 	NaH2PO4 .2H2Q 
Heat while stirring in a fume hood. 
10% Trichloroacetic acid (TCA) 
lg 	Trichloroacetic acid (Sigma) 
10mL 	Milli-QC) water 
0.3% Triton/PBS 
6004 	Triton X (Flulca) 
200mL 	0.01M PBS 
WESTERN BLOTTING SOLUTIONS 
Bis/Acrylamide 
29.2g 	acrylamide (Sigma) 
0.8g 	N'N'-bis-methylene-acrylamide (Sigma) 
Make up to 100mL with Milli-QC) water, filter through Whatman filter paper and store 
at 4°C, in the dark 
1.5M Tris-HC1, pH 8.8 
27.23g 	Tris base (Bio-Rad) 
—80mL 	Milli-QC) water 
Adjust to pH 8.8 with 10M HC1 and make up to 150mL with Milli-QC) water. Store at 
4°C. 
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0.5M Tris-HC1, pH 6.8 
6g 	Tris base 
—60mL 	Milli-QC) water 
Adjust to pH 6.8 with 10M HC1 and make up to 100mL with Milli-Q® water. Store at 
4°C. 
10% Sodium Dodecyl Sulfate (SDS) 
lOg 	SDS (BDH) 
Dissolve in 90mL of Milli-QC) water with gentle stirring and adjust to 100mL with 
Milli-QC). Store at room temperature. 
5X Running Buffer, pH 8.3 
9g 	Tris base 
43.2g 	Glycine (Bio-Rad) 
3g 	SDS 
Combine and add 600mL of Milli-QC) water. Store at 4°C. Prior to use combine 
100mL Running Buffer with 400mL Milli-QC) water. 
Transfer Buffer 
3.03g 	Tris base 
14.4g 	Glycine 
200mL 	Methanol (Sigma) 
Combine reagents in a fume cabinet and make up to 1L with 800mL of Milli-Q8 water. 
Store at room temperature. 
Tris buffered saline (TBS) 
4.84g 	Tris base 
58.4g 	NaC1 
1.5L 	Milli-QC) 
Adjust to pH 7.5 with 10M HC1 and make up to 2L with Milli-QC) water. 
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Tris buffered saline with Tween (TTBS) 
1.1L 	TBS 
55011L 	Tween-20 (Bio-Rad) 
TTBS/5%FCS/5`)/0 skim milk powder 
100mL 	TTBS 
5mL 	FCS (Gibco) 
5g 	skim milk powder 
Store at 4°C for a limited time. 
12% Separating gel 
3.35mL 	Milli-Q® water 
2.5mL 	1.5M Tris-HC1, pH 8.8 
100[iL 	10% SDS 
4mL 	Bis/Acrylamide 
Add quickly immediately prior to pouring 
504 	10% APS (Bio-Rad) 
5[IL 	TEMED (Bio-Rad) 
Combine ingredients in the listed order and pour gel immediately. Allow to polymerise 
for 45 minutes. 
7.5% Separating gel 
4.85mL 	Milli-Q® water 
2.5mL 	1.5M Tris-HC1, pH 8.8 
100[IL 	10% SDS 
2.5mL 	Bis/Acrylamide 
Add quickly immediately prior to pouring 
50[AL 	10% APS 
TEMED 
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Combine ingredients in the listed order and pour gel immediately. Allow to polymerise 
for 45 minutes. 
4% Stacking gel 
6.1mL 	Milli-QC) water 
2.5mL 	0.5M Tris-HC1, pH 6.8 
1004 	10% SDS 
1.33mL 	Bis/Acrylamide 
50[AL 	10% APS 
1011L 	TEMED 
Coomassie stain 
lg 	Coomassie blue R-250 (Bio-Rad) 
40mL 	methanol, 10% 
10mL 	acetic acid (Spectrum) 
Coomassie destain 
40mL 	methanol, 10% 
10mL 	acetic acid 
50mL 	Milli-QC) water 
2X Sample buffer 
2.5mL 	0.5M Tris HC1 pH6.8 
2mL 	glycerol (Sigma) 
200RL 	2-13 mercaptoethanol (Serva) 
2mL 	10% SDS (in water) 
Make up to 10mL with Milli-QC) water, add a small amount of bromophenol blue, 
aliquot and freeze 
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PLASMID DNA PREPARATION SOLUTIONS 
NZY + Broth 
lOg 	casein hydrosolate (NZ amine) (Oxoid) 
5g 	yeast extract (Oxoid) 
5g 	NaC1 
Adjust to pH 7.5 with NaOH and autoclave 
Add the following supplements before use: 
12.5mL 	1M MgC12 (Sigma) 
12.5mL 	M MgSO4 (Sigma) 
10mL 	2M filter sterilised glucose solution or 20mL of 20% (w/v) glucose 
Filter sterilise 
LB medium and plates 
475mL 	Milli Q water 
5g 	Bacto-tryptone (Oxoid) 
2.5g 	Bacto-yeast extract (Oxoid) 
5g 	NaCl 
7.5g 	Bacto-agar (for plates only) (Oxoid) 
Shake until dissolved and adjust pH to 7.0 with 5N NaOH, make volume of solution to 
500m1. Autoclave and allow media to cool to before adding antibiotics at 301.ig per mL. 
Antibiotics 
Kanamycin (10mg/mL) and Ampicillin/Carbenicillin (50mg/mL) are used at a final 
concentration of 3011g/mL. 
50X TAE 
242g 	Tris Base 
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57.1mL 	glacial acetic acid 
100mL 	0.5M EDTA pH8.0 (BDH) 
Make up to 1L with Milli-QC) water 
0.8% Agarose Gel 
0.4g 	Agarose (Invitrogen) 
lmL 	50x TAE 
50mL 	Milli-Q0 water 
Microwave for two minutes. Add 20 of Ethidium Bromide swirl, pour. Run gel in 
TAE. 
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